<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29311971</article-id>
<article-id pub-id-type="pmc">5735950</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2017.01038</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Update on 13 Syndromes Affecting Craniofacial and Dental Structures</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bartzela</surname>
<given-names>Theodosia N.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/440734/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carels</surname>
<given-names>Carine</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/408894/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maltha</surname>
<given-names>Jaap C.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/504830/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Orthodontics, Dentofacial Orthopedics and Pedodontics, Charité—Universitätsmedizin</institution>, <addr-line>Berlin</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Orthodontics, Aristotle University of Thessaloniki</institution>, <addr-line>Thessaloniki</addr-line>, <country>Greece</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Oral Health Sciences, KU Leuven</institution>, <addr-line>Leuven</addr-line>, <country>Belgium</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Orthodontics and Craniofacial Biology, Radboud University Medical Center</institution>, <addr-line>Nijmegen</addr-line>, <country>Netherlands</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Agnes Bloch-Zupan, Université de Strasbourg, France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Joan Therese Richtsmeier, Pennsylvania State University, United States; David Clouthier, University of Colorado Anschutz Medical Campus, United States</p>
</fn>
<corresp id="fn001">*Correspondence: Theodosia N. Bartzela <email xlink:type="simple">theodosia.bartzela@charite.de</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Craniofacial Biology and Dental Research, a section of the journal Frontiers in Physiology</p>
</fn>
<fn fn-type="other" id="fn003">
<p>†These authors have contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>1038</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Bartzela, Carels and Maltha.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Bartzela, Carels and Maltha</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Care of individuals with syndromes affecting craniofacial and dental structures are mostly treated by an interdisciplinary team from early childhood on. In addition to medical and dental specialists that have a vivid interest in these syndromes and for whom these syndromes are of evident interest, experts of scientific background—like molecular and developmental geneticists, but also computational biologists and bioinformaticians—, become more frequently involved in the refined diagnostic and etiological processes of these patients. Early diagnosis is often crucial for the effective treatment of functional and developmental aspects. However, not all syndromes can be clinically identified early, especially in cases of absence of known family history. Moreover, the treatment of these patients is often complicated because of insufficient medical knowledge, and because of the dental and craniofacial developmental variations. The role of the team is crucial for the prevention, proper function, and craniofacial development which is often combined with orthognathic surgery. Although the existing literature does not provide considerable insight into this topic, this descriptive review aims to provide tools for the interdisciplinary team by giving an update on the genetics and general features, and the oral and craniofacial manifestations for early diagnosis. Clinical phenotyping together with genetic data and pathway information will ultimately pave the way for preventive strategies and therapeutic options in the future. This will improve the prognosis for better functional and aesthetic outcome for these patients and lead to a better quality of life, not only for the patients themselves but also for their families. The aim of this review is to promote interdisciplinary interaction and mutual understanding among all specialists involved in the diagnosis and therapeutic guidance of patients with these syndromal conditions in order to provide optimal personalized care in an integrated approach.</p>
</abstract>
<kwd-group>
<kwd>syndromes</kwd>
<kwd>oral manifestations</kwd>
<kwd>dental dysmorphologies</kwd>
<kwd>craniofacial characteristics</kwd>
<kwd>genetics</kwd>
</kwd-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="247"></ref-count>
<page-count count="25"></page-count>
<word-count count="20500"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>There is a wide spectrum of syndromes that include dental, oral, and craniofacial abnormalities. The range of these disorders encompasses over 1/3 of all congenital malformations (Twigg and Wilkie, <xref ref-type="bibr" rid="B217">2015</xref>). Ideally, interdisciplinary teams in which medical and dental specialists collaborate are treating patients with these syndromes. Medical specialists like pediatricians and geneticists focus on general health issues related to diagnosis and prognosis of the condition, having a holistic view of the patient, while maxillofacial surgeons deal with (major) facial corrections. Dental specialists like pediatric dentists and orthodontists primarily work with caries prevention, diagnosis, and treatment of structural tooth abnormalities, tooth size-shape discrepancies, deviations in tooth number and treatment of malocclusions or facial growth disturbances.</p>
<p>Contrary to the general and genetic diagnosis, most dental abnormalities can only be identified after the first years of life. This delays the dental and orofacial components of the syndromic diagnosis, which are, however, vital for the evaluation of prognostic factors and for the proper timing and management of oral function and, aesthetics as well as for social aspects. On the other hand, early genetic testing, leading to a molecular genetic diagnosis, can be crucial to establish an optimal (therapeutic) strategy, with the ultimate goal to improve the quality of life for these patients.</p>
<p>In addition to the traditional specialists, specialists with a more basic research profile in molecular life sciences become more frequently involved in refined genomics diagnostic processes; moreover the therapeutic planning is expected to further evolve toward the direction of precision medicine aided by pharmacogenomics approaches, with familial transgenerational counseling and personalized preventive strategies ahead. Here, we therefore also provide an update on the advances in the genetic etiology, in genotype-phenotype relations and eventual therapeutic strategies for 13 selected rare syndromes with emphasis on the associated dental and orofacial features. Specifically for the advances in genetic etiology, this update also aims to summarize the Super-Pathways where the causal genetic products operate, as well as their terms for Human Phenotype Ontology (HPO) and Gene Ontology (GO) on locations, molecular functions, and biological processes involved.</p>
<p>Overall, our primary aim with this review is to promote interdisciplinary interaction and mutual understanding among all specialties involved in the diagnosis and therapeutic guidance of patients presenting these syndromes, in order to provide personalized care in an integrated approach.</p>
</sec>
<sec id="s2">
<title>Method</title>
<p>For this descriptive review, we selected 13 syndromes based on a combination of criteria:
<list list-type="order"><list-item><p>Supportive evidence (in literature or online databases; e.g., OMIM) for presence of associated facial, oral, and/or dental conditions.</p></list-item><list-item><p>Prevalence of the disorders around 1/100,000 of the population or higher.</p></list-item><list-item><p>Evidence on genomic locus/loci association or causal gene.</p></list-item></list></p>
<p>Furthermore, we excluded syndromes with a predominant cranial component (e.g., like craniosynostosis syndromes), or syndromal conditions on which a review was recently published (like orofacial clefts with tooth agenesis; Phan et al., <xref ref-type="bibr" rid="B157">2016</xref>).</p>
<p>We adopted the following categories of syndromes involving gingivodental tissues (I), branchial arches (II), orofacial clefts (III), and unusual faces (IV).</p>
<p>In each section, we provide a paragraph with genetics and general features (including potential etiological mechanisms, and potential novel therapeutic considerations), craniofacial features, and oral and dental features. Furthermore, we summarize highly ranked molecular pathways in which the respective causal gene products are reported to be active, as well as the Human Phenotype Ontology (HPO) terms for each of the syndromes/conditions (Table <xref ref-type="table" rid="T1">1A</xref>). Moreover, Gene Ontology (GO) terms for localization, molecular function, and biological functions of the genes known to underlie the 13 selected orofacial syndromes, are listed in Table <xref ref-type="table" rid="T2">1B</xref>. Additional information for each of the conditions is available in Table <xref ref-type="supplementary-material" rid="SM1">S1</xref> and includes the names and aliases of the genes and disorders, their MIM and ORPHA numbers, the type of inheritance and the estimated prevalence. Table <xref ref-type="table" rid="T3">2</xref> provides syndromes that did not fulfill the three criteria to be included in this review.</p>
<table-wrap id="T1" position="float">
<label>Table 1A</label>
<caption>
<p>Genes, Genomic Locations, prioritized (Super) Pathways, and Human Phenotype Ontology (HPO) terms (original citation: current source: <ext-link ext-link-type="uri" xlink:href="http://pathcards.genecards.org/Search/Results?query=gene">http://pathcards.genecards.org/Search/Results?query=gene</ext-link>) for each of the 13 selected syndromes (with 21 entities).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Category/Syndrome</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Chrom locus</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene(s)</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>SuperPathways</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Human Phenotype Ontology (HPO) terms</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>I. SYNDROME INVOLVING GINGIVODENTAL TISSUES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurofibromatosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">17q11</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Signaling by PTK6</p></list-item><list-item><p>G-protein signaling M-RAS regulation pathway</p></list-item><list-item><p>Syndecan-2-mediated signaling events (3 of 25 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0009023 Abdominal wall muscle weakness<break></break>HP:0001626 Abn. of the cardiovascular system<break></break>HP:0011039 Abn. of the helix<break></break>HP:0100763 Abn. of the lymphatic system<break></break>HP:0000765 Abn. of the thorax</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>II. SYNDROMES INVOLVING BRANCHIAL ARCHES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hemifacial microsomia</td>
<td align="left" colspan="1" rowspan="1" valign="top">14q32</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OTX2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers</p></list-item><list-item><p>Dopaminergic Neurogenesis</p></list-item><list-item><p>Mesodermal Commitment Pathway</p></list-item><list-item><p>TP53 Network</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0040086 Abn. prolactin level<break></break>HP:0030680 Abn. of cardiovascular system morphology<break></break>HP:0009888 Abn. of secondary sexual hair<break></break>HP:0001291 Abn. of the cranial nerves<break></break>HP:0008187 Absence of secondary sex characteristics</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">3q29</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ATP13A3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">3q29</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>XXYLT1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">20q13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MYT1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Cyclins and Cell Cycle Regulation</p></list-item><list-item><p>Mitotic Roles of Polo Like Kinases</p></list-item><list-item><p>Mitotic G1-G1/S phases</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">13 assoc loci</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>ROBO1, GATA3, GBX2, FGF3, NRP2, EDNRB, SHROOM3, SEMA7A, PLCD3, KLF12 &amp; EPAS1</italic> (important genes in these loci)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Neural crest cell (NCC) development and</p></list-item><list-item><p>Vasculogenesis</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Treacher Collins syndrome (TCS1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">5q32</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TCOF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Ribosome biogenesis in eukaryotes (only 1 superpathway)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0004348 Abn. of bone mineral density<break></break>HP:0030680 Abn. of cardiovascular system morphology<break></break>HP:0000682 Abn. of dental enamel<break></break>HP:0006482 Abn. of dental morphology</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Treacher Collins syndrome (TCS2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">13q12.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>POLR1D</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Assembly of RNA Polymerase-I Initiation Complex</p></list-item><list-item><p>Inhibition of Ribosome Biogenesis by p14(ARF)</p></list-item><list-item><p>RNA Polymerase I Promoter Escape (3 of 14 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0004348 Abn. of bone mineral density<break></break>HP:0000682 Abn. of dental enamel<break></break>HP:0006482 Abn. of dental morphology<break></break>HP:0000834 Abn. of the adrenal glands<break></break>HP:0000925 Abn. of the vertebral column</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Treacher Collins syndrome (TCS3)</td>
<td align="left" colspan="1" rowspan="1" valign="top">6p21.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>POLR1C</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Assembly of RNA Polymerase-I Initiation Complex</p></list-item><list-item><p>Inhibition of Ribosome Biogenesis by p14(ARF)</p></list-item><list-item><p>RNA Polymerase I Promoter Escape (3 of 13 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0004348 Abn. of bone mineral density<break></break>HP:0000682 Abn. of dental enamel<break></break>HP:0006482 Abn. of dental morphology<break></break>HP:0000834 Abn. of the adrenal glands<break></break>HP:0000356 Abn. of the outer ear</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Möbius syndr (MBS1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">13q12.2-q13</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MBS2</td>
<td align="left" colspan="1" rowspan="1" valign="top">3q21-q22</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MBS3</td>
<td align="left" colspan="1" rowspan="1" valign="top">10q21</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MBS4</td>
<td align="left" colspan="1" rowspan="1" valign="top">1p22.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>III. SYNDROMES INVOLVING OROFACIAL CLEFTS</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Velocardiofacial syndrome (VCFS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2 (del syndr)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TBX1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>FTO Obesity variant mechanism</p></list-item><list-item><p>Heart Development</p></list-item><list-item><p>Mesodermal Commitment Pathway (3 of 3 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0002101 Abn. lung lobation<break></break>HP:0000682 Abn. of dental enamel<break></break>HP:0010978 Abn. of immune system physiology<break></break>HP:0001939 Abn. of metabolism/homeostasis<break></break>HP:0012303 Abn. of the aortic arch</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Ectodermal dysplasia, Ectrodactyly, Cleft syndrome (EEC3)</td>
<td align="left" colspan="1" rowspan="1" valign="top">3q28</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TP63</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Hypothetical craniofacial development pathway</p></list-item><list-item><p>TP53 Network</p></list-item><list-item><p>TP53 Regulates Transcription of Cell Death Genes (3 of 14 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0004691 2-3 toe syndactyly<break></break>HP:0000682 Abn. of dental enamel<break></break>HP:0006482 Abn. of dental morphology<break></break>HP:0004378 Abn. of the anus<break></break>HP:0000056 Abn. of the clitoris</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Kabuki syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">12q13</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KMT2D</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Deactivation of the beta-catenin transactivating complex</p></list-item><list-item><p>Lysine degradation</p></list-item><list-item><p>PKMTs methylate histone lysines (3 of 8 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0007477 Abn. Dermatoglyphics<break></break>HP:0001671 Abn. of the cardiac septa<break></break>HP:0000164 Abn. of the teeth<break></break>HP:0003468 Abn. of the vertebrae<break></break>HP:0002023 Anal atresia</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Xp12</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KDM6A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Pathways Affected in Adenoid Cystic Carcinoma</p></list-item><list-item><p>Chromatin Regulation/Acetylation</p></list-item><list-item><p>Transcriptional misregulation in cancer (3 of 7 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0007477 Abn dermatoglyphics;<break></break>HP:0000769 Abn. of the breast;<break></break>HP:0001671 Abn. of the cardiac septa<break></break>HP:0000164 Abn. of the teeth</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Kallmann syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xp22.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ANOS1 (&amp;PROKR2)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Negative regulation of FGFR1 signaling</p></list-item><list-item><p>Signaling by FGFR2</p></list-item><list-item><p>Signaling by GPCR (3 of 3 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0000002 Abn. of body height<break></break>HP:0030680 Abn. of the cardiovascular system morphology<break></break>HP: 0000551 Abn. of color vision<break></break>HP:0000164 Abn. of the teeth</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">10q26.13</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FGFR2(&amp;FGF8, &amp;GNRHR)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Signaling by FGFR2</p></list-item><list-item><p>Signaling by FGFR2 fusions</p></list-item><list-item><p>Downstream signaling of activated FGFR2 (3 of 55 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0001233 2-3 finger syndactyly<break></break>HP:0004691 2-3 toe syndactyly<break></break>HP:0001999 Abn. facial shape<break></break>HP:0003312 Abn. form of the vertebral bodies<break></break>HP:0001627 Abn. heart morphology</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Pierre Robin sequence</td>
<td align="left" colspan="1" rowspan="1" valign="top">17q24.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOX9</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Deactivation of the beta-catenin transactivating complex</p></list-item><list-item><p>Neural Stem Cell Diff. Pathways and Lineage-specific markers</p></list-item><list-item><p>Endochondral ossification (3 of 11 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0001627 Abn heart<break></break>HP:0012856 Abn. scrotal rugation<break></break>HP:0012244 Abn. sex determination<break></break>HP:0030680 Abn. of cardiovascular system morphology</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">van der Woude syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">1q32.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IRF6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Hypothetical Craniofacial Development Pathway</p></list-item><list-item><p>NF-kB (NFkB) Pathway</p></list-item><list-item><p>Primary Focal Segmental Glomerulosclerosis FSGS (3 of 11 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0001597 Abnormality of the nail<break></break>HP:0000772 Abnormality of the ribs<break></break>HP:0010286 Abnormality of the salivary glands</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">1p36.11</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRHL3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0010286 Abnormality of the salivary glands<break></break>HP:0000674 Anodontia<break></break>HP:0000175 Cleft palate<break></break>HP:0000204 Cleft upper lip<break></break>HP:0009755 Ankyloblepharon</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>IV. SYNDROMES INVOLVING UNUSUAL FACES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Coffin-Lowry syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xp22.12</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RSK2/RPS6KA3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0000940 Abn. diaphysis morphology;<break></break>HP:0003312 Abn. form of the vertebral bodies;<break></break>HP:0006482 Abn. of dental morphology;<break></break>HP:0002269 Abn. of neuronal migration;<break></break>HP:0007703 Abn. of retinal pigmentation</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Opitz GBBB syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xp22.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MID1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Import of palmitoyl-CoA into the mitochondrial matrix</p></list-item><list-item><p>Ubiquitin mediated proteolysis</p></list-item><list-item><p>Interferon gamma signaling (3 of 7 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0001627 Abn. heart morphology<break></break>HP:0001739 Abn. of the nasopharynx<break></break>HP:0001274 Agenesis of corpus callosum<break></break>HP:0002023 Anal atresia</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.23</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SPECC1L</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0011039 Abnormality of the helix<break></break>HP:0000077 Abnormality of the kidney<break></break>HP:0000924 Abnormality of the skeletal system<break></break>HP:0000069 Abnormality of the ureter</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Smith-Lemli-Opitz syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">11q13.4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DHCR7</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="order"><list-item><p>Cholesterol biosynthesis I</p></list-item><list-item><p>Metabolism</p></list-item><list-item><p>Terpenoid backbone biosynthesis</p></list-item><list-item><p>Vitamin D (4 of 5 superpathways)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">HP:0004691 2-3 toe syndactyly<break></break>HP:0007477 Abnormal dermatoglyphics<break></break>HP:0003312 Abnormal form of the vertebral bodies<break></break>HP:0100542 Abnormal localization of kidney<break></break>HP:0002101 Abnormal lung lobation</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Abn., Abnormal; Abnormality</italic>.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 1B</label>
<caption>
<p>Genes, Genomic Locations, and Ontology (GO) terms for location, molecular function, and biological processes (original citation: Ashburner et al., <xref ref-type="bibr" rid="B12">2000</xref>; current source: <ext-link ext-link-type="uri" xlink:href="http://pathcards.genecards.org/Search/Results?query=gene">http://pathcards.genecards.org/Search/Results?query=gene</ext-link>) for the 13 selected syndromes (21 different entities).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Syndrome/Condition</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Chromosome locus</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene(s)</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene Ontology (GO) terms for location</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>GO terms or molecular function</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>GO terms for biological process</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="6" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>I. SYNDROME INVOLVING GINGIVODENTAL TISSUES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurofibromatosis type 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">17q11</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005730 nucleolus<break></break>GO:0005737 cytoplasm<break></break>GO:0005829 cytosol<break></break>GO:0016020 membrane</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005096 GTPase activator activity<break></break>GO:0005515 protein binding<break></break>GO:0008289 lipid binding<break></break>GO:0008429 phosphatidylethanolamine binding<break></break>GO:0031210 phosphatidylcholine binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000165 MAPK cascade<break></break>GO:0001649 osteoblast differentiation<break></break>GO:0001656 metanephros development<break></break>GO:0001666 response to hypoxia<break></break>GO:0001889 liver development</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>II. SYNDROMES INVOLVING BRANCHIAL ARCHES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hemifacial microsomia</td>
<td align="left" colspan="1" rowspan="1" valign="top">14q32</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>OTX2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0030426 growth cone<break></break>GO:0043234 protein complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000978 RNA pol II core promoter proximal region seq-specific DNA binding<break></break>GO:0001077 transcript activator activity, RNA pol II core promoter proximal region seq-specific binding<break></break>GO:0003677 DNA binding<break></break>GO:0003700 transcription factor activity, sequence-specific DNA binding<break></break>GO:0005515 protein binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0006355 regulation of transcription, DNA-templated<break></break>GO:0006366 transcription from RNA polymerase II promoter<break></break>GO:0006461 protein complex assembly<break></break>GO:0007275 multicellular organism development<break></break>GO:0007411 axon guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">3q29</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ATP13A3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005887 integral component of plasma membrane<break></break>GO:0016020 membrane<break></break>GO:0016021 integral component of membrane<break></break>GO:0043231 intracellular membrane-bounded organelle</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005388 calcium-transporting ATPase activity<break></break>GO:0005524 ATP binding<break></break>GO:0016787 hydrolase activity<break></break>GO:0016887 ATPase activity<break></break>GO:0046872 metal ion binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0006812 cation transport<break></break>GO:0006874 cellular calcium ion homeostasis<break></break>GO:0070588 calcium ion transmembrane transport<break></break>GO:0099132 ATP hydrolysis coupled cation transmembrane transport</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">3q29</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>XXYLT1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005783 endoplasmic reticulum<break></break>GO:0005789 endoplasmic reticulum membrane<break></break>GO:0016020 membrane<break></break>GO:0016021 integral component of membrane<break></break>GO:0030176 integral comp of endoplasmic reticulum membrane</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000287 magnesium ion binding<break></break>GO:0016740 transferase activity<break></break>GO:0016757 transferase activity, transferring glycosyl groups<break></break>GO:0030145 manganese ion binding<break></break>GO:0035252 UDP-xylosyltransferase activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0016266 O-glycan processing</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">20q13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MYT1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm<break></break>GO:0005829 cytosol</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0003677 DNA binding<break></break>GO:0003700 transcription factor activity, sequence-specific DNA binding<break></break>GO:0008270 zinc ion binding<break></break>GO:0046872 metal ion binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0006351 transcription, DNA-templated<break></break>GO:0006355 regulation of transcription, DNA-templated<break></break>GO:0007275 multicellular organism development<break></break>GO:0007399 nervous system development<break></break>GO:0030154 cell differentiation</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Treacher Collins syndrome (TCS1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">5q32</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TCOF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001650 fibrillar center<break></break>GO:0005634 nucleus<break></break>GO:0005730 nucleolus<break></break>GO:0005829 cytosol</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001042 RNA polymerase I core binding<break></break>GO:0003723 RNA binding<break></break>GO:0005215 transporter activity<break></break>GO:0005515 protein binding<break></break>GO:0046982 protein heterodimerization activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001501 skeletal system development<break></break>GO:0006417 regulation of translation<break></break>GO:0006810 transport<break></break>GO:0014029 neural crest formation<break></break>GO:0014032 neural crest cell development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Treacher Collins syndrome (TCS2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">13q12.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>POLR1D</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm<break></break>GO:0005666 DNA-directed RNA polymerase III complex<break></break>GO:0005736 DNA-directed RNA polymerase I complex<break></break>GO:0005829 cytosol</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001054 contributes to RNA polymerase I activity<break></break>GO:0001056 contributes to RNA polymerase III activity<break></break>GO:0003677 DNA binding<break></break>GO:0003899 DNA-directed 5-3 RNA polymerase activity<break></break>GO:0005515 protein binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0006351 transcription, DNA-templated<break></break>GO:0006361 transcription initiation from RNA pol I promoter<break></break>GO:0006362 transcript elongation from RNA pol I promoter<break></break>GO:0006363 termination of RNA pol I transcription<break></break>GO:0006383 transcription from RNA pol III promoter</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Treacher Collins syndrome (TCS3)</td>
<td align="left" colspan="1" rowspan="1" valign="top">6p21.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>POLR1C</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm<break></break>GO:0005666 DNA-directed RNA polymerase III complex<break></break>GO:0005736 DNA-directed RNA polymerase I complex<break></break>GO:0005829 cytosol</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001054 contributes to RNA polymerase I activity<break></break>GO:0001056 contributes to RNA polymerase III activity<break></break>GO:0003677 DNA binding<break></break>GO:0003899 DNA-directed 5-3 RNA polymerase activity<break></break>GO:0005515 protein binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0006351 transcription, DNA-templated<break></break>GO:0006361 transcription initiation from RNA pol I promoter<break></break>GO:0006362 transcript elongation from RNA pol I prom<break></break>GO:0006363 termination of RNA pol I transcription<break></break>GO:0006383 transcription from RNA pol III promoter</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Möbius syndrome (MBS1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">13q12.2-q13</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MBS2</td>
<td align="left" colspan="1" rowspan="1" valign="top">3q21-q22</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MBS3</td>
<td align="left" colspan="1" rowspan="1" valign="top">10q21</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MBS4</td>
<td align="left" colspan="1" rowspan="1" valign="top">1p22.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>III. SYNDROMES INVOLVING OROFACIAL CLEFTS</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Velocardiofacial syndrome (VCFS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2DS (deletion syndrome)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TBX1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0003677 DNA binding<break></break>GO:0003700 NOT transcription factor activity, sequence-specific DNA binding<break></break>GO:0042803 protein homodimerization activity<break></break>GO:0043565 sequence-specific DNA binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001525 angiogenesis<break></break>GO:0001568 blood vessel development<break></break>GO:0001708 cell fate specification<break></break>GO:0001755 neural crest cell migration<break></break>GO:0001934 positive regulation of protein phosphorylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ectodermal dysplasia, Ectrodactyly, Cleft syndrome (EEC3)</td>
<td align="left" colspan="1" rowspan="1" valign="top">3q28</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TP63</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000790 nuclear chromatin<break></break>GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm<break></break>GO:0005667 transcription factor complex<break></break>GO:0005829 cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000989 transcription factor activity<break></break>GO:0001077 transcriptional activator activity<break></break>GO:0002039 p53 binding<break></break>GO:0003677 DNA binding<break></break>GO:0003682 chromatin binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000122 negative regulation of transcription from RNA pol II promoter<break></break>GO:0001302 replicative cell aging<break></break>GO:0001501 skeletal system development<break></break>GO:0001736 establishment of planar polarity<break></break>GO:0001738 morphogenesis of a polarized epithelium</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kabuki syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">12q13</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KMT2D</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm<break></break>GO:0035097 histone methyltransferase complex<break></break>GO:0044666 MLL3/4 complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0003677 DNA binding<break></break>GO:0005515 protein binding<break></break>GO:0008168 methyltransferase activity<break></break>GO:0008270 zinc ion binding<break></break>GO:0016740 transferase activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001555 oocyte growth<break></break>GO:0006342 chromatin silencing<break></break>GO:0006351 transcription, DNA-templated<break></break>GO:0006355 regulation of transcription, DNA-templated<break></break>GO:0008284 positive regulation of cell proliferation</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">10q26.13</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FGFR2 (&amp;FGF8, &amp;GNRHR)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005576 extracellular region<break></break>GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm<break></break>GO:0005737 cytoplasm<break></break>GO:0005794 Golgi apparatus</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000166 nucleotide binding<break></break>GO:0004672 protein kinase activity<break></break>GO:0004713 protein tyrosine kinase activity<break></break>GO:0004714 transmembrane receptor protein tyrosine kinase activity<break></break>GO:0005007 fibroblast growth factor-activated receptor activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000122 negative regulation of transcription from RNA pol II promoter<break></break>GO:0000165 MAPK cascade<break></break>GO:0001525 angiogenesis<break></break>GO:0001657 ureteric bud development<break></break>GO:0001701 <italic>in utero</italic> embryonic development</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Pierre Robin sequence</td>
<td align="left" colspan="1" rowspan="1" valign="top">17q24.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOX9</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm<break></break>GO:0005667 transcription factor complex<break></break>GO:0043234 protein complex<break></break>GO:0044798 nuclear transcription factor complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000976 transcription regulatory region sequence-specific DNA binding<break></break>GO:0000981 RNA pol II transcription factor activity, sequence-specific DNA binding<break></break>GO:0001046 core promoter sequence-specific DNA binding<break></break>GO:0001077 transcriptional activator activity, RNA pol II core promoter proximal region seq-specific binding<break></break>GO:0001158 enhancer sequence-specific DNA binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001501 skeletal system development<break></break>GO:0001502 cartilage condensation<break></break>GO:0001503 ossification<break></break>GO:0001658 branching involved in ureteric bud morphogenesis<break></break>GO:0001708 cell fate specification</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">van der Woude syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">1q32.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IRF6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005737 cytoplasm<break></break>GO:0005829 cytosol<break></break>GO:0070062 extracellular exosome</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000975 regulatory region DNA binding<break></break>GO:0003677 DNA binding<break></break>GO:0003700 transcription factor activity<break></break>GO:0005515 protein binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0006351 transcription, DNA-templated<break></break>GO:0006355 regulation of transcription, DNA-templated<break></break>GO:0007050 cell cycle arrest<break></break>GO:0008285 negative regulation of cell proliferation<break></break>GO:0030154 cell differentiation</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">1p36.11</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GRHL3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001228 transcriptional activator activity, RNA pol II transcription regulatory region seq-specific binding<break></break>GO:0003677 DNA binding<break></break>GO:0005515 protein binding<break></break>GO:0031490 chromatin DNA binding<break></break>GO:0043565 sequence-specific DNA binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001736 establishment of planar polarity<break></break>GO:0001843 neural tube closure<break></break>GO:0006351 transcription, DNA-templated<break></break>GO:0006355 regulation of transcription, DNA-templated<break></break>GO:0006366 transcription from RNA polymerase II promoter</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>IV. SYNDROMES INVOLVING UNUSUAL FACES</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Coffin-Lowry syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xp22.12</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RSK2/RPS6KA3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005634 nucleus<break></break>GO:0005654 nucleoplasm<break></break>GO:0005737 cytoplasm<break></break>GO:0005829 cytosol</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000287 magnesium ion binding<break></break>GO:0004672 protein kinase activity<break></break>GO:0004674 protein serine/threonine kinase activity<break></break>GO:0005515 protein binding<break></break>GO:0005524 ATP binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001501 skeletal system development<break></break>GO:0002224 toll-like receptor signaling pathway<break></break>GO:0006468 protein phosphorylation<break></break>GO:0006915 apoptotic process<break></break>GO:0007049 cell cycle</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Opitz GBBB syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xp22.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MID1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005622 intracellular<break></break>GO:0005737 cytoplasm<break></break>GO:0005819 spindle<break></break>GO:0005829 cytosol<break></break>GO:0005856 cytoskeleton</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005515 protein binding<break></break>GO:0008017 microtubule binding<break></break>GO:0008270 zinc ion binding<break></break>GO:0016740 transferase activity<break></break>GO:0031625 ubiquitin protein ligase binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0000226 microtubule cytoskeleton organization<break></break>GO:0007026 negative regulation of microtubule depolymerization<break></break>GO:0032874 post regulation of stress-activated MAPK cascade<break></break>GO:0035372 protein localization to microtubule</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.23</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SPECC1L</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005815 microtubule organizing center<break></break>GO:0005819 spindle<break></break>GO:0005829 cytosol<break></break>GO:0005856 cytoskeleton<break></break>GO:0005921 gap junction</td>
<td align="left" colspan="1" rowspan="1" valign="top">/</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0007026 negative regulation of microtubule depolymerization<break></break>GO:0007049 cell cycle<break></break>GO:0007155 cell adhesion<break></break>GO:0016477 cell migration<break></break>GO:0030036 actin cytoskeleton organization</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">Smith-Lemli-Opitz syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">11q13.4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DHCR7</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0005640 nuclear outer membrane<break></break>GO:0005783 endoplasmic reticulum<break></break>GO:0005789 endoplasmic reticulum membrane<break></break>GO:0005829 cytosol</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0009918 sterol delta7 reductase activity<break></break>GO:0016491 oxidoreductase activity<break></break>GO:0016628 oxidoreductase activity, acting on the CH-CH group of donors, NAD, or NADP as acceptor<break></break>GO:0047598 7-dehydrocholesterol reductase activity<break></break>GO:0050661 NADP binding</td>
<td align="left" colspan="1" rowspan="1" valign="top">GO:0001568 blood vessel development<break></break>GO:0006629 lipid metabolic process<break></break>GO:0006694 steroid biosynthetic process<break></break>GO:0006695 cholesterol biosynthetic process<break></break>GO:0008202 steroid metabolic process</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table 2</label>
<caption>
<p>Syndromes affecting craniofacial and dental structures below cut off, as not meeting the three inclusion criteria of this review.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Syndrome</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Prevalence/100,000</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>OMIM ID</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Orpha ID</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cornelia de Lange</td>
<td align="left" colspan="1" rowspan="1" valign="top">1–9</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="300590">300590</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="610759">610759</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="614701">614701</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="300882">300882</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="122470">122470</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">199</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Apert</td>
<td align="left" colspan="1" rowspan="1" valign="top">1–9</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="101200">101200</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">87</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Crouzon</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.1–0.9</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="123500">123500</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="612247">612247</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="101200">101200</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">207</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">10–50</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="190685">190685</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">870</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fetal alcohol</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">1,915</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Holoprosencephaly (non-syndromic)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="142945">142945</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="142946">142946</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="147250">147250</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="157170">157170</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="236100">236100</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="605934">605934</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="609408">609408</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="609637">609637</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="610828">610828</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="610829">610829</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="612530">612530</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="614226">614226</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">2,162</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Marfan</td>
<td align="left" colspan="1" rowspan="1" valign="top">10–50</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="616914">616914</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="154700">154700</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">558</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Silver-Russell</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.1–0.9</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="180860">180860</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="312789">312789</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="616489">616489</ext-link></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Smith-Magenis</td>
<td align="left" colspan="1" rowspan="1" valign="top">1–9</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="182290">182290</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">819</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sotos</td>
<td align="left" colspan="1" rowspan="1" valign="top">1–9</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="617169">617169</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="117550">117550</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">821</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stickler</td>
<td align="left" colspan="1" rowspan="1" valign="top">1–9</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="614134">614134</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="614284">614284</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="184840">184840</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="609508">609508</ext-link>, <ext-link ext-link-type="OMIM" xlink:href="604841">604841</ext-link>,<ext-link ext-link-type="OMIM" xlink:href="108300">108300</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">828</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Turner</td>
<td align="left" colspan="1" rowspan="1" valign="top">10–50 (F)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">881</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Williams</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">#<ext-link ext-link-type="OMIM" xlink:href="194050">194050</ext-link></td>
<td align="center" colspan="1" rowspan="1" valign="top">904</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Prevalence, OMIM ID, Orpha ID are provided. F, females</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec>
<title>Syndromes involving gingivodental tissues</title>
<p>Gingivodental syndromes are characterized by gingival hyperplasia and characteristic dental manifestations.</p>
<sec>
<title>Neurofibromatosis type 1</title>
<sec>
<title>Genetics and general features</title>
<p>Neurofibromatosis type 1 (NF1) is a tumor predisposing syndrome which is clinically heterogeneous. It is caused by heterozygous mutations in the neurofibromin gene (<italic>NF1</italic>) on chromosome 17q11 (OMIM # <ext-link ext-link-type="OMIM" xlink:href="162200">162200</ext-link>). The incidence is 1 in 2,000–3,000 live births (Uusitalo et al., <xref ref-type="bibr" rid="B218">2015</xref>) and until recently only two genotype-phenotype (G-P) correlations had been identified. The first G-P correlation is the association of <italic>NF1</italic> missense mutations with spinal NF1 and the second one is an association between missense mutations in <italic>NF1</italic> affecting codon p.Arg1809 without externally visible plexiform neurofibromas or cutaneous neurofibromas (Pinna et al., <xref ref-type="bibr" rid="B158">2015</xref>). Neurofibromas are benign tumors which may also occur along nerves and in the proximity of the spinal cord, and in some cases cancerous tumors may develop (Garcia-Romero et al., <xref ref-type="bibr" rid="B69">2015</xref>). In a recent review, a third genotype-phenotype correlation was identified (Kehrer-Sawatzki et al., <xref ref-type="bibr" rid="B95">2017</xref>). This study shows that the recurrent mutations of <italic>NF1</italic> are (micro) deletions comprising the <italic>NF1</italic> gene (with its 57 constitutive and 3 alternatively spliced exons) and its flanking regions. The majority of these deletions encompass 1.4-Mb associated with the loss of 14 protein-coding genes and four microRNA genes, and are correlated with the most severe phenotype of the NF1 spectrum. This not only includes its hallmark features—i.e., café-au-lait spots, iris Lisch nodules, and multiple neurofibromas that are mainly l on or just underneath the skin—but also facial dysmorphologies (see Table <xref ref-type="supplementary-material" rid="SM1">S1</xref> in Kehrer-Sawatzki et al., <xref ref-type="bibr" rid="B95">2017</xref>). The clinical features are highly variable and may include hypertension, and skeletal abnormalities such as scoliosis (Ruggieri and Huson, <xref ref-type="bibr" rid="B180">2001</xref>; Garcia-Romero et al., <xref ref-type="bibr" rid="B69">2015</xref>).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Patients affected with NF1 commonly show macrocephaly, a short mandible, maxilla, cranial base, and low face height (Heerva et al., <xref ref-type="bibr" rid="B82">2011</xref>; Cung et al., <xref ref-type="bibr" rid="B44">2015</xref>). In approximately 20% of the patients, an enlargement of the mandibular canal has been described (Visnapuu et al., <xref ref-type="bibr" rid="B229">2012</xref>).</p>
<p>The prevalence of Class III molar relationship is increased and in sagittal aspect, a marked antegonial notch can be observed in the posterior border of the mandibular ramus, as well as an increased length of the coronoid process and hypoplastic condyles and zygomatic processes (Remberger et al., <xref ref-type="bibr" rid="B170">1985</xref>; Scarano et al., <xref ref-type="bibr" rid="B186">2005</xref>; Bardellini et al., <xref ref-type="bibr" rid="B15">2011</xref>; Javed et al., <xref ref-type="bibr" rid="B92">2014</xref>). Comparing the facial dysmorphology of a NF1 reference group with the patients showing the most severe NF1 phenotype (i.e., with type-1 <italic>NF1</italic> deletions; see previous paragraph), clearly lower frequencies of facial dysmorphology (like asymmetries and hypertelorisms) were observed in the whole NF1 reference group (6–8%) vs. the <italic>NF1</italic> deletions group (28%; see Table 1 in Kehrer-Sawatzki et al., <xref ref-type="bibr" rid="B95">2017</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>Intra-orally, patients with NF1 usually show unilateral swelling of the gingiva. This may manifest with diffuse enlargements of the attached, and—in some cases—the interproximal gingiva (Javed et al., <xref ref-type="bibr" rid="B92">2014</xref>). These swellings are caused by the plexiform neurofibromas consisting of hypertrophic nerves (Doufexi et al., <xref ref-type="bibr" rid="B59">2005</xref>; Mahajan et al., <xref ref-type="bibr" rid="B126">2010</xref>). Neurofibromas may also be present in other regions of the oral cavity (Sigillo et al., <xref ref-type="bibr" rid="B195">2002</xref>; Scarano et al., <xref ref-type="bibr" rid="B186">2005</xref>). In rare cases, melanin pigmentation of the gingiva is seen.</p>
<p>The timing of the dental development is not different from controls (Jaasaari et al., <xref ref-type="bibr" rid="B89">2012</xref>), but the dental phenotype often comprises impacted, supernumerary, missing, or displaced teeth, and in some cases periapical cementum dysplasia is apparent (Friedrich et al., <xref ref-type="bibr" rid="B65">2012</xref>; Visnapuu et al., <xref ref-type="bibr" rid="B229">2012</xref>). Although the size of the tooth crowns is normal, spacing is often observed (Friedrich et al., <xref ref-type="bibr" rid="B65">2012</xref>).</p>
</sec>
</sec>
</sec>
<sec>
<title>Syndromes involving branchial arches</title>
<p>Branchial arch syndromes affect the first and second branchial arch derivatives, and therefore lead to craniofacial deformities (Alfi et al., <xref ref-type="bibr" rid="B5">2014</xref>). The most frequent syndromes in this category are: Hemifacial Microsomia (HFM), Treacher-Collins (TCS) (subdivided in 3 types), and Möbius Syndrome (MBS).</p>
<sec>
<title>Hemifacial microsomia</title>
<sec>
<title>Genetics and general features</title>
<p>Hemifacial Microsomia (HFM) is the most frequent craniofacial condition after cleft lip palate (CLP) and affects 1 in 4,000–5,600 live births (Akram et al., <xref ref-type="bibr" rid="B3">2015</xref>). HFM has many aliases, including Goldenhar syndrome, Oculo-auriculo-vertebral (OAV) spectrum (OAVS) or OAV dysplasia, or Facio-auriculo-vertebral (FAV) sequence. Although it can be inherited in an autosomal dominant (AD) way, most cases are sporadic. Familial cases have been reported, but discordances in monozygotic twins are also present (Akram et al., <xref ref-type="bibr" rid="B3">2015</xref>). Recent findings highlight the genetic heterogeneity of OAVS/HFM (Ballesta-Martínez et al., <xref ref-type="bibr" rid="B14">2013</xref>; Beleza-Meireles et al., <xref ref-type="bibr" rid="B16">2015</xref>; Guida et al., <xref ref-type="bibr" rid="B79">2015</xref>; Zhang et al., <xref ref-type="bibr" rid="B245">2016</xref>; Berenguer et al., <xref ref-type="bibr" rid="B18">2017</xref>). Ballesta-Martínez et al. (<xref ref-type="bibr" rid="B14">2013</xref>) described a family with autosomal dominant inheritance of OAVS, and detected a 14q23.1 duplication of 1.34 Mb segregating with the phenotype. This region contains the <italic>OTX2</italic> (Orthodenticle Homeobox 2) gene, encoding a member of the bicoid subfamily of homeodomain-containing transcription factors, which is involved in craniofacial, forebrain, and sensory organ (eyes and ears) development. Therefore, the authors suggested <italic>OTX2</italic> was a good candidate gene for OAVS. Zielinski et al. (<xref ref-type="bibr" rid="B246">2014</xref>) failed to identify a pathogenic coding point mutation using whole-exome sequencing in the affected members of a big family. When performing a genome-wide survey of segmental variations they revealed a 1.3 Mb duplication at chromosome 14q22.3 in all affected individuals, that was not present in more than 1,000 chromosomes of ethnically matched controls. Consistent with the heterogeneity of the disorder, they did not identify this duplication in seven additional sporadic HFM cases. When signatures of human craniofacial disease networks, mouse expression data, and predictions of dosage sensitivity were analyzed, they suggested <italic>OTX2</italic> as the most likely causal gene (Zielinski et al., <xref ref-type="bibr" rid="B246">2014</xref>). The fact that OTX2 is also known as an oncogenic driver in medulloblastoma, a condition that was diagnosed in the proband of the family during the course of the study. The authors suggested a role for OTX2 dosage sensitivity in human craniofacial development and raised the possibility of a shared etiology between a subtype of HFM and medulloblastoma (Zielinski et al., <xref ref-type="bibr" rid="B246">2014</xref>). Beleza-Meireles et al. (<xref ref-type="bibr" rid="B16">2015</xref>) performed deep phenotyping in 51 patients with OAVS and their parents, and comparative genomic hybridization microarrays to identify potential causative loci. In 10 out of 22 index patients screened, 22q11 dosage anomalies were identified in the array-CGH analysis. They suspected that the 22q11 locus (genes or regulatory components) may be associated with symmetric craniofacial appearance, but their findings in OAVS patients suggest that many factors or even not-identified genes rather contribute to the pathogenesis of the syndrome. In 31% of the patients was a family history of OAVS. Ocular, vertebral, heart, neural, renal, brain (associated often with intellectual disability), limb, urogenital, and/or other organ abnormalities were less common (Gorlin et al., <xref ref-type="bibr" rid="B78">1963</xref>; Akram et al., <xref ref-type="bibr" rid="B3">2015</xref>; Beleza-Meireles et al., <xref ref-type="bibr" rid="B16">2015</xref>).</p>
<p>A <italic>de novo</italic> microduplication spanning 723 Kb on chromosome 3q29 was identified to be associated with HFM (Guida et al., <xref ref-type="bibr" rid="B79">2015</xref>); in the microduplicated region 9 genes were mapped, including <italic>ATP13A3</italic> and <italic>XXYLT1</italic> which are respectively known for their role in organogenesis and in Notch pathway regulation. Zhang et al. (<xref ref-type="bibr" rid="B245">2016</xref>) identified eight significantly associated loci and 5 suggestive loci with craniofacial microsomia (CFM). These 13 associated loci, harbored by genes like <italic>ROBO1, GATA3, GBX2, FGF3, NRP2, EDNRB, SHROOM3, SEMA7A, PLCD3, KLF12</italic>, and <italic>EPAS1</italic>, were found to be enriched for genes involved in neural crest cell (NCC) development and vasculogenesis. Then whole-genome sequencing was performed on 21 samples from the case cohort, and several novel loss-of-function mutations were identified (Zhang et al., <xref ref-type="bibr" rid="B245">2016</xref>).</p>
<p>Mutations in <italic>MYT1</italic>, the gene encoding myelin transcription factor 1, which is involved in the retinoic acid (RA) pathway, have recently been identified as causal for OAVS (Berenguer et al., <xref ref-type="bibr" rid="B18">2017</xref>). Therefore, other genes in the RA pathways may be good candidates to further elucidate the genetically heterogeneous HFM/OVA syndrome (Berenguer et al., <xref ref-type="bibr" rid="B18">2017</xref>). Apart from genetic factors, early fetal exposure to drugs such as thalidomide, retinoic acid, and primidone implicated in neuro-ectodermal death may lead to a similar phenotype (Gorlin et al., <xref ref-type="bibr" rid="B77">2001</xref>).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Forty seven out of 51 patients (92%) present with uni- or bilateral (24/23) ear abnormalities that were associated with hearing loss (Beleza-Meireles et al., <xref ref-type="bibr" rid="B16">2015</xref>). HFM was present in 90% of the patients (often associated with facial nerve palsy; FNP). FNP can influence the craniofacial growth asymmetry in addition to the mandibular condyle hypoplasia and the soft tissue discrepancy (Choi et al., <xref ref-type="bibr" rid="B38">2014</xref>). Some of the most common craniofacial features of HFM include hypoplasia of the zygomatic, mandibular and maxillary bones, and facial muscle hypoplasia (Beleza-Meireles et al., <xref ref-type="bibr" rid="B16">2015</xref>). Colobomas of the upper eyelids are common. In some cases, other facial structures, such as the orbit, eye, nose, cranium, or neck, may be involved. Involvement is usually limited to one side, but bilateral involvement is known. Cephalometric analysis shows that patients with HM present an upward cant of the occlusal plane and a smaller mandibular body and ramus at the affected side (Shibazaki-Yorozuya et al., <xref ref-type="bibr" rid="B191">2014</xref>; Brandstetter and Patel, <xref ref-type="bibr" rid="B25">2016</xref>; Heike et al., <xref ref-type="bibr" rid="B83">2016</xref>).</p>
<p>As a consequence, patients with HFM tend to have large and steep gonial angles, a retrognathic mandible, and a mildly convex face in profile (Seow et al., <xref ref-type="bibr" rid="B188">1998</xref>; Ongkosuwito et al., <xref ref-type="bibr" rid="B149">2013a</xref>; Ahiko et al., <xref ref-type="bibr" rid="B2">2015</xref>). Despite their shorter mandibles, mandibular growth rate is similar to the normal population (Ongkosuwito et al., <xref ref-type="bibr" rid="B150">2013b</xref>). CLP is present in ~10% of patients with HFM (Ye et al., <xref ref-type="bibr" rid="B239">2005</xref>). Unilateral Craniofacial Microsomia (UCM) is also reported to be an underappreciated cause of obstructive sleep apnea (OSA). The prevalence of OSA in patients with UCM is up to 10 times higher than in the general population (Szpalski et al., <xref ref-type="bibr" rid="B204">2015</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>In deciduous and permanent dentition the mesiodistal dimensions of all molars are smaller than in control individuals, supporting the concept that HFM is a bilateral rather than a unilateral condition (Seow et al., <xref ref-type="bibr" rid="B188">1998</xref>). However, the difference is most pronounced in the mandibular permanent first molar on the affected side. The canines and the incisors have normal size, both in the deciduous and in the permanent dentition, although deviating development of the mandibular canines has also been reported (Seow et al., <xref ref-type="bibr" rid="B188">1998</xref>; Ahiko et al., <xref ref-type="bibr" rid="B2">2015</xref>).</p>
<p>The prevalence of tooth agenesis (TA) is higher than in controls, and amounts approximately 25%; the mandibular second premolar and second molars are the ones most affected (Maruko et al., <xref ref-type="bibr" rid="B129">2001</xref>; Ongkosuwito et al., <xref ref-type="bibr" rid="B148">2010</xref>). Compared to non-affected controls, tooth development is delayed in patients with HFM, and only in the most severe cases with an absent mandibular ramus and glenoid fossa, the affected side is significantly more delayed than on the “non-affected” side (Ongkosuwito et al., <xref ref-type="bibr" rid="B148">2010</xref>; Ahiko et al., <xref ref-type="bibr" rid="B2">2015</xref>). About half of the HM children show mild tongue dysmorphology; this feature however seems to be easily overlooked (Chen et al., <xref ref-type="bibr" rid="B35">2009</xref>).</p>
</sec>
</sec>
<sec>
<title>Treacher collins</title>
<sec>
<title>Genetics and general features</title>
<p>Treacher Collins Syndrome (TCS), is a largely AD condition with a penetrance of ~90% and variable expressivity (Dixon et al., <xref ref-type="bibr" rid="B56">2007</xref>), affecting 1:50,000 live births. There are mainly 3 types can be discerned with bilateral oto-mandibular dysplasia as a common characteristic in craniofacial development. TCS1 and TCS2 show AD inheritance (suggested with incomplete penetrance), while TCS3 is an AR condition. In most cases the mutation is in the gene <italic>TCOF1</italic> located on 5q32-q33.1 chromosome. TCS1 is caused by mutations in the Treacle Ribosome Biogenesis Factor 1 (<italic>TCOF1</italic>) gene, which encodes a nucleolar phosphoprotein involved in rRNA transcription (Valdez et al., <xref ref-type="bibr" rid="B219">2004</xref>), regulating RNA polymerase I by connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification, essential in normal cell function. It is also required for neural crest specification (Hayano et al., <xref ref-type="bibr" rid="B81">2003</xref>) and is highly expressed in embryogenesis during fusion of the neural tube and in the branchial arches, suggesting a role for the gene in the development of the craniofacial complex (Dixon et al., <xref ref-type="bibr" rid="B54">1997</xref>). TCS2 and TCS3 are caused by mutations in the RNA Polymerase I Subunit D (<italic>POLR1D)</italic> gene at 13q12.2 and RNA Polymerase I Subunit C (<italic>POLR1C</italic>) gene at 6p21.1, respectively. These genes encode RNA polymerases I and III subunits, which are also involved in rRNA transcription (Dauwerse et al., <xref ref-type="bibr" rid="B50">2011</xref>). These findings suggest that TCS is a ribosomopathy (Dauwerse et al., <xref ref-type="bibr" rid="B50">2011</xref>). In 10% of the patients with TCS, the genetic defect for the molecular diagnosis is still unknown. Although so far no clear genotype-phenotype correlation has been documented for TCS, Dixon et al. (<xref ref-type="bibr" rid="B55">2006</xref>) showed that Tcof1 haplo insufficiency results in oxidative stress-induced DNA damage with neuroepithelial cell death as a result. Importantly, Sakai et al. (<xref ref-type="bibr" rid="B183">2016</xref>) demonstrate that maternal treatment with antioxidants minimizes cell death in the neuroepithelium and substantially ameliorates or even prevents the pathogenesis of craniofacial anomalies in Tcof1(+/−) mice (Sakai et al., <xref ref-type="bibr" rid="B183">2016</xref>). They conclude that antioxidant therapy may provide an avenue of protection against the pathogenesis of TCS and similar neurocristopathies (Sakai et al., <xref ref-type="bibr" rid="B183">2016</xref>).</p>
<p>In a large TCS group of patients, cardiac malformations were present in 12%, while brain, kidney, and limb anomalies were rare (Vincent et al., <xref ref-type="bibr" rid="B227">2016</xref>). In a case report Li et al. (<xref ref-type="bibr" rid="B113">2009</xref>) described a patient with TCS who had additional features including an encephalocele, and several extra-craniofacial anomalies involving the thyroid, the thymus, the heart, an accessory spleen, ectopic adrenal gland tissue, and underdeveloped external genitalia (Li et al., <xref ref-type="bibr" rid="B113">2009</xref>).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Recently, the rate of all clinical features observed in TCS1 were described in 70 patients (Vincent et al., <xref ref-type="bibr" rid="B227">2016</xref>). These authors proved that the vast majority of the symptoms were: craniofacial and comprised downward-slanting palpebral fissures (in 100% of the patients); malar hypoplasia (in 99%); conductive deafness (in 91%); mandibular hypoplasia (in 87%); atresia of external ear canal (in 72%), microtia (in 71%); coloboma of the lower eyelid (in 65%); facial asymmetry (in 53%), and projection of scalp hair onto the lateral cheek (in 48%). Twenty two percent of the patients with TCS1 in this study had a cleft palate and 14% had choanal stenosis or atresia (Vincent et al., <xref ref-type="bibr" rid="B227">2016</xref>).</p>
<p>Moreover, a large proportion of the children with TCS (irrespective the TCS type) are reported to have a narrow arched palate, hypoplasia of the maxilla and a retrognathic mandible (Posnick and Ruiz, <xref ref-type="bibr" rid="B162">2000</xref>). Predominant hypoplasia of soft tissues is observed on the face. Also complex abnormalities in the temporomandibular joint may lead to a limitation of mouth opening (Poswillo, <xref ref-type="bibr" rid="B163">1975</xref>; Posnick and Ruiz, <xref ref-type="bibr" rid="B162">2000</xref>) and an anterior open bite of varying severity (Posnick and Ruiz, <xref ref-type="bibr" rid="B162">2000</xref>; Martelli-Junior et al., <xref ref-type="bibr" rid="B127">2009</xref>; Trainor and Andrews, <xref ref-type="bibr" rid="B214">2013</xref>). While the presence of cleft palate with or without cleft lip is reported in many patients in some studies (Posnick and Ruiz, <xref ref-type="bibr" rid="B162">2000</xref>; da Silva Dalben et al., <xref ref-type="bibr" rid="B46">2006</xref>; Martelli-Junior et al., <xref ref-type="bibr" rid="B127">2009</xref>). Martelli-Junior et al. (<xref ref-type="bibr" rid="B127">2009</xref>) reported the absence of orofacial clefts in seven sporadic cases with TCS (Martelli-Junior et al., <xref ref-type="bibr" rid="B127">2009</xref>).</p>
<p>In a prospective case study, which included 19 patients who underwent genetic testing, medical and dental examinations, and polysomnography, disturbed respiration was demonstrated in all participating patients. Eighteen of them met the diagnostic criteria for obstructive sleep apnea syndrome (OSAS) (Akre et al., <xref ref-type="bibr" rid="B4">2012</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>Dental anomalies have been reported in about 60% of the children with TCS. Tooth agenesis (TA) is the most frequent anomaly and it most commonly affects the mandibular second premolars, followed by maxillary second premolars, lateral incisors, and maxillary canines (da Silva Dalben et al., <xref ref-type="bibr" rid="B46">2006</xref>). Also, impacted maxillary supernumerary teeth, hypoplastic, and malpositioned maxillary central incisors (da Silva Dalben et al., <xref ref-type="bibr" rid="B46">2006</xref>) and ectopic eruption of the maxillary first molars have been reported (da Silva Dalben et al., <xref ref-type="bibr" rid="B46">2006</xref>).</p>
<p>Seven sporadic patients (six females and one male) with TCS without obvious family history for related features, manifested various types of malocclusions, three of which had an anterior open bite and one had a short soft palate (Martelli-Junior et al., <xref ref-type="bibr" rid="B127">2009</xref>).</p>
</sec>
</sec>
<sec>
<title>Möbius syndrome</title>
<sec>
<title>Genetics and general features</title>
<p>Möbius syndrome (MBS) is a rare congenital disorder with the preliminary diagnostic criteria of congenital facial and abducent nerve palsy with impairment of ocular abduction. Other cranial nerves are also commonly involved. The prevalence rate of MBS is ~1 in 100,000 live births (Ghosh et al., <xref ref-type="bibr" rid="B74">2017</xref>). The genetic etiology of the syndrome is heterogeneous with four genetic loci described: MBS1 on chromosome 13q12.2-q13, MBS2 on chromosome 3q21-q22, MBS3 on chromosome 10q21 and MBS4 on chromosome 1p22.5. Various other etiologic factors have however been associated with MBS, including vascular interruption in the subclavian artery territory, infections, hyperthermia, trauma, and teratogens such as benzodiazepines, thalidomide, alcohol, cocaine, misoprostol, and ergotamine (Ghosh et al., <xref ref-type="bibr" rid="B74">2017</xref>). Its proximal cause is the abnormal development—or absence—of the 7<sup>th</sup> cranial nerve (facial) in 100% of patients and of the 6<sup>th</sup> cranial nerve (abducens) in 75% of them. Occasionally, other cranial nerves can also be affected (Verzijl et al., <xref ref-type="bibr" rid="B226">2003</xref>); moreover, mild intellectual disability can occur in 10% of cases (Verzijl et al., <xref ref-type="bibr" rid="B226">2003</xref>). MBS also comprises a large phenotype variation including variable features such as limb, and musculoskeletal, behavioral, and cognitive abnormalities (Van Der Zwaag et al., <xref ref-type="bibr" rid="B222">2002</xref>; Verzijl et al., <xref ref-type="bibr" rid="B226">2003</xref>; Ghosh et al., <xref ref-type="bibr" rid="B74">2017</xref>). Recently, McClure et al. (<xref ref-type="bibr" rid="B131">2016</xref>) reported that MBS is accompanied by an increased rate of several orthopedic problems, including clubfoot, scoliosis, and upper extremity differences that often require surgical treatment. Therefore, early involvement of orthopedic surgeons in the care of patients with MBS is often necessary. Congenital heart diseases and other syndromes are often associated with MBS (Sharma et al., <xref ref-type="bibr" rid="B189">2015</xref>; Budic et al., <xref ref-type="bibr" rid="B26">2016</xref>; Gaudin et al., <xref ref-type="bibr" rid="B71">2016</xref>).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>The first manifestation is sucking impairment and excessive drooling often accompanied by respiratory difficulties (Verzijl et al., <xref ref-type="bibr" rid="B226">2003</xref>). As the child grows, the inability to move the facial muscles and the eyes becomes obvious (Zuker et al., <xref ref-type="bibr" rid="B247">2000</xref>; Sjogreen et al., <xref ref-type="bibr" rid="B196">2001</xref>, <xref ref-type="bibr" rid="B197">2011</xref>; Bianchi et al., <xref ref-type="bibr" rid="B20">2010</xref>). Other anomalies are also commonly associated, such as orofacial dysmorphology and jaw abnormalities (Van Der Zwaag et al., <xref ref-type="bibr" rid="B222">2002</xref>; Verzijl et al., <xref ref-type="bibr" rid="B226">2003</xref>). Children with MBS are commonly born with persisting micrognathia and microstomia (De Serpa Pinto et al., <xref ref-type="bibr" rid="B52">2002</xref>; Magalhaes et al., <xref ref-type="bibr" rid="B124">2006</xref>; Bianchi et al., <xref ref-type="bibr" rid="B21">2013</xref>). The maxilla is mostly narrow and high arched, and cleft palate is present in about 30% of the cases (De Serpa Pinto et al., <xref ref-type="bibr" rid="B52">2002</xref>; Stromland et al., <xref ref-type="bibr" rid="B202">2002</xref>; Magalhaes et al., <xref ref-type="bibr" rid="B124">2006</xref>). In their report on two patients with MBS Ghosh et al. (<xref ref-type="bibr" rid="B74">2017</xref>) show a marked facial asymmetry in one of their patients; this patient also suffers from torticollis (Ghosh et al., <xref ref-type="bibr" rid="B74">2017</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>The time of eruption of the deciduous dentition varies. The upper lip often is hypoplastic, and a frontal open bite is seen in about 50% of the patients (De Serpa Pinto et al., <xref ref-type="bibr" rid="B52">2002</xref>; Magalhaes et al., <xref ref-type="bibr" rid="B124">2006</xref>#1655). Agenesis of the lower second premolars, enamel hypoplasia and crowding has been reported in 30–40% of the cases (Stromland et al., <xref ref-type="bibr" rid="B202">2002</xref>). The presence of a short or fissured and abnormally shaped tongue has been described (De Serpa Pinto et al., <xref ref-type="bibr" rid="B52">2002</xref>). Incompetent lips and failure to close the mouth were the main complaints in the two patients of a case report; a multi-disciplinary approach was planned to correct these features (Ghosh et al., <xref ref-type="bibr" rid="B74">2017</xref>). Patients with MBS have been described with higher risk for caries, most probably due to reduced salivary rate (Castro et al., <xref ref-type="bibr" rid="B30">2016</xref>; Martins Mussi et al., <xref ref-type="bibr" rid="B128">2016</xref>), and higher occurrence of periodontal disease (Martins Mussi et al., <xref ref-type="bibr" rid="B128">2016</xref>).</p>
</sec>
</sec>
</sec>
<sec>
<title>Syndromes involving orofacial clefts</title>
<p>Syndromes in this group are all related to the development of cleft lip and/or palate. Apart from that they also include a highly variable spectrum of clinical features, such as ectrodactyly, ectodermal anomalies, musculoskeletal problems, hypogonadism, mental retardation, and hearing loss. The 22q11.2 deletion syndrome (22q11.2DS), is also known as velocardiofacial (VCF), Shprintzen, or DiGeorge syndrome.</p>
<sec>
<title>22q11.2 deletion syndrome</title>
<sec>
<title>Genetics and general features</title>
<p>The 22q11.2DS has first been described by Shprintzen et al. (<xref ref-type="bibr" rid="B193">1978</xref>) as the Velocardiofacial Syndrome (VCFS), and has been extensively studied since then. It is one of the most frequent microdeletion syndromes with an incidence of 2–5 in 10,000 live births and is caused by a 1.5–3.0 Mb hemizygous deletion of chromosome 22q11.2. In particular, haploinsufficiency of the <italic>TBX1</italic> gene is found to be responsible for most of the physical malformations. However, also point mutations in the <italic>TBX1</italic> gene can cause the disorder (Chieffo et al., <xref ref-type="bibr" rid="B37">1997</xref>). Although many cases are sporadic, autosomal dominant inheritance of the disorder has been reported, caused by a 1.5–3.0 Mb hemizygous deletion of chromosome 22q11.2. Haploinsufficiency of the TBX1 gene in particular is accountable for most of the physical malformations. There is evidence that point mutations in the TBX1 gene can also cause the disorder. Typical frequent signs and symptoms originally described by Shprintzen et al. (<xref ref-type="bibr" rid="B194">1981</xref>) comprise cleft palate, cardiac anomalies, typical facial characteristics and learning disabilities. Less frequent features in various body parts have been described in many reports on VCFS which may also vary widely among family members. These include dysgenesis of the thymus and parathyroid glands, immune deficiencies, hypocalcaemia, and disturbances in cognitive and behavioral development (Borglum Jensen et al., <xref ref-type="bibr" rid="B23">1983</xref>; Ryan et al., <xref ref-type="bibr" rid="B181">1997</xref>; Wang et al., <xref ref-type="bibr" rid="B231">1997</xref>; Gaspar et al., <xref ref-type="bibr" rid="B70">1999</xref>; Pradel et al., <xref ref-type="bibr" rid="B164">2003</xref>; Yang et al., <xref ref-type="bibr" rid="B237">2005</xref>; Nugent et al., <xref ref-type="bibr" rid="B144">2010</xref>; Toka et al., <xref ref-type="bibr" rid="B212">2010</xref>; Wu et al., <xref ref-type="bibr" rid="B236">2013</xref>). The majority of patients are constitutionally small, including height or weight parameters (Ryan et al., <xref ref-type="bibr" rid="B181">1997</xref>). Because of the high phenotypic variability and the genetic heterogeneity of VCFS, it remains challenging to define its complex genotype-phenotype relation. The description of the animal models moreover guides the reader through the important breakthroughs concerning the etiological mechanisms lying at the origin of VCFS (Stalmans et al., <xref ref-type="bibr" rid="B201">2003</xref>; Liao et al., <xref ref-type="bibr" rid="B114">2004</xref>), and which are directly relevant for clinical diagnosis and will ultimately lead to targeted therapeutic strategies.</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>More than 75% of the individuals have cleft palate or palatal anomalies and specific facial characteristics like hypertelorism (Nugent et al., <xref ref-type="bibr" rid="B144">2010</xref>; Toka et al., <xref ref-type="bibr" rid="B212">2010</xref>; Wu et al., <xref ref-type="bibr" rid="B236">2013</xref>). Many patients with VCFS have a short philtrum, thick and reflected lips (Wang et al., <xref ref-type="bibr" rid="B231">1997</xref>; Fukui et al., <xref ref-type="bibr" rid="B66">2000</xref>). The face can appear long and asymmetric, often with hypotonic muscles, and microcephaly (Toka et al., <xref ref-type="bibr" rid="B212">2010</xref>). Typical facial features include a bulbous-tipped nose, malar flattening, narrow alar base, and thin alae nasi. Skeletal alterations include a short velum, a deep cavum, and malformed or short cranial base (Wang S. et al., <xref ref-type="bibr" rid="B233">2009</xref>; Leveau-Geffroy et al., <xref ref-type="bibr" rid="B111">2011</xref>), large cranial base angle (Oberoi and Vargervik, <xref ref-type="bibr" rid="B146">2005b</xref>), micrognathia (Wang et al., <xref ref-type="bibr" rid="B231">1997</xref>), or retrognathia (Gaspar et al., <xref ref-type="bibr" rid="B70">1999</xref>; Wang K. et al., <xref ref-type="bibr" rid="B232">2009</xref>), steep mandibular plane angle, increased anterior face height, retruded chin, retroclined lower incisors, and increased interincisal angle (Oberoi and Vargervik, <xref ref-type="bibr" rid="B146">2005b</xref>; Oberoi et al., <xref ref-type="bibr" rid="B147">2011</xref>). Malocclusions associated with 22q11.2DS are skeletal class II, with a retruded mandible and open bite (Oberoi et al., <xref ref-type="bibr" rid="B147">2011</xref>; Lewyllie et al., <xref ref-type="bibr" rid="B112">2017</xref>). Interestingly, a general trend of facial hypoplasia in the lower part of the face was evidenced with 3D facial analysis in 20 children with 22q11.2DS compared to controls (Lewyllie et al., <xref ref-type="bibr" rid="B112">2017</xref>).</p>
<p>Furthermore, functional impairment can lead to craniospinal growth disorders (Leveau-Geffroy et al., <xref ref-type="bibr" rid="B111">2011</xref>), asymmetric development of the pharynx and larynx, velopharyngeal insufficiency (Nugent et al., <xref ref-type="bibr" rid="B144">2010</xref>; Leveau-Geffroy et al., <xref ref-type="bibr" rid="B111">2011</xref>) and alternations in palatal motion. These developmental abnormalities, increase speech and respiration difficulties (Pradel et al., <xref ref-type="bibr" rid="B164">2003</xref>; Chegar et al., <xref ref-type="bibr" rid="B34">2006</xref>; Kummer et al., <xref ref-type="bibr" rid="B105">2007</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>Patients with 22q11.2DS show a higher prevalence of missing permanent teeth, especially mandibular incisors, maxillary second premolars, and maxillary lateral incisors (Heliovaara et al., <xref ref-type="bibr" rid="B85">2011</xref>). Despite individual variability, a significantly higher prevalence of tooth agenesis was also observed in 20 children with 22q11.2DS (20%) compared to controls (Lewyllie et al., <xref ref-type="bibr" rid="B112">2017</xref>). A solitary median maxillary or mandibular central incisor has been reported in some cases as well (Oberoi and Vargervik, <xref ref-type="bibr" rid="B146">2005b</xref>; Yang et al., <xref ref-type="bibr" rid="B237">2005</xref>).</p>
<p>The development and eruption of permanent teeth is often delayed, with enamel opacities (Fukui et al., <xref ref-type="bibr" rid="B66">2000</xref>) and hypoplastic alterations (Fukui et al., <xref ref-type="bibr" rid="B66">2000</xref>; da Silva Dalben et al., <xref ref-type="bibr" rid="B47">2008</xref>). Hypomineralizations are observed in both dentitions but in permanent dentition they are twice as frequent as in the primary one (Nordgarden et al., <xref ref-type="bibr" rid="B142">2012</xref>). Impaired salivary flow has also been reported (Toka et al., <xref ref-type="bibr" rid="B212">2010</xref>).</p>
<p>Mitsiadis et al. (<xref ref-type="bibr" rid="B134">2008</xref>) showed that the expression of the <italic>Tbx1</italic> gene implicated in human DiGeorge syndrome, requires mesenchyme-derived FGF signaling for tooth development and correlates with determination of the ameloblast lineage. With their long-term culture techniques, allowing unharmed growth of incisors until their full maturity. Caton et al. (<xref ref-type="bibr" rid="B31">2009</xref>) showed that incisors of <italic>Tbx1</italic><sup>−/−</sup> mice were hypoplastic and lacked enamel. Their further experiments demonstrated that Tbx1 proved essential for the maintenance of ameloblast progenitor cells in rodent incisors and that its deletion results in the absence of enamel formation. These results explain why dental phenotypes like enamel hypoplasia and possibly tooth agenesis, are often found in patients with 22q11.2DS/DiGeorge or VCF syndrome. Using Tbx1 lineage tracing experiments it was shown that <italic>Tbx1</italic> conditional knockout [<italic>Tbx1(cKO)</italic>] mice featured microdontia, coincide with decreased stem cell proliferation (Gao et al., <xref ref-type="bibr" rid="B68">2015</xref>). Their further results also suggested that Tbx1 regulates the proliferation of dental progenitor cells and craniofacial development through miR-96-5p and PITX2. Cleft palate was observed in <italic>Tbx1(cKO)</italic> consistent with the orofacial and tooth defects associated with <italic>TBX1</italic> deletion (Gao et al., <xref ref-type="bibr" rid="B68">2015</xref>).</p>
</sec>
</sec>
<sec>
<title>EEC-syndrome</title>
<sec>
<title>Genetics and general features</title>
<p>EEC is an autosomal dominant disorder with variable expression, characterized by the triad of ectrodactyly (“claw-like” hands and feet), ectodermal dysplasia, and orofacial clefts. Celli et al. (<xref ref-type="bibr" rid="B32">1999</xref>) mapped EEC3 to 3q27. With mutation analysis of the <italic>TP63</italic> gene the phenotype-genotype relation could be determined for EEC3 with heterozygous mutations in <italic>TP63</italic> (fine mapped on 3q28) as molecular causes of this syndrome. <italic>TP63</italic> encodes multiple isoforms of the p63 transcription factor; its biological role is quite complex, with wide-ranging effects on development and differentiation. As can be observed in <italic>Tp63</italic> knockout mice, the development of stratified epithelia is blocked leading to aplasia of multiple ectodermal appendages (including teeth), as well as orofacial clefting and limb defects (Romano et al., <xref ref-type="bibr" rid="B179">2012</xref>). Ectrodactyly is described in 68–84% and ectodermal dysplasia in 50–77% of the cases (Roelfsema and Cobben, <xref ref-type="bibr" rid="B177">1996</xref>; Rinne et al., <xref ref-type="bibr" rid="B171">2006</xref>).</p>
<p>Ectodermal dysplasia often leads to skin hypopigmentation and dry skin, hyperkeratosis, or atrophy, nail dystrophy, fine and sparse hair and eyebrows, reduced or absence of salivary and sweat glands (Buss et al., <xref ref-type="bibr" rid="B28">1995</xref>; Rinne et al., <xref ref-type="bibr" rid="B171">2006</xref>). Other features in this syndrome are lacrimal tract abnormalities, ophthalmological problems, urogenital abnormalities, mammary gland/nipple hypoplasia, and hearing loss (Maas et al., <xref ref-type="bibr" rid="B122">1996</xref>; Roelfsema and Cobben, <xref ref-type="bibr" rid="B177">1996</xref>; Rinne et al., <xref ref-type="bibr" rid="B171">2006</xref>). Hypothalamopituitary dysfunction (Gershoni-Baruch et al., <xref ref-type="bibr" rid="B72">1997</xref>), growth hormone-deficiency (Knudtzon and Aarskog, <xref ref-type="bibr" rid="B100">1987</xref>), and growth retardation (Roelfsema and Cobben, <xref ref-type="bibr" rid="B177">1996</xref>) have also been described in EEC syndrome.</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Forty to 70% of the patients diagnosed with EEC, have an orofacial cleft (Buss et al., <xref ref-type="bibr" rid="B28">1995</xref>; Roelfsema and Cobben, <xref ref-type="bibr" rid="B177">1996</xref>). One to five percent of the EEC patients exhibit midfacial, zygomatic, maxillary, and mandibular hypoplasia, microcephaly, and premaxillary protrusion. However, these features are not considered typical characteristics of the syndrome (Roelfsema and Cobben, <xref ref-type="bibr" rid="B177">1996</xref>). Interestingly, in Genome-wide meta-analyses of non-syndromic orofacial clefts an association was also found between SNPs located in a <italic>TP63</italic> enhancer and clefts of the lip with or without cleft palate (CL/P) (Leslie et al., <xref ref-type="bibr" rid="B109">2017</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>EEC patients have primary and permanent dentitions affected (Klein et al., <xref ref-type="bibr" rid="B99">2013</xref>). In some patients where the EEC syndrome was caused by mutations in <italic>TP63</italic>, the primary dentition was normal (Sripathomsawat et al., <xref ref-type="bibr" rid="B200">2011</xref>). <italic>TP63</italic> mutations may have less effect on deciduous dentition but more data is needed to confirm it (Sripathomsawat et al., <xref ref-type="bibr" rid="B200">2011</xref>). However, their permanent dentition is universally affected (Buss et al., <xref ref-type="bibr" rid="B28">1995</xref>; van Bokhoven et al., <xref ref-type="bibr" rid="B220">2001</xref>; Sripathomsawat et al., <xref ref-type="bibr" rid="B200">2011</xref>). The most common dental features are hypodontia (King et al., <xref ref-type="bibr" rid="B98">1994</xref>), or even anodontia (Wallis, <xref ref-type="bibr" rid="B230">1988</xref>), enamel hypoplasia (Leibowitz and Jenkins, <xref ref-type="bibr" rid="B108">1984</xref>; Knudtzon and Aarskog, <xref ref-type="bibr" rid="B100">1987</xref>; Wallis, <xref ref-type="bibr" rid="B230">1988</xref>; King et al., <xref ref-type="bibr" rid="B98">1994</xref>), generalized microdontia (King et al., <xref ref-type="bibr" rid="B98">1994</xref>), or poorly developed (Wallis, <xref ref-type="bibr" rid="B230">1988</xref>) and peg-shaped teeth (Leibowitz and Jenkins, <xref ref-type="bibr" rid="B108">1984</xref>; Wallis, <xref ref-type="bibr" rid="B230">1988</xref>). The dental phenotypes can be explained as <italic>TP63</italic> is expressed in almost all phases of prenatal human tooth development (Kock et al., <xref ref-type="bibr" rid="B101">2005</xref>). In the latter study a positive of <italic>TP63</italic> was observed in both the cap stage and the bell stage in the cells of the oral mucosa, the inner and outer enamel epithelium, and in the primary and secondary dental lamina. In the early cap stage, there is a strong positive <italic>TP63</italic> in the enamel knot, but not in the late cap stage. Therefore, an important regulatory function of <italic>TP63</italic> in the enamel knot was suggested (Kock et al., <xref ref-type="bibr" rid="B101">2005</xref>). Recently, several p63-positive stem cell reservoirs in the non-ameloblast layers of the enamel organ were also evidenced pointing to a role of p63 in stem cell maintenance (Liu et al., <xref ref-type="bibr" rid="B115">2016</xref>). As p63 is important in transcriptional and signaling networks of epithelial cells, its dysregulation is also associated with tumorigenesis (like squamous cell carcinoma), metastasis, and senescence (Nekulova et al., <xref ref-type="bibr" rid="B138">2011</xref>). Moreover, p63 autoantibodies were found to be associated with an increased susceptibility to oral candidiasis (King et al., <xref ref-type="bibr" rid="B98">1994</xref>), and immunologically mediated chronic ulcerative stomatitis (Romano et al., <xref ref-type="bibr" rid="B179">2012</xref>) and with xerostomia and/or deep tongue fissures (King et al., <xref ref-type="bibr" rid="B98">1994</xref>). The dental age and tooth eruption are as well late (Klein et al., <xref ref-type="bibr" rid="B99">2013</xref>).</p>
</sec>
</sec>
<sec>
<title>Kabuki syndrome</title>
<sec>
<title>Genetics and general features</title>
<p>Kabuki syndrome (KS) is a congenital mental retardation syndrome with additional features, including postnatal dwarfism and a peculiar facies. It is genetically heterogeneous caused by heterozygous mutation in <italic>MLL2</italic> (now called <italic>KMT2D</italic> gene) on chromosome 12q13, causing Kabuk-1 with autosomal dominant (AD) inheritance, and the <italic>KDM6A</italic> gene on chromosome Xp11.3 causing Kabuki-2 with X-linked dominant inheritance. KS was described for the first time in Japanese children (Kuroki et al., <xref ref-type="bibr" rid="B106">1981</xref>), and has a prevalence of 3.2/100,000 in the Japanese population. It is however more common in non-Japanese populations, especially in patients with orofacial clefting (Burke and Jones, <xref ref-type="bibr" rid="B27">1995</xref>). The syndrome affects many parts of the body. The main characteristics of the syndrome appear later in life, making an early diagnosis difficult. KS patients have developmental delay of variable severity (Adam and Hudgins, <xref ref-type="bibr" rid="B1">2005</xref>; Schrander-Stumpel et al., <xref ref-type="bibr" rid="B187">2005</xref>; Petersen et al., <xref ref-type="bibr" rid="B154">2010</xref>; Cheon and Ko, <xref ref-type="bibr" rid="B36">2015</xref>) and intellectual disability that ranges from mild to severe (Wessels et al., <xref ref-type="bibr" rid="B234">2002</xref>; Schrander-Stumpel et al., <xref ref-type="bibr" rid="B187">2005</xref>; Vaux et al., <xref ref-type="bibr" rid="B225">2005</xref>). Early puberty is frequently reported (Schrander-Stumpel et al., <xref ref-type="bibr" rid="B187">2005</xref>). Skeletal abnormalities such as scoliosis, brachydactyly V, brachymesophalangy, clinodactyly of the fifth fingers, or hypermobility and dislocation of hip and knee joints are often encountered. Affected individuals may also have seizures, or muscle hypotonia, related with a defect of the connective tissue (Burke and Jones, <xref ref-type="bibr" rid="B27">1995</xref>).</p>
<p>Heart abnormalities (Yuan, <xref ref-type="bibr" rid="B242">2013</xref>; Yoon et al., <xref ref-type="bibr" rid="B240">2015</xref>), frequent otitis media and hearing loss (Kawame et al., <xref ref-type="bibr" rid="B94">1999</xref>; Tekin et al., <xref ref-type="bibr" rid="B207">2006</xref>), ocular problems such as nystagmus or strabismus, and ptosis, are often features of the syndrome (Turner et al., <xref ref-type="bibr" rid="B216">2005</xref>).</p>
<p>Van Laarhoven et al. (<xref ref-type="bibr" rid="B223">2015</xref>) used morpholino antisense oligonucleotides to knock down Kmt2d in zebrafish, and at 5 days post-fertilization they observed significant craniofacial defects with severe hypoplasia of the viscerocranium, including complete loss of branchial arches 3–7 and Meckel and ceratohyal cartilage (Van Laarhoven et al., <xref ref-type="bibr" rid="B223">2015</xref>). When these structures were present, they were often incompletely formed or clefted. In addition, at 48 h post-fertilization Kmt2d morphants exhibited abnormal development of the atria and/or ventricle as well as prominent bulging of the myocardial wall, and progression through cardiac looping morphogenesis was significantly lower than that observed with wildtype. Compared to wildtype embryos, cross-sectional areas of morphant brains were notably reduced and had a reduced cell layer thickness within the hypothalamus, optic tectum, and midbrain tegmentum. Analysis of neural precursor cell (NPC) markers demonstrated that morphant NPCs are defective in their ability to differentiate in the forebrain and midbrain; the differentiation defects were not observed in the hindbrain.</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>The craniofacial characteristics of the KS include microcephaly, short columella, flat broadened tip of the nose, arched eyebrows, long eyelashes, long palpebral fissures with eversion of lateral parts of the lower lids, and large protruding or cupped earlobes (Wessels et al., <xref ref-type="bibr" rid="B234">2002</xref>; Spano et al., <xref ref-type="bibr" rid="B199">2008</xref>; Teixeira et al., <xref ref-type="bibr" rid="B206">2009</xref>; Tuna et al., <xref ref-type="bibr" rid="B215">2012</xref>).</p>
<p>Cleft palate is seen in almost half of the KS patients while a high arched palate is also a common finding (Adam and Hudgins, <xref ref-type="bibr" rid="B1">2005</xref>; Schrander-Stumpel et al., <xref ref-type="bibr" rid="B187">2005</xref>). Malocclusions, such as open bites, are commonly observed (Matsune et al., <xref ref-type="bibr" rid="B130">2001</xref>; Tuna et al., <xref ref-type="bibr" rid="B215">2012</xref>), as also are unilateral posterior cross bite (Matsune et al., <xref ref-type="bibr" rid="B130">2001</xref>) and Angle class III malocclusion (do Prado Sobral et al., <xref ref-type="bibr" rid="B57">2013</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>The majority of the patients show hypodontia, mainly with agenesis of incisors and /or premolars (Teixeira et al., <xref ref-type="bibr" rid="B206">2009</xref>). Other manifestations include microdontia and “screwdriver”—or peg-shaped incisors (Matsune et al., <xref ref-type="bibr" rid="B130">2001</xref>; Adam and Hudgins, <xref ref-type="bibr" rid="B1">2005</xref>; Rocha et al., <xref ref-type="bibr" rid="B176">2008</xref>). Also supernumerary teeth and widely spaced teeth have been reported (Kuroki et al., <xref ref-type="bibr" rid="B106">1981</xref>; Matsune et al., <xref ref-type="bibr" rid="B130">2001</xref>; Petzold et al., <xref ref-type="bibr" rid="B155">2003</xref>; Rocha et al., <xref ref-type="bibr" rid="B176">2008</xref>). Retention of primary (Rocha et al., <xref ref-type="bibr" rid="B176">2008</xref>) and permanent teeth (Petzold et al., <xref ref-type="bibr" rid="B155">2003</xref>), as well as ectopic upper molars (Cogulu et al., <xref ref-type="bibr" rid="B42">2008</xref>) are commonly observed disturbances of tooth eruption.</p>
</sec>
</sec>
<sec>
<title>Kallmann syndrome</title>
<sec>
<title>General features and genetics</title>
<p>Congenital hypogonadotropic hypogonadism (CHH) is a genetically heterogeneous syndrome caused primarily by gonadotropin-releasing hormone deficiency. About half of the CHH patients suffer from a reduced or deficient sense of smell (hyposmia or anosmia). This subtype of CHH is called Kallmann syndrome (KALS) (Boehm et al., <xref ref-type="bibr" rid="B22">2015</xref>; Yoon et al., <xref ref-type="bibr" rid="B240">2015</xref>).</p>
<p>Most Kallmann cases are diagnosed during infancy in males with cryptorchidism, micropenis, or associated non-reproductive signs or at the time of puberty due to lack of sexual development in combination with hyposmia or anosmia in both sexes. Different forms of KALS have been described, based on their genetic background. Kallmann−1 (KAL-1) is caused by X-linked recessive mutations in <italic>KAL1</italic> on chromosome Xp22.3, sometimes in association with a mutation in another gene, e.g., <italic>PROKR2</italic>. A main feature of this type are mirror movements of the upper limbs (MacColl and Quinton, <xref ref-type="bibr" rid="B123">2005</xref>; Dode and Hardelin, <xref ref-type="bibr" rid="B58">2009</xref>). Kallmann-2 (KAL-2) and is caused by AD mutations in <italic>FGFR1</italic> on chromosome 8p11, sometimes in association with mutation in other genes, e.g., <italic>FGF8</italic> and <italic>GNRHR</italic>). Approximately 30% of the KAL-2 type 2 cases are caused by <italic>de novo</italic> mutations (Sato et al., <xref ref-type="bibr" rid="B185">2004</xref>; Zenaty et al., <xref ref-type="bibr" rid="B244">2006</xref>; Dode and Hardelin, <xref ref-type="bibr" rid="B58">2009</xref>; Boehm et al., <xref ref-type="bibr" rid="B22">2015</xref>).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Cleft palate is reported in approximately 13% of the patients with KAL-1 (Honig, <xref ref-type="bibr" rid="B87">1992</xref>; Molsted et al., <xref ref-type="bibr" rid="B135">1997</xref>; Zenaty et al., <xref ref-type="bibr" rid="B244">2006</xref>). Kallmann patients show an increased angulation of the mandible accompanied by an extreme mandibular and maxillary retrognathia (Molsted et al., <xref ref-type="bibr" rid="B135">1997</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>Tooth agenesis occurs in about 50% of KAL-1 syndrome (Honig, <xref ref-type="bibr" rid="B87">1992</xref>; Molsted et al., <xref ref-type="bibr" rid="B135">1997</xref>; Zenaty et al., <xref ref-type="bibr" rid="B244">2006</xref>) both in cleft and non-cleft patients. It is highly variable, ranging from one to multiple congenitally missing teeth. The most frequently missing teeth are the lateral mandibular incisors, second mandibular and maxillary premolars, and lateral maxillary incisors. Apart from tooth agenesis microdontia, typical “screwdriver”-shaped mandibular incisors, and thin molar roots have also been observed in these patients (Molsted et al., <xref ref-type="bibr" rid="B135">1997</xref>; Sato et al., <xref ref-type="bibr" rid="B185">2004</xref>; Dode and Hardelin, <xref ref-type="bibr" rid="B58">2009</xref>; Bailleul-Forestier et al., <xref ref-type="bibr" rid="B13">2010</xref>).</p>
</sec>
</sec>
<sec>
<title>Pierre Robin sequence</title>
<sec>
<title>Genetics and general features</title>
<p>Pierre Robin syndrome is first described by the French surgeon Pierre Robin (Robin, <xref ref-type="bibr" rid="B174">1923</xref>, <xref ref-type="bibr" rid="B175">1934</xref>). However, it is nowadays called Pierre Robin Sequence (PRS), since its multiple anomalies result from a sequential chain of malformations, one entailing the next (Butow et al., <xref ref-type="bibr" rid="B29">2009</xref>; Gangopadhyay et al., <xref ref-type="bibr" rid="B67">2012</xref>). The primary cause is probably a growth defect of the embryonic mandible due to mutation in the <italic>SOX9</italic> gene. Activity of SOX9 is of importance for the formation of Meckel's cartilage and other chondral structures in the skull. Also, cartilaginous structures derived from the second and third branchial arches, such as stapes, the hyoid, the styloid, and the thyroid, are affected by the <italic>SOX9</italic> mutation (Mori-Akiyama et al., <xref ref-type="bibr" rid="B136">2003</xref>). In a study of 2,530 non-syndromic cleft trios, Ghassibe-Sabbagh et al. (<xref ref-type="bibr" rid="B73">2011</xref>) found the <italic>FAF1</italic> locus to be strongly associated with cleft palate (Ghassibe-Sabbagh et al., <xref ref-type="bibr" rid="B73">2011</xref>). In about half of the cases, PRS is associated with another syndrome, such as 22q11.2 deletion, Stickler, van der Woude, Möbius, and many others (Yu et al., <xref ref-type="bibr" rid="B241">2005</xref>; Butow et al., <xref ref-type="bibr" rid="B29">2009</xref>; Gangopadhyay et al., <xref ref-type="bibr" rid="B67">2012</xref>; Ansari et al., <xref ref-type="bibr" rid="B8">2014</xref>). Looking for the causal genetic variant in a 4-generation family with PRS, Benko et al. (<xref ref-type="bibr" rid="B17">2009</xref>) sequenced 4 candidate genes <italic>SOX9, KCNJ2, KCNJ16</italic>, and <italic>MAP2K6</italic>, but did not find any genomic changes or coding-sequence mutations (Benko et al., <xref ref-type="bibr" rid="B17">2009</xref>). Performing an array comparative genomic hybridization (aCGH) analysis, a heterozygous 75-kb deletion located 1.38-Mb centromeric to the <italic>SOX9</italic> gene was identified. This region also encompassed 10 highly conserved noncoding elements (HCNEs) that segregated with the PRS. In 11 additional unrelated patients with PRS the aCGH analysis revealed <italic>de novo</italic> deletions in 2 sporadic cases, also involving a centromeric deletion (of more than 319 kb) and a telomeric 36-kb deletion, respectively. DNA sequencing of the 10 HCNEs in the remaining nine individuals with PRS revealed a heterozygous T-C transition in 1 family within an HCNE with features of a developmental enhancer <italic>in vitro</italic> and <italic>in vivo</italic>. The <italic>in vitro</italic> enhancer function was abrogated by the mutation and altered the binding of the MSX1 transcription factor compared to wildtype. In the developing mouse mandible, the 3-Mb region bounded by the microdeletions showed a regionally specific chromatin decompaction in cells expressing <italic>SOX9</italic>. Thus, PRS may also result from developmental misexpression of <italic>SOX9</italic> due to disruption of long range cis-regulatory elements (Benko et al., <xref ref-type="bibr" rid="B17">2009</xref>).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>In 75–100% of the cases with PRS, a cleft palate is a common finding (Butow et al., <xref ref-type="bibr" rid="B29">2009</xref>; van Lieshout et al., <xref ref-type="bibr" rid="B224">2014</xref>; Cote et al., <xref ref-type="bibr" rid="B43">2015</xref>). PRS patients have a variable mandibular morphology and position depending on the occurrence and type of the associated syndromes (Rogers et al., <xref ref-type="bibr" rid="B178">2009</xref>). However, if patients with isolated PRS are compared with unaffected control individuals, the mandibular length is significantly smaller and the ratio between ramus height and mandibular body is higher as also is the gonial angle (Suri et al., <xref ref-type="bibr" rid="B203">2010</xref>; Boyce et al., <xref ref-type="bibr" rid="B24">2012</xref>). Furthermore, non-syndromic PRS patients show a smaller cranial base and maxillary length, and increased palatal and mandibular plane inclinations (Suri et al., <xref ref-type="bibr" rid="B203">2010</xref>). There is no evidence of the mandible showing an adolescent catch-up growth (Daskalogiannakis et al., <xref ref-type="bibr" rid="B49">2001</xref>; Suri et al., <xref ref-type="bibr" rid="B203">2010</xref>), which will lead to mandibular micrognathia (Mori-Akiyama et al., <xref ref-type="bibr" rid="B136">2003</xref>; Yu et al., <xref ref-type="bibr" rid="B241">2005</xref>; Cote et al., <xref ref-type="bibr" rid="B43">2015</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>The tongue develops in an abnormal dorsal position (glossoptosis), which can result in glossopharyngeal-laryngeal respiratory obstruction, vagal syncope, and feeding problems (Gangopadhyay et al., <xref ref-type="bibr" rid="B67">2012</xref>).</p>
<p>The prevalence of tooth agenesis in the permanent dentition of PRS patients, is reported to range between 30 and 50% (excluding the 3rd molars), with the prevalence in the mandible being higher than in the maxilla. The most affected teeth are mandibular 2nd premolars (Ranta, <xref ref-type="bibr" rid="B168">1986</xref>; Andersson et al., <xref ref-type="bibr" rid="B7">2010</xref>, <xref ref-type="bibr" rid="B6">2015</xref>; Antonarakis and Suri, <xref ref-type="bibr" rid="B9">2014</xref>).</p>
</sec>
</sec>
<sec>
<title>Van der Woude syndrome</title>
<sec>
<title>Genetics and general features</title>
<p>Van der Woude syndrome (VWS) is the most frequent form of syndromic clefting (Rintala and Ranta, <xref ref-type="bibr" rid="B172">1981</xref>) and accounts for 2% of all CLP patients. It was first described in 1954 (Van Der Woude, <xref ref-type="bibr" rid="B221">1954</xref>) and is characterized by paramedian lip pits and sinuses, the second cardinal sign being orofacial clefting. VWS is genetically heterogeneous with VWS1 (OMIM #<ext-link ext-link-type="OMIM" xlink:href="119300">119300</ext-link>) being caused by heterozygous mutations in <italic>IRF6</italic> on chromosome 1q32.2 and VWS2 (OMIM #<ext-link ext-link-type="OMIM" xlink:href="606713">606713</ext-link>) by heterozygous mutations in <italic>GRHL3</italic> on chromosome 1p36.11 (Peyrard-Janvid et al., <xref ref-type="bibr" rid="B156">2014</xref>). While epistatic genetic interaction was previously demonstrated between <italic>p63</italic> and <italic>IRF6</italic> (Thomason et al., <xref ref-type="bibr" rid="B210">2010</xref>), this could not be demonstrated between <italic>Irf6</italic> and <italic>Grhl3</italic> (Peyrard-Janvid et al., <xref ref-type="bibr" rid="B156">2014</xref>). <italic>GRHL3</italic> however belongs to a group of epidermal genes, which are significantly downregulated by mutations in AEC-related <italic>TP63</italic> mutations (Zarnegar et al., <xref ref-type="bibr" rid="B243">2012</xref>). Recently mutations in <italic>IRF6</italic> were also shown to cause non-syndromic OFCs (Leslie et al., <xref ref-type="bibr" rid="B110">2016</xref>; Khandelwal et al., <xref ref-type="bibr" rid="B97">2017</xref>).</p>
<p>Like other individuals with OFC, especially cleft palate, patients with VWS have delayed language development, and mild cognitive problems (Nopoulos et al., <xref ref-type="bibr" rid="B139">2002</xref>, <xref ref-type="bibr" rid="B140">2007a</xref>,<xref ref-type="bibr" rid="B141">b</xref>).</p>
<p>Nopoulos et al. (<xref ref-type="bibr" rid="B139">2002</xref>) reported anterior cerebrum changes in brain MRI, in 14 adults with VWS. The intelligence score was lower and men were more affected than women (Nopoulos et al., <xref ref-type="bibr" rid="B141">2007b</xref>). Other associated features of the syndrome include congenital heart disease, limb abnormalities (syndactyly of the hands, thumb hypoplasia, club foot), and sensorineural hearing loss (Rizos and Spyropoulos, <xref ref-type="bibr" rid="B173">2004</xref>).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Clefts are reported in 21–100% of the VWS patients (Janku et al., <xref ref-type="bibr" rid="B91">1980</xref>; Onofre et al., <xref ref-type="bibr" rid="B151">1997</xref>) with different degree of severity (Onofre et al., <xref ref-type="bibr" rid="B151">1997</xref>; Rizos and Spyropoulos, <xref ref-type="bibr" rid="B173">2004</xref>).</p>
<p>VWS patients show an underdevelopment of the maxillary sagittal length and maxillary height. This is also reflected in a reduced ANB angle (Kane et al., <xref ref-type="bibr" rid="B93">2002</xref>; Oberoi and Vargervik, <xref ref-type="bibr" rid="B145">2005a</xref>). A more recent study (Heliovaara et al., <xref ref-type="bibr" rid="B84">2015</xref>), did not support these findings. Compared to non-syndromic OFC patients a smaller diameter of the lower pharyngeal airway was observed in VWS patients (Heliovaara et al., <xref ref-type="bibr" rid="B84">2015</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>At birth, approximately 88% of the patients with VWS present with: paramedian lower-lip pits (usually bilateral) and/or a sinus tract leading from a mucous gland of the lip. These pits may show continuous or intermittent dribbling of watery or salivary secretions (Janku et al., <xref ref-type="bibr" rid="B91">1980</xref>; Rintala and Ranta, <xref ref-type="bibr" rid="B172">1981</xref>; Rizos and Spyropoulos, <xref ref-type="bibr" rid="B173">2004</xref>). Hypodontia and dental hypoplasia are also considered cardinal features in VWS patients (Rizos and Spyropoulos, <xref ref-type="bibr" rid="B173">2004</xref>; Hoefele et al., <xref ref-type="bibr" rid="B86">2013</xref>). The prevalence is related to the severity of the cleft. Unilateral and bilateral cleft lip and palate (UCLP and BCLP) patients all have missing teeth, while in the isolated cleft palate and in the submucous cleft palate patients, missing teeth are seen in about 50% of the cases (Oberoi and Vargervik, <xref ref-type="bibr" rid="B145">2005a</xref>). When all VWS patients are considered as a whole, tooth agenesis is reported in up to 80% of the cases (Ranta and Rintala, <xref ref-type="bibr" rid="B169">1982</xref>; Rizos and Spyropoulos, <xref ref-type="bibr" rid="B173">2004</xref>; Lam et al., <xref ref-type="bibr" rid="B107">2010</xref>). The most affected teeth are the maxillary second premolars, followed by the maxillary lateral incisors (Ranta and Rintala, <xref ref-type="bibr" rid="B169">1982</xref>). Conical elevations of the lower lip (Hoefele et al., <xref ref-type="bibr" rid="B86">2013</xref>) and ankyloglossia (Rizos and Spyropoulos, <xref ref-type="bibr" rid="B173">2004</xref>) are also among the findings of VWS. In order to gain insight into the molecular mechanisms contributing to the frequent co-occurrence of syndromic or non-syndromic tooth agenesis and OFCs, a systematic review revealed 84 articles including phenotype and genotype description of 9 genomic loci and 26 gene candidates underlying the co-occurrence of the combined congenital defects, one of them being <italic>IRF6</italic> (Phan et al., <xref ref-type="bibr" rid="B157">2016</xref>). In another study the authors hypothesized that the expression of CLP genes may persist in the dental epithelium and thus, in addition to their role in labiopalatine development, may play an important functional role in subsequent tooth patterning and amelogenesis. Using a novel dental epithelium-specific <italic>Irf6</italic> conditional knockout (<italic>Irf6</italic>-cKO) mouse, Chu et al. (<xref ref-type="bibr" rid="B40">2016</xref>) were able to assess all post-eruption dental phenotypes, which include variable hypodontia, occasional supernumerary incisors and molars, as well as, crown and root patterning anomalies, peg-shaped first molars and taurodontic and C-shaped mandibular second molars (Chu et al., <xref ref-type="bibr" rid="B40">2016</xref>). In addition, enamel density was reduced compared to control mice, ameloblasts exhibited disturbances in adhesion and polarity, and delayed enamel formation was observed. As these findings could perfectly be explained by the role of Irf6 in the organization of polarity of epithelial cell types, this data reinforced the notion that the various isolated tooth defects could be considered as part of the CLP spectrum in relatives of an affected individual (Chu et al., <xref ref-type="bibr" rid="B40">2016</xref>). This also could explain earlier observations on a significantly higher frequency of solitary tooth agenesis in sibs of patients with non-syndromic OFCs (Eerens et al., <xref ref-type="bibr" rid="B60">2001</xref>). On the other hand no significant <italic>IRF6</italic> variants could be identified in 67 patients with solitary (familial) tooth agenesis, but without sibs affected with OFCs (Khandelwal et al., <xref ref-type="bibr" rid="B97">2017</xref>). This could however be due to the relatively small patient cohort.</p>
</sec>
</sec>
</sec>
<sec>
<title>Syndromes with unusual faces</title>
<p>The syndromes with unusual faces described as well as their synonyms are presented in Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>.</p>
<sec>
<title>Coffin-Lowry syndrome</title>
<sec>
<title>Genetics and general features</title>
<p>Coffin-Lowry syndrome (CLS) is caused by mutation in the <italic>RSK2</italic> gene (<italic>RPS6KA3</italic>) on chromosome Xp22.12. Its incidence is estimated 1 in 50,000–100,000 (Pereira et al., <xref ref-type="bibr" rid="B153">2010</xref>). While inheritance occurs in an X-linked dominant manner, 70–80% of the patients are sporadic (Pereira et al., <xref ref-type="bibr" rid="B153">2010</xref>). CLS was described by Coffin et al. (<xref ref-type="bibr" rid="B41">1966</xref>) and later by Lowry et al. (<xref ref-type="bibr" rid="B118">1971</xref>) as a different entity. Temtamy et al. (<xref ref-type="bibr" rid="B208">1975</xref>) showed that the two entities represented the same syndrome and since then is called CLS. Besides cognitive impairment, this rare X-linked intellectual disability syndrome, is also characterized by mainly skeletal malformations, osteopenia, and growth retardation. The causal gene, <italic>RSK2</italic>, was identified in 1996 and contains 22 exons which encode a protein of 740 amino acids (Hanauer and Young, <xref ref-type="bibr" rid="B80">2002</xref>). Mutations in the ribosomal S6 kinase RSK2 encoding a growth factor-regulated kinase are required for osteoblast differentiation and function, were identified to cause the skeletal phenotype and osteopenia in individuals with CLS. Moreover, lack of the transcription factor ATF4, which was identified as a critical substrate for phosphorylation by RSK2, was found to dysregulate osteoblast differentiation and function like in patients with CLS (Yang et al., <xref ref-type="bibr" rid="B238">2004</xref>). Women are more severely affected than men, and the disorder had a wide range of severity. Affected newborn males often show joint hyperlaxity and hypotonia. The hands are broad with soft, stubby, tapering fingers which may also be present at birth and are a strong diagnostic feature. Physical growth and psychomotor development is delayed and it is obvious since the very early age. Other typical general symptoms are short stature (95%), pectus deformity (80%), hearing deficit (sensorineural hearing loss), paroxysmal movement disorders and kyphosis and/or scoliosis which are seen in ~80% of the male individuals with CLS (Touraine et al., <xref ref-type="bibr" rid="B213">2002</xref>). Cardiomyopathy including mitral valve dysfunction, has also been reported (Facher et al., <xref ref-type="bibr" rid="B62">2004</xref>). In a brain morphometric study individuals with CLS consistently showed markedly reduced total brain volume. Particularly the cerebellum and the hippocampus were affected in patients diagnosed with CLS compared to controls (Kesler et al., <xref ref-type="bibr" rid="B96">2007</xref>).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Craniofacial abnormalities in babies with CLS are not specific and it is only by the 2nd year of life that the typical facial characteristics of the syndrome become apparent. Most affected boys and some affected girls show typical craniofacial features like prominent forehead, hypertelorism, flat nasal bridge, downward sloping of palpebral fissures, large and prominent ears, and a wide mouth with full lips. All these characteristics progress mildly as the patient grows (Touraine et al., <xref ref-type="bibr" rid="B213">2002</xref>; Lopez-Jimenez and Gimenez-Prats, <xref ref-type="bibr" rid="B117">2003</xref>). Malocclusions, including frontal open bites (unpublished observations 2014, by author C.C.), and a high narrow palate are often present (Gilgenkrantz et al., <xref ref-type="bibr" rid="B75">1988</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>Hypodontia is seen in 85% of the males. Peg shaped or absent upper lateral incisors are also common (Pereira et al., <xref ref-type="bibr" rid="B153">2010</xref>). Large divergent central incisors, with a wide upper interincisal diastema are also observed in CLS (Gilgenkrantz et al., <xref ref-type="bibr" rid="B75">1988</xref>; Lopez-Jimenez and Gimenez-Prats, <xref ref-type="bibr" rid="B117">2003</xref>), as also is a lingual midline fissure (Gilgenkrantz et al., <xref ref-type="bibr" rid="B75">1988</xref>). As alveolar bone loss and premature tooth exfoliation were also consistently reported symptoms in patients with CLS, a Rsk2-deficient mouse model was generated, and the results showed that besides the requirement for alveolar bone formation, Rsk2 is also a critical regulator of cementoblast function. Using multiple techniques, it was demonstrated that Rsk2 is necessary for proper acellular cementum formation. Besides cementum hypoplasia, Rsk2 deficiency also causes detachment and disorganization of the periodontal ligament and is associated with significant alveolar bone loss with age. Rsk2 was thus identified as a non-redundant regulator of cementum homeostasis, alveolar bone maintenance, and periodontal health, with all these features being independent of Rsk2 function in systemic bone formation (Koehne et al., <xref ref-type="bibr" rid="B102">2016</xref>).</p>
</sec>
</sec>
<sec>
<title>Opitz GBBB syndrome</title>
<sec>
<title>Genetics and general features</title>
<p>The Opitz GBBB syndrome is genetically heterogeneous of which an X-linked recessive and an autosomal dominant form have been described, with their signs and symptoms being in general the same. The X-linked form of Opitz GBBB syndrome-type1 (Opitz-GBBB1) is caused by mutation in the <italic>MID1</italic> gene on Xp22.2 and transmitted in an X-linked recessive way. It is characterized by several abnormalities along the midline of the body. Mutations in <italic>MID1</italic>, which encodes a microtubule-binding protein, have been found in ~50% of Opitz GBBB syndrome patients consistent with the genetically heterogeneous nature of the disorder (Short et al., <xref ref-type="bibr" rid="B192">2002</xref>). The Opitz GBBB syndrome-type2 (Opitz-GBBB2) is caused by <italic>SPECC1L</italic> gene located on 22q11,23 (Kruszka et al., <xref ref-type="bibr" rid="B104">2015</xref>).</p>
<p>Common general features for GBBB1 and GBBB2 are laryngo-tracheo-oesophagal abnormalities, and urogenital defects like hypospadias, cryptorchidism, and bifid scrotum in males and splayed labia majora in females, imperforate anus, and congenital heart defects. Mild intellectual disability and developmental delay occur in about 50% of the individuals with Opitz GBBB1-2 syndrome, and some patients present features of autistic spectrum disorders (Wilson and Oliver, <xref ref-type="bibr" rid="B235">1988</xref>; Meroni, <xref ref-type="bibr" rid="B133">1993</xref>; Quaderi et al., <xref ref-type="bibr" rid="B165">1997</xref>; Jacobson et al., <xref ref-type="bibr" rid="B90">1998</xref>; De Falco et al., <xref ref-type="bibr" rid="B51">2003</xref>; Parashar et al., <xref ref-type="bibr" rid="B152">2005</xref>; Aranda-Orgilles et al., <xref ref-type="bibr" rid="B11">2008</xref>). Five patients were previously described with the Opitz (GBBB) syndrome phenotype and 22q11.2 deletion determined by fluorescent <italic>in situ</italic> hybridisation (FISH) but the precise limits of their deletions have not been determined. Since one locus of Opitz syndrome maps to 22q11.2 chromosomal arrangements are frequently complex and can inactivate such a locus. Erickson et al. (<xref ref-type="bibr" rid="B61">2007</xref>) performed high-resolution array-based comparative genomic hybridization (CGH) on a new Opitz syndrome-like phenotype patient with a 22q11.2 deletion. This patient shares the same deletion as patients with velocardiofacial (VCF) and DiGeorge syndrome (see earlier in this review).</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Distinct craniofacial features that may be seen in this disorder include a prominent forehead, with a widow's peak hairline, hypertelorism, a flat nasal bridge, a thin upper lip, and low-set ears (Hsieh et al., <xref ref-type="bibr" rid="B88">2008</xref>). Cleft lip and/or palate is seen in ~50% of the individuals (Meroni, <xref ref-type="bibr" rid="B133">1993</xref>; Parashar et al., <xref ref-type="bibr" rid="B152">2005</xref>; Aranda-Orgilles et al., <xref ref-type="bibr" rid="B11">2008</xref>; Hsieh et al., <xref ref-type="bibr" rid="B88">2008</xref>; Bhoj et al., <xref ref-type="bibr" rid="B19">2015</xref>).</p>
</sec>
<sec>
<title>Oral and dental manifestations</title>
<p>Only one case history is published that describes neonatal mandibular incisors in two brothers from one family (Shaw et al., <xref ref-type="bibr" rid="B190">2006</xref>).</p>
</sec>
</sec>
<sec>
<title>Smith-Lemli-Opitz syndrome</title>
<sec>
<title>Genetics and general features</title>
<p>Smith-Lemli-Opitz syndrome (SLOS) is a developmental disorder that affects many parts of the body, and is caused by a homozygous or compound heterozygous mutation in the gene encoding sterol delta-7-reductase (<italic>DHCR7</italic>) located on chromosome 11q13, with autosomal recessive inheritance (Tint et al., <xref ref-type="bibr" rid="B211">1995</xref>). The syndrome has been initially described by Smith et al. (<xref ref-type="bibr" rid="B198">1964</xref>). DHCR7 is an enzyme for the biosynthesis of cholesterol of which over 160 different mutations have been described, and the severity of the physical effects of the mutations correlates with the severity of the cholesterol deficiency (Tint et al., <xref ref-type="bibr" rid="B211">1995</xref>; Tanwar et al., <xref ref-type="bibr" rid="B205">2013</xref>) leading to the syndrome with a variable phenotype severity (Saher and Stumpf, <xref ref-type="bibr" rid="B182">2015</xref>). SLOS therefore constitutes a clinical and biochemical continuum. The discovery of the deficiency of DHCR7 as a cause for the SLOS (Tint et al., <xref ref-type="bibr" rid="B211">1995</xref>) made this syndrome the first true metabolic syndrome of multiple congenital malformations. About 80% of the patients show limb deformities such as syndactyly or polydactyly. Almost all patients show learning disabilities and mental deficiencies. Congenital heart deformities, gastrointestinal problems and urogenital anomalies have also been described (Antoniades et al., <xref ref-type="bibr" rid="B10">1994</xref>; Muzzin and Harper, <xref ref-type="bibr" rid="B137">2003</xref>; Pizzo et al., <xref ref-type="bibr" rid="B159">2008</xref>).</p>
<p>The wide variability of the signs and symptoms of SLOS, may range from mildly affected individuals with minor learning and behavioral abnormalities and physical deviations till severe life-threatening forms of the syndrome.</p>
<p>Quintana et al. (<xref ref-type="bibr" rid="B166">2017</xref>) reported on eight different human syndromes caused by mutations in the cholesterol synthesis pathway (Quintana et al., <xref ref-type="bibr" rid="B166">2017</xref>). A subset of these disorders such as SLOS, is associated with facial dysmorphia. However, the molecular and cellular mechanisms underlying such facial deficits are not fully understood, primarily because of the diverse functions associated with the cholesterol synthesis pathway. Their data raise a novel function for isoprenoids in facial development and collectively suggest that cholesterol regulates craniofacial development through versatile mechanisms (Quintana et al., <xref ref-type="bibr" rid="B166">2017</xref>). These authors conclude that future studies deciphering the downstream pathways modulated by cholesterol and isoprenoids will be necessary to gain a more comprehensive understanding of neural crest associated human diseases, including SLOS.</p>
</sec>
<sec>
<title>Craniofacial features</title>
<p>Craniofacial characteristics of this syndrome include microcephaly, bitemporal narrowing, ptosis, short nose with anteverted nares, low-set and retroversed ears, ocular problems and hypertelorism, a small chin, and micrognathia (Antoniades et al., <xref ref-type="bibr" rid="B10">1994</xref>; Muzzin and Harper, <xref ref-type="bibr" rid="B137">2003</xref>; Pizzo et al., <xref ref-type="bibr" rid="B159">2008</xref>).</p>
<p>Other clinical features include cleft palate or bifid uvula that is related to the increased level of 7DHC (Saher and Stumpf, <xref ref-type="bibr" rid="B182">2015</xref>). Cleft palate has been reported in 40–50% of the patients (Cunniff et al., <xref ref-type="bibr" rid="B45">1997</xref>; Muzzin and Harper, <xref ref-type="bibr" rid="B137">2003</xref>; Porter, <xref ref-type="bibr" rid="B161">2006</xref>). Cleft lip is however uncommon (Rajpopat et al., <xref ref-type="bibr" rid="B167">2011</xref>).</p>
</sec>
<sec>
<title>Oral and dental features</title>
<p>The oral and dental manifestations in SLOS individuals include, oligodontia or supernumerary teeth, broad alveolar ridges, enamel hypoplasia, protrusion of the maxillary front teeth, lip incompetence and an anterior open bite (Antoniades et al., <xref ref-type="bibr" rid="B10">1994</xref>; Pizzo et al., <xref ref-type="bibr" rid="B159">2008</xref>).</p>
</sec>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>In this review we updated recent advances in genetic etiology and genotype-phenotype relations of 13 syndromes affecting craniofacial and dental structures. Considerable phenotype variability is reported in literature, also among the affected individuals of one family with the same causal variant. For better understanding the pathogenic mechanisms of these syndromes, the disrupted molecular pathways as well the prioritized HPO terms (Köhler et al., <xref ref-type="bibr" rid="B103">2017</xref>), were presented in Table <xref ref-type="table" rid="T1">1A</xref>. A frequency count in this table suggests for example that in 7 different craniofacial syndromes, i.e., NF1, HFM, TCS1, Kallmann syndrome, Pierre Robin sequence, Kabuki Syndrome and VCFS, enrichment was found for abnormalities of the cardiovascular system (HP:0001626) including abnormalities of cardiac septa (HP:0001671) and of the aortic arch (HP:0012303). Importantly, the HPO term, abnormalities of the cardiovascular system (HP:0001626) thereby emerges as the most frequent common phenotype of the selected syndromes. Interestingly, the HPO term “abnormalities of bone mineral density” (HP:0004348) was exclusively enriched in the three TCS-forms, while “abnormalities of the cranial nerves” (HP:0001291), was unique for Hemifacial Microsomia syndrome. On the other hand, the HPO term for “abnormalities of dental enamel” (HP:0000682) was enriched in 5 of our entities, namely in TCS1, TCS2, TCS3, VCFS, and EEC3 syndrome. In TCS1, TCS2, TCS3, and VCSF, enrichment was also found in “abnormalities of dental morphology” (HP:0006482). The latter term also overlapped with “abnormalities of dental enamel” (HP:0000682), and with CLS as an additional condition (Table <xref ref-type="table" rid="T1">1A</xref>).</p>
<p>When the GO terms for preferred cellular component, molecular function, and biological processes (Ashburner et al., <xref ref-type="bibr" rid="B12">2000</xref>; The Gene Ontology Consortium, <xref ref-type="bibr" rid="B209">2015</xref>) were analyzed in Table <xref ref-type="table" rid="T2">1B</xref>, the causal mutant proteins were enriched in the nucleus or in the nuclear membrane. On the other hand their most frequently involved molecular functions appear to be “protein binding” (GO:0005515) including “chromatin binding” (GO:0003682) and “DNA binding, including regulatory region DNA binding” (GO:0000975) and “transcription regulatory region sequence specific binding” (GO:0000976). The GO terms for the biological process involvement were more diverse. The highest enriched functions were regulatory activities, skeletal system development (GO:0001501) and angiogenesis (GO:0001525 and GO:0001568).</p>
<p>Combining deep clinical phenotyping, eventually aided with 3D facial imaging (Vink et al., <xref ref-type="bibr" rid="B228">2014</xref>; Lewyllie et al., <xref ref-type="bibr" rid="B112">2017</xref>) and including the use of HPO and GO terms as above, we could promote interdisciplinary interaction and contribute to a mechanistic diagnosis. Moreover, pathway information (Table <xref ref-type="table" rid="T1">1A</xref>) could also provide clues for molecular preventive counseling in parents at risk, in the future. In this respect, the experiments in mouse of Sakai et al. (<xref ref-type="bibr" rid="B183">2016</xref>) can be considered as a breakthrough. While Dixon et al. (<xref ref-type="bibr" rid="B56">2007</xref>) showed that Tcof1 haploinsufficiency results in oxidative stress-induced DNA damage with neuroepithelial cell death. Sakai et al. (<xref ref-type="bibr" rid="B183">2016</xref>) demonstrate that maternal treatment with antioxidants minimizes cell death in the neuroepithelium and substantially ameliorates or even prevents the pathogenesis of craniofacial anomalies in Tcof1(+/−) mice. The authors conclude that antioxidant therapy may provide an avenue of protection against the pathogenesis of TCS and similar neurocristopathies (Sakai et al., <xref ref-type="bibr" rid="B183">2016</xref>).</p>
<p>Finally, we would like to address some practical issues for a better mutual understanding of the specialists in the interdisciplinary guiding team. First of all “deep phenotyping” will be postponed in syndromes with involvement of the dentition. While the deciduous dentition is normally completed around the age of 3, the permanent dentition (with exception of the wisdom teeth) will be completely erupted by around 14 years of age. This definitely postpones the full phenotyping in patients diagnosed with one of the syndromes affecting craniofacial, oral, and dental structures.</p>
<p>Secondly, all team members should be aware of the fact that treatment of facial mimic together with other facial morphologic corrections (Ferrari et al., <xref ref-type="bibr" rid="B64">2017</xref>; Magnifico et al., <xref ref-type="bibr" rid="B125">2017</xref>), post-operative physiotherapy (Gaudin et al., <xref ref-type="bibr" rid="B71">2016</xref>; McKay et al., <xref ref-type="bibr" rid="B132">2016</xref>) and orthodontic treatment can improve function and esthetics in patients diagnosed with conditions described in our review (Ferrari et al., <xref ref-type="bibr" rid="B64">2017</xref>; Magnifico et al., <xref ref-type="bibr" rid="B125">2017</xref>).</p>
<p>In growing individuals with craniofacial asymmetries like patients with NF1 or HM, the use of hybrid functional orthodontic appliance (Nouri and Farzan, <xref ref-type="bibr" rid="B143">2015</xref>) or distraction osteogenesis (DO) (Chauhan and Guruprasad, <xref ref-type="bibr" rid="B33">2015</xref>) is the treatment of choice in mild to moderate asymmetries. Bimaxillary DO has been suggested as treatment alternative in non-growing patients (Sant'Anna et al., <xref ref-type="bibr" rid="B184">2015</xref>; Liu et al., <xref ref-type="bibr" rid="B116">2017</xref>). Since DO has not given always satisfactory results in severe craniofacial asymmetries (Lu et al., <xref ref-type="bibr" rid="B119">2016</xref>; Luo et al., <xref ref-type="bibr" rid="B120">2016</xref>) the staged orthognathic surgery is advocated (Liu et al., <xref ref-type="bibr" rid="B116">2017</xref>). Stability of the treatment outcome is an issue in the facial asymmetries and craniofacial discrepancies. Overcorrection of orthognathic treatment and surgery planning only at the end of craniofacial growth, individualized according to the patient and the syndrome, can limit esthetic complications and additional surgical procedures (Fattah et al., <xref ref-type="bibr" rid="B63">2014</xref>).</p>
<p>Focusing on the etiopathogenesis like the facial nerve palsy in HM patients and not only in skeletal and soft tissue deficiencies results in better esthetic and functional treatment outcome (Choi et al., <xref ref-type="bibr" rid="B38">2014</xref>, <xref ref-type="bibr" rid="B39">2015</xref>).</p>
<p>Many of these patients have reduced nasal airway volume like the TCS patients (Ma et al., <xref ref-type="bibr" rid="B121">2015</xref>) resulting in impaired phonation and OSA (Plomp et al., <xref ref-type="bibr" rid="B160">2015</xref>). ENT detailed examination is required for identification of important components for future treatment interventions (Plomp et al., <xref ref-type="bibr" rid="B160">2015</xref>). In many cases the orthognathic correction, like the mandibular DO increases the airway and prevents the OSAS (Damlar et al., <xref ref-type="bibr" rid="B48">2016</xref>). Articulatory dysfunction should be improved or corrected for proper social integration and quality of life of these children (Golinko et al., <xref ref-type="bibr" rid="B76">2016</xref>).</p>
<p>In conclusion, the early detection of syndromes affecting craniofacial and dental structures, improves genetic diagnostic counseling and long-term treatment planning (Dentici et al., <xref ref-type="bibr" rid="B53">2015</xref>). However, as dental development and facial growth are lagging behind (being normally only complete around 14 and 18 years of age, respectively), deep phenotyping of craniofacial syndromes will only be possible in young adulthood. This makes early interventions and decisions concerning the type and timing of orthodontic treatment and maxillofacial surgery often difficult and critical, especially in patients with disrupted development in the craniofacial and dental structures.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>TB and JM: conceived the idea; TB, CC, and JM: performed the literature search. TB and CC: wrote the review and finalized the work; JM: edited the text and tables.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<sec id="s6" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2017.01038/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphys.2017.01038/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Table1.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>M. P.</given-names></name><name><surname>Hudgins</surname><given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Kabuki syndrome: a review</article-title>. <source/>Clin. Genet.
<volume>67</volume>, <fpage>209</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2004.00348.x</pub-id><pub-id pub-id-type="pmid">15691356</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahiko</surname><given-names>N.</given-names></name><name><surname>Baba</surname><given-names>Y.</given-names></name><name><surname>Tsuji</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>S.</given-names></name><name><surname>Kaneko</surname><given-names>T.</given-names></name><name><surname>Kindaichi</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Investigation of maxillofacial morphology and dental development in hemifacial microsomia</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>52</volume>, <fpage>203</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1597/13-179</pub-id><pub-id pub-id-type="pmid">24617329</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akram</surname><given-names>A.</given-names></name><name><surname>McKnight</surname><given-names>M. M.</given-names></name><name><surname>Bellardie</surname><given-names>H.</given-names></name><name><surname>Beale</surname><given-names>V.</given-names></name><name><surname>Evans</surname><given-names>R. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Craniofacial malformations and the orthodontist</article-title>. <source/>Br. Dent. J.
<volume>218</volume>, <fpage>129</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bdj.2015.48</pub-id><pub-id pub-id-type="pmid">25686430</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akre</surname><given-names>H.</given-names></name><name><surname>Overland</surname><given-names>B.</given-names></name><name><surname>Asten</surname><given-names>P.</given-names></name><name><surname>Skogedal</surname><given-names>N.</given-names></name><name><surname>Heimdal</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Obstructive sleep apnea in Treacher Collins syndrome</article-title>. <source/>Eur. Arch. Otorhinolaryngol.
<volume>269</volume>, <fpage>331</fpage>–<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1007/s00405-011-1649-0</pub-id><pub-id pub-id-type="pmid">21626120</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfi</surname><given-names>D.</given-names></name><name><surname>Lam</surname><given-names>D.</given-names></name><name><surname>Gateno</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Branchial arch syndromes</article-title>. <source/>Atlas Oral Maxillofac. Surg. Clin. North Am.
<volume>22</volume>, <fpage>167</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.cxom.2014.04.003</pub-id><pub-id pub-id-type="pmid">25171997</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>E. M.</given-names></name><name><surname>Feragen</surname><given-names>K. B.</given-names></name><name><surname>Mikalsen</surname><given-names>D.</given-names></name><name><surname>Kaul</surname><given-names>J.</given-names></name><name><surname>Holla</surname><given-names>T. M.</given-names></name><name><surname>Filip</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Bilateral hypodontia in adolescents with Pierre Robin sequence</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>52</volume>, <fpage>452</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1597/AAID-JOI-D-11-00190</pub-id><pub-id pub-id-type="pmid">25058123</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>E. M.</given-names></name><name><surname>Sandvik</surname><given-names>L.</given-names></name><name><surname>Abyholm</surname><given-names>F.</given-names></name><name><surname>Semb</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Clefts of the secondary palate referred to the Oslo Cleft Team: epidemiology and cleft severity in 994 individuals</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>47</volume>, <fpage>335</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1597/07-230.1</pub-id><pub-id pub-id-type="pmid">19860491</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansari</surname><given-names>M.</given-names></name><name><surname>Rainger</surname><given-names>J. K.</given-names></name><name><surname>Murray</surname><given-names>J. E.</given-names></name><name><surname>Hanson</surname><given-names>I.</given-names></name><name><surname>Firth</surname><given-names>H. V.</given-names></name><name><surname>Mehendale</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>A syndromic form of Pierre Robin sequence is caused by 5q23 deletions encompassing FBN2 and PHAX</article-title>. <source/>Eur. J. Med. Genet.
<volume>57</volume>, <fpage>587</fpage>–<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2014.08.007</pub-id><pub-id pub-id-type="pmid">25195018</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonarakis</surname><given-names>G. S.</given-names></name><name><surname>Suri</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Prevalence and patterns of permanent tooth agenesis in patients with nonsyndromic Pierre Robin sequence</article-title>. <source/>Am. J. Orthod. Dentofacial Orthop.
<volume>145</volume>, <fpage>452</fpage>–<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajodo.2013.11.021</pub-id><pub-id pub-id-type="pmid">24703283</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoniades</surname><given-names>K.</given-names></name><name><surname>Peonidis</surname><given-names>A.</given-names></name><name><surname>Pehlivanidis</surname><given-names>C.</given-names></name><name><surname>Kavadia</surname><given-names>S.</given-names></name><name><surname>Panagiotidis</surname><given-names>P.</given-names></name></person-group> (<year>1994</year>). <article-title>Craniofacial manifestations of Smith-Lemli-Opitz syndrome: case report</article-title>. <source/>Int. J. Oral Maxillofac. Surg.
<volume>23</volume>, <fpage>363</fpage>–<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1016/S0901-5027(05)80056-6</pub-id><pub-id pub-id-type="pmid">7699276</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aranda-Orgilles</surname><given-names>B.</given-names></name><name><surname>Trockenbacher</surname><given-names>A.</given-names></name><name><surname>Winter</surname><given-names>J.</given-names></name><name><surname>Aigner</surname><given-names>J.</given-names></name><name><surname>Kohler</surname><given-names>A.</given-names></name><name><surname>Jastrzebska</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex</article-title>. <source/>Hum. Genet.
<volume>123</volume>, <fpage>163</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-007-0456-6</pub-id><pub-id pub-id-type="pmid">18172692</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M.</given-names></name><name><surname>Ball</surname><given-names>C. A.</given-names></name><name><surname>Blake</surname><given-names>J. A.</given-names></name><name><surname>Botstein</surname><given-names>D.</given-names></name><name><surname>Butler</surname><given-names>H.</given-names></name><name><surname>Cherry</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title>. <source/>Nat. Genet.
<volume>25</volume>, <fpage>25</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/75556</pub-id><pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailleul-Forestier</surname><given-names>I.</given-names></name><name><surname>Gros</surname><given-names>C.</given-names></name><name><surname>Zenaty</surname><given-names>D.</given-names></name><name><surname>Bennaceur</surname><given-names>S.</given-names></name><name><surname>Leger</surname><given-names>J.</given-names></name><name><surname>De Roux</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Dental agenesis in Kallmann syndrome individuals with FGFR1 mutations</article-title>. <source/>Int. J. Paediatr. Dent.
<volume>20</volume>, <fpage>305</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-263X.2010.01056.x</pub-id><pub-id pub-id-type="pmid">20536592</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballesta-Martínez</surname><given-names>M. J.</given-names></name><name><surname>Lopez-Gonzalez</surname><given-names>V.</given-names></name><name><surname>Dulcet</surname><given-names>L. A.</given-names></name><name><surname>Rodriguez-Santiago</surname><given-names>B.</given-names></name><name><surname>Garcia-Minaur</surname><given-names>S.</given-names></name><name><surname>Guillen-Navarro</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>Autosomal dominant oculoauriculovertebral spectrum and 14q23.1 microduplication</article-title>. <source/>Am. J. Med. Genet. A
<volume>161a</volume>, <fpage>2030</fpage>–<lpage>2035</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36007</pub-id><pub-id pub-id-type="pmid">23794319</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardellini</surname><given-names>E.</given-names></name><name><surname>Amadori</surname><given-names>F.</given-names></name><name><surname>Flocchini</surname><given-names>P.</given-names></name><name><surname>Conti</surname><given-names>G.</given-names></name><name><surname>Piana</surname><given-names>G.</given-names></name><name><surname>Majorana</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Oral findings in 50 children with neurofibromatosis type 1. A case control study</article-title>. <source/>Eur. J. Paediatr. Dent.
<volume>12</volume>, <fpage>256</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="pmid">22185252</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beleza-Meireles</surname><given-names>A.</given-names></name><name><surname>Hart</surname><given-names>R.</given-names></name><name><surname>Clayton-Smith</surname><given-names>J.</given-names></name><name><surname>Oliveira</surname><given-names>R.</given-names></name><name><surname>Reis</surname><given-names>C. F.</given-names></name><name><surname>Venancio</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Oculo-auriculo-vertebral spectrum: clinical and molecular analysis of 51 patients</article-title>. <source/>Eur. J. Med. Genet.
<volume>58</volume>, <fpage>455</fpage>–<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2015.07.003</pub-id><pub-id pub-id-type="pmid">26206081</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benko</surname><given-names>S.</given-names></name><name><surname>Fantes</surname><given-names>J. A.</given-names></name><name><surname>Amiel</surname><given-names>J.</given-names></name><name><surname>Kleinjan</surname><given-names>D. J.</given-names></name><name><surname>Thomas</surname><given-names>S.</given-names></name><name><surname>Ramsay</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence</article-title>. <source/>Nat. Genet.
<volume>41</volume>, <fpage>359</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1038/ng.329</pub-id><pub-id pub-id-type="pmid">19234473</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berenguer</surname><given-names>M.</given-names></name><name><surname>Tingaud-Sequeira</surname><given-names>A.</given-names></name><name><surname>Colovati</surname><given-names>M.</given-names></name><name><surname>Melaragno</surname><given-names>M. I.</given-names></name><name><surname>Bragagnolo</surname><given-names>S.</given-names></name><name><surname>Perez</surname><given-names>A. B. A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A novel <italic>de novo</italic> mutation in MYT1, the unique OAVS gene identified so far</article-title>. <source/>Eur. J. Hum. Genet.
<volume>25</volume>, <fpage>1083</fpage>–<lpage>1086</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2017.101</pub-id><pub-id pub-id-type="pmid">28612832</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhoj</surname><given-names>E. J.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Harr</surname><given-names>M. H.</given-names></name><name><surname>Tian</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Expanding the SPECC1L mutation phenotypic spectrum to include Teebi hypertelorism syndrome</article-title>. <source/>Am. J. Med. Genet. A
<volume>167a</volume>, <fpage>2497</fpage>–<lpage>2502</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37217</pub-id><pub-id pub-id-type="pmid">26111080</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>B.</given-names></name><name><surname>Copelli</surname><given-names>C.</given-names></name><name><surname>Ferrari</surname><given-names>S.</given-names></name><name><surname>Ferri</surname><given-names>A.</given-names></name><name><surname>Sesenna</surname><given-names>E.</given-names></name></person-group> (<year>2010</year>). <article-title>Facial animation in patients with Moebius and Moebius-like syndromes</article-title>. <source/>Int. J. Oral Maxillofac. Surg.
<volume>39</volume>, <fpage>1066</fpage>–<lpage>1073</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijom.2010.06.020</pub-id><pub-id pub-id-type="pmid">20655175</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>B.</given-names></name><name><surname>Ferri</surname><given-names>A.</given-names></name><name><surname>Brevi</surname><given-names>B.</given-names></name><name><surname>Di Blasio</surname><given-names>A.</given-names></name><name><surname>Copelli</surname><given-names>C.</given-names></name><name><surname>Di Blasio</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Orthognathic surgery for the complete rehabilitation of Moebius patients: principles, timing and our experience</article-title>. <source/>J. Craniomaxillofac. Surg.
<volume>41</volume>, <fpage>e1</fpage>–<lpage>e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcms.2012.07.002</pub-id><pub-id pub-id-type="pmid">22878220</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>U.</given-names></name><name><surname>Bouloux</surname><given-names>P. M.</given-names></name><name><surname>Dattani</surname><given-names>M. T.</given-names></name><name><surname>De Roux</surname><given-names>N.</given-names></name><name><surname>Dode</surname><given-names>C.</given-names></name><name><surname>Dunkel</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism–pathogenesis, diagnosis and treatment</article-title>. <source/>Nat. Rev. Endocrinol.
<volume>11</volume>, <fpage>547</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2015.112</pub-id><pub-id pub-id-type="pmid">26194704</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borglum Jensen</surname><given-names>S.</given-names></name><name><surname>Jacobsen</surname><given-names>P.</given-names></name><name><surname>Rotne</surname><given-names>L.</given-names></name><name><surname>Enk</surname><given-names>C.</given-names></name><name><surname>Illum</surname><given-names>F.</given-names></name></person-group> (<year>1983</year>). <article-title>Oral findings in DiGeorge syndrome</article-title>. <source/>Int. J. Oral Surg.
<volume>12</volume>, <fpage>250</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/S0300-9785(83)80050-7</pub-id><pub-id pub-id-type="pmid">6418672</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>A. E.</given-names></name><name><surname>McGrath</surname><given-names>J. A.</given-names></name><name><surname>Techanukul</surname><given-names>T.</given-names></name><name><surname>Murrell</surname><given-names>D. F.</given-names></name><name><surname>Chow</surname><given-names>C. W.</given-names></name><name><surname>McGregor</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Ectodermal dysplasia-skin fragility syndrome due to a new homozygous internal deletion mutation in the PKP1 gene</article-title>. <source/>Australas. J. Dermatol.
<volume>53</volume>, <fpage>61</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-0960.2011.00846.x</pub-id><pub-id pub-id-type="pmid">22309335</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandstetter</surname><given-names>K. A.</given-names></name><name><surname>Patel</surname><given-names>K. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Craniofacial Microsomia</article-title>. <source/>Facial Plast. Surg. Clin. North Am.
<volume>24</volume>, <fpage>495</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1016/j.fsc.2016.06.006</pub-id><pub-id pub-id-type="pmid">27712817</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budic</surname><given-names>I.</given-names></name><name><surname>Surdilovic</surname><given-names>D.</given-names></name><name><surname>Slavkovic</surname><given-names>A.</given-names></name><name><surname>Marjanovic</surname><given-names>V.</given-names></name><name><surname>Stevic</surname><given-names>M.</given-names></name><name><surname>Simic</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Möbius Syndrome: challenges of airway management</article-title>. <source/>Acta Clin. Croat.
<volume>55</volume>(<issue>Suppl. 1</issue>), <fpage>94</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.20471/acc.2016.55.s1.14</pub-id><pub-id pub-id-type="pmid">27276780</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>L. W.</given-names></name><name><surname>Jones</surname><given-names>M. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Kabuki syndrome: underdiagnosed recognizable pattern in cleft palate patients</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>32</volume>, <fpage>77</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1597/1545-1569(1995)032&lt;0077:KSURPI&gt;2.3.CO;2</pub-id><pub-id pub-id-type="pmid">7727492</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buss</surname><given-names>P. W.</given-names></name><name><surname>Hughes</surname><given-names>H. E.</given-names></name><name><surname>Clarke</surname><given-names>A.</given-names></name></person-group> (<year>1995</year>). <article-title>Twenty-four cases of the EEC syndrome: clinical presentation and management</article-title>. <source/>J. Med. Genet.
<volume>32</volume>, <fpage>716</fpage>–<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.32.9.716</pub-id><pub-id pub-id-type="pmid">8544192</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butow</surname><given-names>K. W.</given-names></name><name><surname>Hoogendijk</surname><given-names>C. F.</given-names></name><name><surname>Zwahlen</surname><given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Pierre Robin sequence: appearances and 25 years of experience with an innovative treatment protocol</article-title>. <source/>J. Pediatr. Surg.
<volume>44</volume>, <fpage>2112</fpage>–<lpage>2118</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpedsurg.2009.04.018</pub-id><pub-id pub-id-type="pmid">19944218</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>T.</given-names></name><name><surname>Ortega</surname><given-names>A. O.</given-names></name><name><surname>Mussi</surname><given-names>M. C.</given-names></name><name><surname>Braga</surname><given-names>M. M.</given-names></name><name><surname>Gallottini</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Caries experience in individuals with Moebius Syndrome</article-title>. <source/>Pediatr. Dent.
<volume>38</volume>, <fpage>68</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="pmid">26892218</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caton</surname><given-names>J.</given-names></name><name><surname>Luder</surname><given-names>H. U.</given-names></name><name><surname>Zoupa</surname><given-names>M.</given-names></name><name><surname>Bradman</surname><given-names>M.</given-names></name><name><surname>Bluteau</surname><given-names>G.</given-names></name><name><surname>Tucker</surname><given-names>A. S.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Enamel-free teeth: Tbx1 deletion affects amelogenesis in rodent incisors</article-title>. <source/>Dev. Biol.
<volume>328</volume>, <fpage>493</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2009.02.014</pub-id><pub-id pub-id-type="pmid">19233155</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celli</surname><given-names>J.</given-names></name><name><surname>Duijf</surname><given-names>P.</given-names></name><name><surname>Hamel</surname><given-names>B. C.</given-names></name><name><surname>Bamshad</surname><given-names>M.</given-names></name><name><surname>Kramer</surname><given-names>B.</given-names></name><name><surname>Smits</surname><given-names>A. P.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome</article-title>. <source/>Cell
<volume>99</volume>, <fpage>143</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81646-3</pub-id><pub-id pub-id-type="pmid">10535733</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>D. S.</given-names></name><name><surname>Guruprasad</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Goldenhar syndrome with Tessier's 7 cleft: report of a case</article-title>. <source/>J. Maxillofac. Oral Surg.
<volume>14</volume>, <fpage>42</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1007/s12663-011-0279-9</pub-id><pub-id pub-id-type="pmid">25838668</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chegar</surname><given-names>B. E.</given-names></name><name><surname>Tatum</surname><given-names>S. A.</given-names><suffix>III</suffix></name><name><surname>Marrinan</surname><given-names>E.</given-names></name><name><surname>Shprintzen</surname><given-names>R. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Upper airway asymmetry in velo-cardio-facial syndrome</article-title>. <source/>Int. J. Pediatr. Otorhinolaryngol.
<volume>70</volume>, <fpage>1375</fpage>–<lpage>1381</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijporl.2006.02.007</pub-id><pub-id pub-id-type="pmid">16549218</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>E. H.</given-names></name><name><surname>Reid</surname><given-names>R. R.</given-names></name><name><surname>Chike-Obi</surname><given-names>C.</given-names></name><name><surname>Minugh-Purvis</surname><given-names>N.</given-names></name><name><surname>Whitaker</surname><given-names>L. A.</given-names></name><name><surname>Puchala</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Tongue dysmorphology in craniofacial microsomia</article-title>. <source/>Plast. Reconstr. Surg.
<volume>124</volume>, <fpage>583</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1097/PRS.0b013e3181addba9</pub-id><pub-id pub-id-type="pmid">19644278</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheon</surname><given-names>C. K.</given-names></name><name><surname>Ko</surname><given-names>J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Kabuki syndrome: clinical and molecular characteristics</article-title>. <source/>Korean J. Pediatr.
<volume>58</volume>, <fpage>317</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.3345/kjp.2015.58.9.317</pub-id><pub-id pub-id-type="pmid">26512256</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffo</surname><given-names>C.</given-names></name><name><surname>Garvey</surname><given-names>N.</given-names></name><name><surname>Gong</surname><given-names>W.</given-names></name><name><surname>Roe</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Silver</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Isolation and characterization of a gene from the DiGeorge chromosomal region homologous to the mouse Tbx1 gene</article-title>. <source/>Genomics
<volume>43</volume>, <fpage>267</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1997.4829</pub-id><pub-id pub-id-type="pmid">9268629</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J.</given-names></name><name><surname>Park</surname><given-names>S. W.</given-names></name><name><surname>Kwon</surname><given-names>G. Y.</given-names></name><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Hur</surname><given-names>J. A.</given-names></name><name><surname>Baek</surname><given-names>S. H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Influence of congenital facial nerve palsy on craniofacial growth in craniofacial microsomia</article-title>. <source/>J. Plast. Reconstr. Aesthet. Surg.
<volume>67</volume>, <fpage>1488</fpage>–<lpage>1495</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjps.2014.07.020</pub-id><pub-id pub-id-type="pmid">25210001</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J. W.</given-names></name><name><surname>Kim</surname><given-names>B. H.</given-names></name><name><surname>Kim</surname><given-names>H. S.</given-names></name><name><surname>Yu</surname><given-names>T. H.</given-names></name><name><surname>Kim</surname><given-names>B. C.</given-names></name><name><surname>Lee</surname><given-names>S. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Three-dimensional functional unit analysis of hemifacial microsomia mandible-a preliminary report</article-title>. <source/>Maxillofac. Plast. Reconstr. Surg.
<volume>37</volume>:<fpage>28</fpage>. <pub-id pub-id-type="doi">10.1186/s40902-015-0027-z</pub-id><pub-id pub-id-type="pmid">26413495</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>E. Y.</given-names></name><name><surname>Tamasas</surname><given-names>B.</given-names></name><name><surname>Fong</surname><given-names>H.</given-names></name><name><surname>Foster</surname><given-names>B. L.</given-names></name><name><surname>Lacourse</surname><given-names>M. R.</given-names></name><name><surname>Tran</surname><given-names>A. B.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Full spectrum of postnatal tooth phenotypes in a novel Irf6 cleft lip model</article-title>. <source/>J. Dent. Res.
<volume>95</volume>, <fpage>1265</fpage>–<lpage>1273</lpage>. <pub-id pub-id-type="doi">10.1177/0022034516656787</pub-id><pub-id pub-id-type="pmid">27369589</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffin</surname><given-names>G. S.</given-names></name><name><surname>Siris</surname><given-names>E.</given-names></name><name><surname>Eldridge</surname><given-names>C.</given-names></name><name><surname>Wegienka</surname><given-names>L. C.</given-names></name></person-group> (<year>1966</year>). <article-title>Mental retardation with osteocartilaginous anomalies</article-title>. <source/>Am. J. Dis. Child
<volume>112</volume>, <fpage>205</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1001/archpedi.1966.02090120073006</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cogulu</surname><given-names>D.</given-names></name><name><surname>Oncag</surname><given-names>O.</given-names></name><name><surname>Celen</surname><given-names>E.</given-names></name><name><surname>Ozkinay</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Kabuki Syndrome with additional dental findings: a case report</article-title>. <source/>J. Dent. Child.
<volume>75</volume>, <fpage>185</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="pmid">18647516</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cote</surname><given-names>A.</given-names></name><name><surname>Fanous</surname><given-names>A.</given-names></name><name><surname>Almajed</surname><given-names>A.</given-names></name><name><surname>Lacroix</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Pierre Robin sequence: review of diagnostic and treatment challenges</article-title>. <source/>Int. J. Pediatr. Otorhinolaryngol.
<volume>79</volume>, <fpage>451</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijporl.2015.01.035</pub-id><pub-id pub-id-type="pmid">25704848</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cung</surname><given-names>W.</given-names></name><name><surname>Freedman</surname><given-names>L. A.</given-names></name><name><surname>Khan</surname><given-names>N. E.</given-names></name><name><surname>Romberg</surname><given-names>E.</given-names></name><name><surname>Gardner</surname><given-names>P. J.</given-names></name><name><surname>Bassim</surname><given-names>C. W.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Cephalometry in adults and children with neurofibromatosis type 1: implications for the pathogenesis of sphenoid wing dysplasia and the “NF1 facies”</article-title>. <source/>Eur. J. Med. Genet.
<volume>58</volume>, <fpage>584</fpage>–<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2015.09.001</pub-id><pub-id pub-id-type="pmid">26360873</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunniff</surname><given-names>C.</given-names></name><name><surname>Kratz</surname><given-names>L. E.</given-names></name><name><surname>Moser</surname><given-names>A.</given-names></name><name><surname>Natowicz</surname><given-names>M. R.</given-names></name><name><surname>Kelley</surname><given-names>R. I.</given-names></name></person-group> (<year>1997</year>). <article-title>Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism</article-title>. <source/>Am. J. Med. Genet.
<volume>68</volume>, <fpage>263</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19970131)68:3&lt;263::AID-AJMG4&gt;3.0.CO;2-N</pub-id><pub-id pub-id-type="pmid">9024557</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Dalben</surname><given-names>G.</given-names></name><name><surname>Costa</surname><given-names>B.</given-names></name><name><surname>Gomide</surname><given-names>M. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Prevalence of dental anomalies, ectopic eruption and associated oral malformations in subjects with Treacher Collins syndrome</article-title>. <source/>Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
<volume>101</volume>, <fpage>588</fpage>–<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1016/j.tripleo.2005.07.016</pub-id><pub-id pub-id-type="pmid">16632269</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Dalben</surname><given-names>G.</given-names></name><name><surname>Richieri-Costa</surname><given-names>A.</given-names></name><name><surname>De Assis Taveira</surname><given-names>L. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Tooth abnormalities and soft tissue alterations in patients with G/BBB syndrome</article-title>. <source/>Oral Dis.
<volume>14</volume>, <fpage>747</fpage>–<lpage>753</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-0825.2008.01457.x</pub-id><pub-id pub-id-type="pmid">18627501</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damlar</surname><given-names>I.</given-names></name><name><surname>Altan</surname><given-names>A.</given-names></name><name><surname>Turgay</surname><given-names>B.</given-names></name><name><surname>Kilic</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Management of obstructive sleep apnea in a Treacher Collins syndrome patient using distraction osteogenesis of the mandible</article-title>. <source/>J. Korean Assoc. Oral Maxillofac. Surg.
<volume>42</volume>, <fpage>388</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.5125/jkaoms.2016.42.6.388</pub-id><pub-id pub-id-type="pmid">28053912</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daskalogiannakis</surname><given-names>J.</given-names></name><name><surname>Ross</surname><given-names>R. B.</given-names></name><name><surname>Tompson</surname><given-names>B. D.</given-names></name></person-group> (<year>2001</year>). <article-title>The mandibular catch-up growth controversy in Pierre Robin sequence</article-title>. <source/>Am. J. Orthod. Dentofacial Orthop.
<volume>120</volume>, <fpage>280</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1067/mod.2001.115038</pub-id><pub-id pub-id-type="pmid">11552127</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dauwerse</surname><given-names>J. G.</given-names></name><name><surname>Dixon</surname><given-names>J.</given-names></name><name><surname>Seland</surname><given-names>S.</given-names></name><name><surname>Ruivenkamp</surname><given-names>C. A.</given-names></name><name><surname>Van Haeringen</surname><given-names>A.</given-names></name><name><surname>Hoefsloot</surname><given-names>L. H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>20</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1038/ng.724</pub-id><pub-id pub-id-type="pmid">21131976</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Falco</surname><given-names>F.</given-names></name><name><surname>Cainarca</surname><given-names>S.</given-names></name><name><surname>Andolfi</surname><given-names>G.</given-names></name><name><surname>Ferrentino</surname><given-names>R.</given-names></name><name><surname>Berti</surname><given-names>C.</given-names></name><name><surname>Rodriguez Criado</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum</article-title>. <source/>Am. J. Med. Genet. A
<volume>120A</volume>, <fpage>222</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.10265</pub-id><pub-id pub-id-type="pmid">12833403</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Serpa Pinto</surname><given-names>M. V.</given-names></name><name><surname>De Magalhaes</surname><given-names>M. H.</given-names></name><name><surname>Nunes</surname><given-names>F. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Moebius syndrome with oral involvement</article-title>. <source/>Int. J. Paediatr. Dent.
<volume>12</volume>, <fpage>446</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-263X.2002.00402.x</pub-id><pub-id pub-id-type="pmid">12452989</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dentici</surname><given-names>M. L.</given-names></name><name><surname>Di Pede</surname><given-names>A.</given-names></name><name><surname>Lepri</surname><given-names>F. R.</given-names></name><name><surname>Gnazzo</surname><given-names>M.</given-names></name><name><surname>Lombardi</surname><given-names>M. H.</given-names></name><name><surname>Auriti</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Kabuki syndrome: clinical and molecular diagnosis in the first year of life</article-title>. <source/>Arch. Dis. Child.
<volume>100</volume>, <fpage>158</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2013-305858</pub-id><pub-id pub-id-type="pmid">25281733</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>J.</given-names></name><name><surname>Edwards</surname><given-names>S. J.</given-names></name><name><surname>Anderson</surname><given-names>I.</given-names></name><name><surname>Brass</surname><given-names>A.</given-names></name><name><surname>Scambler</surname><given-names>P. J.</given-names></name><name><surname>Dixon</surname><given-names>M. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Treacher Collins syndrome gene</article-title>. <source/>Genome Res.
<volume>7</volume>, <fpage>223</fpage>–<lpage>234</lpage>.<pub-id pub-id-type="pmid">9074926</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>J.</given-names></name><name><surname>Jones</surname><given-names>N. C.</given-names></name><name><surname>Sandell</surname><given-names>L. L.</given-names></name><name><surname>Jayasinghe</surname><given-names>S. M.</given-names></name><name><surname>Crane</surname><given-names>J.</given-names></name><name><surname>Rey</surname><given-names>J. P.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A. <volume>103</volume>, <fpage>13403</fpage>–<lpage>13408</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0603730103</pub-id><pub-id pub-id-type="pmid">16938878</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>J.</given-names></name><name><surname>Trainor</surname><given-names>P.</given-names></name><name><surname>Dixon</surname><given-names>M. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Treacher Collins syndrome</article-title>. <source/>Orthod. Craniofac. Res.
<volume>10</volume>, <fpage>88</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-6343.2007.00388.x</pub-id><pub-id pub-id-type="pmid">17552945</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>do Prado Sobral</surname><given-names>S.</given-names></name><name><surname>Leite</surname><given-names>A. F.</given-names></name><name><surname>Figueiredo</surname><given-names>P. T.</given-names></name><name><surname>Ferrari</surname><given-names>I.</given-names></name><name><surname>Safatle</surname><given-names>H. P.</given-names></name><name><surname>Cordoba</surname><given-names>M. S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Craniofacial and dental features in kabuki syndrome patients</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>50</volume>, <fpage>440</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1597/11-052</pub-id><pub-id pub-id-type="pmid">22023252</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dode</surname><given-names>C.</given-names></name><name><surname>Hardelin</surname><given-names>J. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Kallmann syndrome</article-title>. <source/>Eur. J. Hum. Genet.
<volume>17</volume>, <fpage>139</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.206</pub-id><pub-id pub-id-type="pmid">18985070</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doufexi</surname><given-names>A.</given-names></name><name><surname>Mina</surname><given-names>M.</given-names></name><name><surname>Ioannidou</surname><given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review</article-title>. <source/>J. Periodontol.
<volume>76</volume>, <fpage>3</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2005.76.1.3</pub-id><pub-id pub-id-type="pmid">15830631</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eerens</surname><given-names>K.</given-names></name><name><surname>Vlietinck</surname><given-names>R.</given-names></name><name><surname>Heidbuchel</surname><given-names>K.</given-names></name><name><surname>Van Olmen</surname><given-names>A.</given-names></name><name><surname>Derom</surname><given-names>C.</given-names></name><name><surname>Willems</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Hypodontia and tooth formation in groups of children with cleft, siblings without cleft, and nonrelated controls</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>38</volume>, <fpage>374</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1597/1545-1569(2001)038&lt;0374:HATFIG&gt;2.0.CO;2</pub-id><pub-id pub-id-type="pmid">11420017</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname><given-names>R. P.</given-names></name><name><surname>Díaz de Ståhl</surname><given-names>T.</given-names></name><name><surname>Bruder</surname><given-names>C. E. G.</given-names></name><name><surname>Dumanski</surname><given-names>J. P.</given-names></name></person-group> (<year>2007</year>). <article-title>A patient with 22q11.2 deletion and Opitz syndrome-like phenotype has the same deletion as velocardiofacial patients</article-title>. <source/>Am. J. Med. Genet. A. <volume>143A</volume>, <fpage>3302</fpage>–<lpage>3308</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.32025</pub-id><pub-id pub-id-type="pmid">18000907</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facher</surname><given-names>J. J.</given-names></name><name><surname>Regier</surname><given-names>E. J.</given-names></name><name><surname>Jacobs</surname><given-names>G. H.</given-names></name><name><surname>Siwik</surname><given-names>E.</given-names></name><name><surname>Delaunoy</surname><given-names>J. P.</given-names></name><name><surname>Robin</surname><given-names>N. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Cardiomyopathy in Coffin-Lowry syndrome</article-title>. <source/>Am. J. Med. Genet. A
<volume>128a</volume>, <fpage>176</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30056</pub-id><pub-id pub-id-type="pmid">15214012</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fattah</surname><given-names>A. Y.</given-names></name><name><surname>Caro</surname><given-names>C.</given-names></name><name><surname>Khechoyan</surname><given-names>D. Y.</given-names></name><name><surname>Tompson</surname><given-names>B.</given-names></name><name><surname>Forrest</surname><given-names>C. R.</given-names></name><name><surname>Phillips</surname><given-names>J. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Cephalometric outcomes of orthognathic surgery in hemifacial microsomia</article-title>. <source/>J. Craniofac. Surg.
<volume>25</volume>, <fpage>1734</fpage>–<lpage>1739</lpage>. <pub-id pub-id-type="doi">10.1097/SCS.0000435808.91512.58</pub-id><pub-id pub-id-type="pmid">25203574</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>P. F.</given-names></name><name><surname>Barbot</surname><given-names>A.</given-names></name><name><surname>Bianchi</surname><given-names>B.</given-names></name><name><surname>Ferri</surname><given-names>A.</given-names></name><name><surname>Garofalo</surname><given-names>G.</given-names></name><name><surname>Bruno</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A proposal for new neurorehabilitative intervention on Moebius Syndrome patients after ‘smile surgery’. Proof of concept based on mirror neuron system properties and hand-mouth synergistic activity</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>76</volume>, <fpage>111</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.01.050</pub-id><pub-id pub-id-type="pmid">28434583</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedrich</surname><given-names>R. E.</given-names></name><name><surname>Giese</surname><given-names>M.</given-names></name><name><surname>Stelljes</surname><given-names>C.</given-names></name><name><surname>Froeder</surname><given-names>C.</given-names></name><name><surname>Scheuer</surname><given-names>H. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Size of tooth crowns and position of teeth concerning the extension of facial plexiform neurofibroma in patients with neurofibromatosis type 1</article-title>. <source/>Anticancer Res.
<volume>32</volume>, <fpage>2207</fpage>–<lpage>2214</lpage>. <pub-id pub-id-type="pmid">22593511</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukui</surname><given-names>N.</given-names></name><name><surname>Amano</surname><given-names>A.</given-names></name><name><surname>Akiyama</surname><given-names>S.</given-names></name><name><surname>Daikoku</surname><given-names>H.</given-names></name><name><surname>Wakisaka</surname><given-names>S.</given-names></name><name><surname>Morisaki</surname><given-names>I.</given-names></name></person-group> (<year>2000</year>). <article-title>Oral findings in DiGeorge syndrome: clinical features and histologic study of primary teeth</article-title>. <source/>Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
<volume>89</volume>, <fpage>208</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1067/moe.2000.103884</pub-id><pub-id pub-id-type="pmid">10673658</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangopadhyay</surname><given-names>N.</given-names></name><name><surname>Mendonca</surname><given-names>D. A.</given-names></name><name><surname>Woo</surname><given-names>A. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Pierre robin sequence</article-title>. <source/>Semin. Plast. Surg.
<volume>26</volume>, <fpage>76</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1055/s-0032-1320065</pub-id><pub-id pub-id-type="pmid">23633934</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Moreno</surname><given-names>M.</given-names></name><name><surname>Eliason</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>TBX1 protein interactions and microRNA-96-5p regulation controls cell proliferation during craniofacial and dental development: implications for 22q11.2 deletion syndrome</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>2330</fpage>–<lpage>2348</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu750</pub-id><pub-id pub-id-type="pmid">25556186</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Romero</surname><given-names>M. T.</given-names></name><name><surname>Parkin</surname><given-names>P.</given-names></name><name><surname>Lara-Corrales</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>Mosaic neurofibromatosis type 1: a systematic review</article-title>. <source/>Pediatr. Dermatol.
<volume>33</volume>, <fpage>9</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1111/pde.12673</pub-id><pub-id pub-id-type="pmid">26338194</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspar</surname><given-names>I. M.</given-names></name><name><surname>Lourenco</surname><given-names>M. T.</given-names></name><name><surname>Reis</surname><given-names>M. I.</given-names></name><name><surname>Soares</surname><given-names>M. A.</given-names></name><name><surname>Nogueira</surname><given-names>G.</given-names></name><name><surname>Ferreira</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>The deletions of 22q11–the Portuguese experience</article-title>. <source/>Genet. Couns.
<volume>10</volume>, <fpage>51</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="pmid">10191429</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaudin</surname><given-names>R. A.</given-names></name><name><surname>Jowett</surname><given-names>N.</given-names></name><name><surname>Banks</surname><given-names>C. A.</given-names></name><name><surname>Knox</surname><given-names>C. J.</given-names></name><name><surname>Hadlock</surname><given-names>T. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Bilateral facial paralysis: a 13-year experience</article-title>. <source/>Plast. Reconstr. Surg.
<volume>138</volume>, <fpage>879</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1097/PRS.0000000000002599</pub-id><pub-id pub-id-type="pmid">27307336</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gershoni-Baruch</surname><given-names>R.</given-names></name><name><surname>Goldscher</surname><given-names>D.</given-names></name><name><surname>Hochberg</surname><given-names>Z.</given-names></name></person-group> (<year>1997</year>). <article-title>Ectrodactyly-ectodermal dysplasia-clefting syndrome and hypothalamo-pituitary insufficiency</article-title>. <source/>Am. J. Med. Genet.
<volume>68</volume>, <fpage>168</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19970120)68:2&lt;168::AID-AJMG9&gt;3.0.CO;2-L</pub-id><pub-id pub-id-type="pmid">9028452</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghassibe-Sabbagh</surname><given-names>M.</given-names></name><name><surname>Desmyter</surname><given-names>L.</given-names></name><name><surname>Langenberg</surname><given-names>T.</given-names></name><name><surname>Claes</surname><given-names>F.</given-names></name><name><surname>Boute</surname><given-names>O.</given-names></name><name><surname>Bayet</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>FAF1, a gene that is disrupted in cleft palate and has conserved function in zebrafish</article-title>. <source/>Am. J. Hum. Genet.
<volume>88</volume>, <fpage>150</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.01.003</pub-id><pub-id pub-id-type="pmid">21295280</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>R.</given-names></name><name><surname>Shetty</surname><given-names>V.</given-names></name><name><surname>Hegde</surname><given-names>S.</given-names></name><name><surname>Babu</surname><given-names>G. S.</given-names></name><name><surname>Ajila</surname><given-names>V.</given-names></name><name><surname>Kishore</surname><given-names>P. N.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Rare features associated with Mobius syndrome: report of two cases</article-title>. <source/>J. Dent. Res. Dent. Clin. Dent. Prospects
<volume>11</volume>, <fpage>60</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.15171/joddd.2017.012</pub-id><pub-id pub-id-type="pmid">28413599</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilgenkrantz</surname><given-names>S.</given-names></name><name><surname>Mujica</surname><given-names>P.</given-names></name><name><surname>Gruet</surname><given-names>P.</given-names></name><name><surname>Tridon</surname><given-names>P.</given-names></name><name><surname>Schweitzer</surname><given-names>F.</given-names></name><name><surname>Nivelon-Chevallier</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1988</year>). <article-title>Coffin-Lowry syndrome: a multicenter study</article-title>. <source/>Clin. Genet.
<volume>34</volume>, <fpage>230</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.1988.tb02870.x</pub-id><pub-id pub-id-type="pmid">3069251</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golinko</surname><given-names>M. S.</given-names></name><name><surname>Leblanc</surname><given-names>E. M.</given-names></name><name><surname>Hallett</surname><given-names>A. M.</given-names></name><name><surname>Alperovich</surname><given-names>M.</given-names></name><name><surname>Flores</surname><given-names>R. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Long-term surgical and speech outcomes following palatoplasty in patients with Treacher-Collins syndrome</article-title>. <source/>J. Craniofac. Surg.
<volume>27</volume>, <fpage>1408</fpage>–<lpage>1411</lpage>. <pub-id pub-id-type="doi">10.1097/SCS.0000000000002821</pub-id><pub-id pub-id-type="pmid">27607112</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gorlin</surname><given-names>R. J.</given-names></name><name><surname>Cohen</surname><given-names>M. M.</given-names><suffix>Jr.</suffix></name><name><surname>Hennekam</surname><given-names>R. C. M.</given-names></name></person-group> (<year>2001</year>). <source/>Syndromes of the Head and Neck. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorlin</surname><given-names>R. J.</given-names></name><name><surname>Jue</surname><given-names>K. L.</given-names></name><name><surname>Jacobsen</surname><given-names>U.</given-names></name><name><surname>Goldschmidt</surname><given-names>E.</given-names></name></person-group> (<year>1963</year>). <article-title>Oculoauriculovertebral dysplasia</article-title>. <source/>J. Pediatr.
<volume>63</volume>, <fpage>991</fpage>–<lpage>999</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(63)80233-4</pub-id><pub-id pub-id-type="pmid">14071056</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guida</surname><given-names>V.</given-names></name><name><surname>Sinibaldi</surname><given-names>L.</given-names></name><name><surname>Pagnoni</surname><given-names>M.</given-names></name><name><surname>Bernardini</surname><given-names>L.</given-names></name><name><surname>Loddo</surname><given-names>S.</given-names></name><name><surname>Margiotti</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A <italic>de novo</italic> proximal 3q29 chromosome microduplication in a patient with oculo auriculo vertebral spectrum</article-title>. <source/>Am. J. Med. Genet. A
<volume>167a</volume>, <fpage>797</fpage>–<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36951</pub-id><pub-id pub-id-type="pmid">25735547</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanauer</surname><given-names>A.</given-names></name><name><surname>Young</surname><given-names>I. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Coffin-Lowry syndrome: clinical and molecular features</article-title>. <source/>J. Med. Genet.
<volume>39</volume>, <fpage>705</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.39.10.705</pub-id><pub-id pub-id-type="pmid">12362025</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayano</surname><given-names>T.</given-names></name><name><surname>Yanagida</surname><given-names>M.</given-names></name><name><surname>Yamauchi</surname><given-names>Y.</given-names></name><name><surname>Shinkawa</surname><given-names>T.</given-names></name><name><surname>Isobe</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name></person-group> (<year>2003</year>). <article-title>Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome</article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>34309</fpage>–<lpage>34319</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M304304200</pub-id><pub-id pub-id-type="pmid">12777385</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heerva</surname><given-names>E.</given-names></name><name><surname>Peltonen</surname><given-names>S.</given-names></name><name><surname>Pirttiniemi</surname><given-names>P.</given-names></name><name><surname>Happonen</surname><given-names>R. P.</given-names></name><name><surname>Visnapuu</surname><given-names>V.</given-names></name><name><surname>Peltonen</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Short mandible, maxilla and cranial base are common in patients with neurofibromatosis 1</article-title>. <source/>Eur. J. Oral Sci.
<volume>119</volume>, <fpage>121</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0722.2011.00811.x</pub-id><pub-id pub-id-type="pmid">21410551</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heike</surname><given-names>C. L.</given-names></name><name><surname>Wallace</surname><given-names>E.</given-names></name><name><surname>Speltz</surname><given-names>M. L.</given-names></name><name><surname>Siebold</surname><given-names>B.</given-names></name><name><surname>Werler</surname><given-names>M. M.</given-names></name><name><surname>Hing</surname><given-names>A. V.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Characterizing facial features in individuals with craniofacial microsomia: a systematic approach for clinical research</article-title>. <source/>Birth Defects Res. Part A Clin. Mol. Teratol.
<volume>106</volume>, <fpage>915</fpage>–<lpage>926</lpage>. <pub-id pub-id-type="doi">10.1002/bdra.23560</pub-id><pub-id pub-id-type="pmid">27891784</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heliovaara</surname><given-names>A.</given-names></name><name><surname>Karhulahti</surname><given-names>R.</given-names></name><name><surname>Rautio</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Craniofacial morphology in children with van der Woude syndrome and isolated cleft palate</article-title>. <source/>J. Plast. Surg. Hand Surg.
<volume>49</volume>, <fpage>209</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.3109/2000656X.2014.992904</pub-id><pub-id pub-id-type="pmid">25516228</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heliovaara</surname><given-names>A.</given-names></name><name><surname>Rantanen</surname><given-names>I.</given-names></name><name><surname>Arte</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Dental development and tooth agenesis in children with velocardiofacial syndrome</article-title>. <source/>Int. J. Paediatr. Dent.
<volume>21</volume>, <fpage>446</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-263X.2011.01148.x</pub-id><pub-id pub-id-type="pmid">21689177</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoefele</surname><given-names>J.</given-names></name><name><surname>Wilhelm</surname><given-names>C.</given-names></name><name><surname>Schiesser</surname><given-names>M.</given-names></name><name><surname>Mack</surname><given-names>R.</given-names></name><name><surname>Heinrich</surname><given-names>U.</given-names></name><name><surname>Weber</surname><given-names>L. T.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Expanding the mutation spectrum for Fraser syndrome: identification of a novel heterozygous deletion in FRAS1</article-title>. <source/>Gene
<volume>520</volume>, <fpage>194</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2013.02.031</pub-id><pub-id pub-id-type="pmid">23473829</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honig</surname><given-names>J. F.</given-names></name></person-group> (<year>1992</year>). <article-title>Incomplete bilateral transverse facial cleft–a previously unreported associated defect of the Kallmann's syndrome</article-title>. <source/>Eur. J. Pediatr. Surg.
<volume>2</volume>, <fpage>357</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1055/s-2008-1063479</pub-id><pub-id pub-id-type="pmid">1477065</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>E. W.</given-names></name><name><surname>Vargervik</surname><given-names>K.</given-names></name><name><surname>Slavotinek</surname><given-names>A. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Clinical and molecular studies of patients with characteristics of Opitz G/BBB syndrome shows a novel MID1 mutation</article-title>. <source/>Am. J. Med. Genet. A
<volume>146a</volume>, <fpage>2337</fpage>–<lpage>2345</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.32368</pub-id><pub-id pub-id-type="pmid">18697196</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaasaari</surname><given-names>P.</given-names></name><name><surname>Visnapuu</surname><given-names>V.</given-names></name><name><surname>Nystrom</surname><given-names>M.</given-names></name><name><surname>Peltonen</surname><given-names>S.</given-names></name><name><surname>Peltonen</surname><given-names>J.</given-names></name><name><surname>Happonen</surname><given-names>R. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Dental age in patients with neurofibromatosis 1</article-title>. <source/>Eur. J. Oral Sci.
<volume>120</volume>, <fpage>549</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0722.2012.01000.x</pub-id><pub-id pub-id-type="pmid">23167472</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>Z.</given-names></name><name><surname>Glickstein</surname><given-names>J.</given-names></name><name><surname>Hensle</surname><given-names>T.</given-names></name><name><surname>Marion</surname><given-names>R. W.</given-names></name></person-group> (<year>1998</year>). <article-title>Further delineation of the Opitz G/BBB syndrome: report of an infant with complex congenital heart disease and bladder exstrophy, and review of the literature</article-title>. <source/>Am. J. Med. Genet.
<volume>78</volume>, <fpage>294</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19980707)78:3&lt;294::AID-AJMG18&gt;3.0.CO;2-A</pub-id><pub-id pub-id-type="pmid">9677070</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janku</surname><given-names>P.</given-names></name><name><surname>Robinow</surname><given-names>M.</given-names></name><name><surname>Kelly</surname><given-names>T.</given-names></name><name><surname>Bralley</surname><given-names>R.</given-names></name><name><surname>Baynes</surname><given-names>A.</given-names></name><name><surname>Edgerton</surname><given-names>M. T.</given-names></name></person-group> (<year>1980</year>). <article-title>The van der Woude syndrome in a large kindred: variability, penetrance, genetic risks</article-title>. <source/>Am. J. Med. Genet.
<volume>5</volume>, <fpage>117</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320050203</pub-id><pub-id pub-id-type="pmid">7395906</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>F.</given-names></name><name><surname>Ramalingam</surname><given-names>S.</given-names></name><name><surname>Ahmed</surname><given-names>H. B.</given-names></name><name><surname>Gupta</surname><given-names>B.</given-names></name><name><surname>Sundar</surname><given-names>C.</given-names></name><name><surname>Qadri</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Oral manifestations in patients with neurofibromatosis type-1: a comprehensive literature review</article-title>. <source/>Crit. Rev. Oncol. Hematol.
<volume>91</volume>, <fpage>123</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.critrevonc.2014.02.007</pub-id><pub-id pub-id-type="pmid">24679902</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kane</surname><given-names>A. A.</given-names></name><name><surname>Liao</surname><given-names>Y. F.</given-names></name><name><surname>Lo</surname><given-names>L. J.</given-names></name><name><surname>Huang</surname><given-names>C. S.</given-names></name><name><surname>Huang</surname><given-names>L. M.</given-names></name><name><surname>Chen</surname><given-names>Y. R.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>A cephalometric study of facial growth in van der Woude syndrome</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>39</volume>, <fpage>219</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1597/1545-1569(2002)039&lt;0219:ACSOFG&gt;2.0.CO;2</pub-id><pub-id pub-id-type="pmid">11879081</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawame</surname><given-names>H.</given-names></name><name><surname>Hannibal</surname><given-names>M. C.</given-names></name><name><surname>Hudgins</surname><given-names>L.</given-names></name><name><surname>Pagon</surname><given-names>R. A.</given-names></name></person-group> (<year>1999</year>). <article-title>Phenotypic spectrum and management issues in Kabuki syndrome</article-title>. <source/>J. Pediatr.
<volume>134</volume>, <fpage>480</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(99)70207-6</pub-id><pub-id pub-id-type="pmid">10190924</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrer-Sawatzki</surname><given-names>H.</given-names></name><name><surname>Mautner</surname><given-names>V. F.</given-names></name><name><surname>Cooper</surname><given-names>D. N.</given-names></name></person-group> (<year>2017</year>). <article-title>Emerging genotype-phenotype relationships in patients with large NF1 deletions</article-title>. <source/>Hum. Genet.
<volume>136</volume>, <fpage>349</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-017-1766-y</pub-id><pub-id pub-id-type="pmid">28213670</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kesler</surname><given-names>S. R.</given-names></name><name><surname>Simensen</surname><given-names>R. J.</given-names></name><name><surname>Voeller</surname><given-names>K.</given-names></name><name><surname>Abidi</surname><given-names>F.</given-names></name><name><surname>Stevenson</surname><given-names>R. E.</given-names></name><name><surname>Schwartz</surname><given-names>C. E.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Altered neurodevelopment associated with mutations of RSK2: a morphometric MRI study of Coffin-Lowry syndrome</article-title>. <source/>Neurogenetics
<volume>8</volume>, <fpage>143</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-007-0080-6</pub-id><pub-id pub-id-type="pmid">17318637</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandelwal</surname><given-names>K. D.</given-names></name><name><surname>Ishorst</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Ludwig</surname><given-names>K. U.</given-names></name><name><surname>Venselaar</surname><given-names>H.</given-names></name><name><surname>Gilissen</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Novel IRF6 mutations detected in orofacial cleft patients by targeted massively parallel sequencing</article-title>. <source/>J. Dent. Res.
<volume>96</volume>, <fpage>179</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1177/0022034516678829</pub-id><pub-id pub-id-type="pmid">27834299</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>N. M.</given-names></name><name><surname>Tong</surname><given-names>M. C.</given-names></name><name><surname>Ling</surname><given-names>J. Y.</given-names></name></person-group> (<year>1994</year>). <article-title>The ectrodactyly-ectodermal dysplasia-clefting syndrome: a literature review and case report</article-title>. <source/>Quintessence Int.
<volume>25</volume>, <fpage>731</fpage>–<lpage>736</lpage>. <pub-id pub-id-type="pmid">9161252</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>O. D.</given-names></name><name><surname>Oberoi</surname><given-names>S.</given-names></name><name><surname>Huysseune</surname><given-names>A.</given-names></name><name><surname>Hovorakova</surname><given-names>M.</given-names></name><name><surname>Peterka</surname><given-names>M.</given-names></name><name><surname>Peterkova</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Developmental disorders of the dentition: an update</article-title>. <source/>Am. J. Med. Genet. C Semin. Med. Genet.
<volume>163c</volume>, <fpage>318</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.31382</pub-id><pub-id pub-id-type="pmid">24124058</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knudtzon</surname><given-names>J.</given-names></name><name><surname>Aarskog</surname><given-names>D.</given-names></name></person-group> (<year>1987</year>). <article-title>Growth hormone deficiency associated with the ectrodactyly-ectodermal dysplasia-clefting syndrome and isolated absent septum pellucidum</article-title>. <source/>Pediatrics
<volume>79</volume>, <fpage>410</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="pmid">3822641</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kock</surname><given-names>M.</given-names></name><name><surname>Nolting</surname><given-names>D.</given-names></name><name><surname>Kjaer</surname><given-names>K. W.</given-names></name><name><surname>Hansen</surname><given-names>B. F.</given-names></name><name><surname>Kjaer</surname><given-names>I.</given-names></name></person-group> (<year>2005</year>). <article-title>Immunohistochemical expression of p63 in human prenatal tooth primordia</article-title>. <source/>Acta Odontol. Scand.
<volume>63</volume>, <fpage>253</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1080/00016350510019919</pub-id><pub-id pub-id-type="pmid">16419429</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koehne</surname><given-names>T.</given-names></name><name><surname>Jeschke</surname><given-names>A.</given-names></name><name><surname>Petermann</surname><given-names>F.</given-names></name><name><surname>Seitz</surname><given-names>S.</given-names></name><name><surname>Neven</surname><given-names>M.</given-names></name><name><surname>Peters</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Rsk2, the kinase mutated in Coffin-Lowry syndrome, controls cementum formation</article-title>. <source/>J. Dent. Res
<volume>95</volume>, <fpage>752</fpage>–<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1177/0022034516634329</pub-id><pub-id pub-id-type="pmid">26927527</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>S.</given-names></name><name><surname>Vasilevsky</surname><given-names>N. A.</given-names></name><name><surname>Engelstad</surname><given-names>M.</given-names></name><name><surname>Foster</surname><given-names>E.</given-names></name><name><surname>McMurry</surname><given-names>J.</given-names></name><name><surname>Aymé</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>The human phenotype ontology in 2017</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>D865</fpage>–<lpage>D876</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1039</pub-id><pub-id pub-id-type="pmid">27899602</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruszka</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Harr</surname><given-names>M. H.</given-names></name><name><surname>Wilson</surname><given-names>N. R.</given-names></name><name><surname>Swarr</surname><given-names>D.</given-names></name><name><surname>McCormick</surname><given-names>E. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Mutations in SPECC1L, encoding sperm antigen with calponin homology and coiled-coil domains 1-like, are found in some cases of autosomal dominant Opitz G/BBB syndrome</article-title>. <source/>J. Med. Genet.
<volume>52</volume>, <fpage>104</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2014-102677</pub-id><pub-id pub-id-type="pmid">25412741</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kummer</surname><given-names>A. W.</given-names></name><name><surname>Lee</surname><given-names>L.</given-names></name><name><surname>Stutz</surname><given-names>L. S.</given-names></name><name><surname>Maroney</surname><given-names>A.</given-names></name><name><surname>Brandt</surname><given-names>J. W.</given-names></name></person-group> (<year>2007</year>). <article-title>The prevalence of apraxia characteristics in patients with velocardiofacial syndrome as compared with other cleft populations</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>44</volume>, <fpage>175</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1597/05-170.1</pub-id><pub-id pub-id-type="pmid">17328642</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroki</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Chyo</surname><given-names>H.</given-names></name><name><surname>Hata</surname><given-names>A.</given-names></name><name><surname>Matsui</surname><given-names>I.</given-names></name></person-group> (<year>1981</year>). <article-title>A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation</article-title>. <source/>J. Pediatr.
<volume>99</volume>, <fpage>570</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(81)80256-9</pub-id><pub-id pub-id-type="pmid">7277097</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>A. K.</given-names></name><name><surname>David</surname><given-names>D. J.</given-names></name><name><surname>Townsend</surname><given-names>G. C.</given-names></name><name><surname>Anderson</surname><given-names>P. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Van der Woude syndrome: dentofacial features and implications for clinical practice</article-title>. <source/>Aust. Dent. J.
<volume>55</volume>, <fpage>51</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1111/j.1834-7819.2009.01178.x</pub-id><pub-id pub-id-type="pmid">20415912</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leibowitz</surname><given-names>M. R.</given-names></name><name><surname>Jenkins</surname><given-names>T.</given-names></name></person-group> (<year>1984</year>). <article-title>A newly recognized feature of ectrodactyly, ectodermal dysplasia, clefting (EEC) syndrome: comedone naevus</article-title>. <source/>Dermatologica
<volume>169</volume>, <fpage>80</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1159/000249573</pub-id><pub-id pub-id-type="pmid">6479416</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname><given-names>E. J.</given-names></name><name><surname>Carlson</surname><given-names>J. C.</given-names></name><name><surname>Shaffer</surname><given-names>J. R.</given-names></name><name><surname>Butali</surname><given-names>A.</given-names></name><name><surname>Buxo</surname><given-names>C. J.</given-names></name><name><surname>Castilla</surname><given-names>E. E.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate</article-title>. <source/>Hum. Genet.
<volume>136</volume>, <fpage>275</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-016-1754-7</pub-id><pub-id pub-id-type="pmid">28054174</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname><given-names>E. J.</given-names></name><name><surname>Koboldt</surname><given-names>D. C.</given-names></name><name><surname>Kang</surname><given-names>C. J.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Hecht</surname><given-names>J. T.</given-names></name><name><surname>Wehby</surname><given-names>G. L.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>IRF6 mutation screening in non-syndromic orofacial clefting: analysis of 1521 families</article-title>. <source/>Clin. Genet.
<volume>90</volume>, <fpage>28</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12675</pub-id><pub-id pub-id-type="pmid">26346622</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leveau-Geffroy</surname><given-names>S.</given-names></name><name><surname>Perrin</surname><given-names>J. P.</given-names></name><name><surname>Khonsari</surname><given-names>R. H.</given-names></name><name><surname>Mercier</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>[Cephalometric study of the velocardiofacial syndrome: impact of dysmorphosis on phonation]</article-title>. <source/>Rev. Stomatol. Chir. Maxillofac.
<volume>112</volume>, <fpage>11</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.stomax.2011.01.002</pub-id><pub-id pub-id-type="pmid">21295320</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewyllie</surname><given-names>A.</given-names></name><name><surname>Roosenboom</surname><given-names>J.</given-names></name><name><surname>Indencleef</surname><given-names>K.</given-names></name><name><surname>Claes</surname><given-names>P.</given-names></name><name><surname>Swillen</surname><given-names>A.</given-names></name><name><surname>Devriendt</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A comprehensive craniofacial study of 22q11.2 deletion syndrome</article-title>. <source/>J. Dent. Res.
<volume>96</volume>, <fpage>1386</fpage>–<lpage>1391</lpage>. <pub-id pub-id-type="doi">10.1177/0022034517720630</pub-id><pub-id pub-id-type="pmid">28732176</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Mernagh</surname><given-names>J.</given-names></name><name><surname>Bourgeois</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Novel craniofacial and extracraniofacial findings in a case of Treacher Collins syndrome with a pathogenic mutation and a missense variant in the TCOF1 gene</article-title>. <source/>Clin. Dysmorphol.
<volume>18</volume>, <fpage>63</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1097/MCD.0b013e328318c4fb</pub-id><pub-id pub-id-type="pmid">19050407</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>J.</given-names></name><name><surname>Kochilas</surname><given-names>L.</given-names></name><name><surname>Nowotschin</surname><given-names>S.</given-names></name><name><surname>Arnold</surname><given-names>J. S.</given-names></name><name><surname>Aggarwal</surname><given-names>V. S.</given-names></name><name><surname>Epstein</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage</article-title>. <source/>Hum. Mol. Genet.
<volume>13</volume>, <fpage>1577</fpage>–<lpage>1585</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh176</pub-id><pub-id pub-id-type="pmid">15190012</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Pandya</surname><given-names>M.</given-names></name><name><surname>Luan</surname><given-names>X.</given-names></name><name><surname>Diekwisch</surname><given-names>T. G. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Daughters of the enamel organ: development, fate, and function of the stratum intermedium, stellate reticulum, and outer enamel epithelium</article-title>. <source/>Stem Cells Dev.
<volume>25</volume>, <fpage>1580</fpage>–<lpage>1590</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2016.0267</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Shao</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>Combined bimaxillary distraction osteogenesis associated with orthognathic surgery for hemifacial microsomia in adults</article-title>. <source/>Aesthetic Plast. Surg.
<volume>41</volume>, <fpage>650</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1007/s00266-017-0818-y</pub-id><pub-id pub-id-type="pmid">28233131</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Jimenez</surname><given-names>J.</given-names></name><name><surname>Gimenez-Prats</surname><given-names>M. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Coffin-Lowry syndrome: odontologic characteristics. Review of the literature and presentation of a clinical case</article-title>. <source/>Med. Oral
<volume>8</volume>, <fpage>51</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="pmid">12556724</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowry</surname><given-names>R. B.</given-names></name><name><surname>Maclean</surname><given-names>R.</given-names></name><name><surname>McLean</surname><given-names>D. M.</given-names></name><name><surname>Tischler</surname><given-names>B.</given-names></name></person-group> (<year>1971</year>). <article-title>Cataracts, microcephaly, kyphosis, and limited joint movement in two siblings: a new syndrome</article-title>. <source/>J. Pediatr.
<volume>79</volume>, <fpage>282</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(71)80114-2</pub-id><pub-id pub-id-type="pmid">5560051</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>T. C.</given-names></name><name><surname>Kang</surname><given-names>G. C.</given-names></name><name><surname>Yao</surname><given-names>C. F.</given-names></name><name><surname>Liou</surname><given-names>E. J.</given-names></name><name><surname>Ko</surname><given-names>E. W.</given-names></name><name><surname>Chen</surname><given-names>Z. C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Simultaneous maxillo-mandibular distraction in early adolescence as a single treatment modality for durable correction of type II unilateral hemifacial microsomia: follow-up till completion of growth</article-title>. <source/>J. Craniomaxillofac. Surg.
<volume>44</volume>, <fpage>1201</fpage>–<lpage>1208</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcms.2016.07.002</pub-id><pub-id pub-id-type="pmid">27499513</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>E.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Liao</surname><given-names>C.</given-names></name><name><surname>Fei</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Bimaxillary orthognathic approach to correct skeletal facial asymmetry of hemifacial microsomia in adults</article-title>. <source/>Aesthetic Plast. Surg.
<volume>40</volume>, <fpage>400</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1007/s00266-015-0590-9</pub-id><pub-id pub-id-type="pmid">26908014</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Forte</surname><given-names>A. J.</given-names></name><name><surname>Berlin</surname><given-names>N. L.</given-names></name><name><surname>Alonso</surname><given-names>N.</given-names></name><name><surname>Persing</surname><given-names>J. A.</given-names></name><name><surname>Steinbacher</surname><given-names>D. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Reduced three-dimensional nasal airway volume in Treacher Collins syndrome and its association with craniofacial morphology</article-title>. <source/>Plast. Reconstr. Surg.
<volume>135</volume>, <fpage>885e</fpage>–<lpage>894e</lpage>. <pub-id pub-id-type="doi">10.1097/PRS.0000000000001160</pub-id><pub-id pub-id-type="pmid">25919271</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maas</surname><given-names>S. M.</given-names></name><name><surname>De Jong</surname><given-names>T. P.</given-names></name><name><surname>Buss</surname><given-names>P.</given-names></name><name><surname>Hennekam</surname><given-names>R. C.</given-names></name></person-group> (<year>1996</year>). <article-title>EEC syndrome and genitourinary anomalies: an update</article-title>. <source/>Am. J. Med. Genet.
<volume>63</volume>, <fpage>472</fpage>–<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19960614)63:3&lt;472::AID-AJMG11&gt;3.0.CO;2-J</pub-id><pub-id pub-id-type="pmid">8737655</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacColl</surname><given-names>G.</given-names></name><name><surname>Quinton</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Kallmann's syndrome: bridging the gaps</article-title>. <source/>J. Pediatr. Endocrinol. Metab.
<volume>18</volume>, <fpage>541</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1515/JPEM.2005.18.6.541</pub-id><pub-id pub-id-type="pmid">16042320</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magalhaes</surname><given-names>M.</given-names></name><name><surname>Araujo</surname><given-names>L.</given-names></name><name><surname>Chiaradia</surname><given-names>C.</given-names></name><name><surname>Fraige</surname><given-names>A.</given-names></name><name><surname>Zamunaro</surname><given-names>M.</given-names></name><name><surname>Mantesso</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Early dental management of patients with Mobius syndrome</article-title>. <source/>Oral Dis.
<volume>12</volume>, <fpage>533</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-0825.2006.01231.x</pub-id><pub-id pub-id-type="pmid">17054764</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magnifico</surname><given-names>M.</given-names></name><name><surname>Cassi</surname><given-names>D.</given-names></name><name><surname>Kasa</surname><given-names>I.</given-names></name><name><surname>Di Blasio</surname><given-names>M.</given-names></name><name><surname>Di Blasio</surname><given-names>A.</given-names></name><name><surname>Gandolfini</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Pre- and postsurgical orthodontics in patients with Moebius syndrome</article-title>. <source/>Case Rep. Dent.
<volume>2017</volume>:<fpage>1484065</fpage>. <pub-id pub-id-type="doi">10.1155/2017/1484065</pub-id><pub-id pub-id-type="pmid">28409036</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>A.</given-names></name><name><surname>Dixit</surname><given-names>J.</given-names></name><name><surname>Bhardwaj</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Gingival enlargement in neurofibromatosis type 1: a case report and literature review</article-title>. <source/>J. Contemp. Dent. Pract.
<volume>11</volume>, <fpage>057</fpage>–<lpage>063</lpage>. <pub-id pub-id-type="pmid">20228988</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martelli-Junior</surname><given-names>H.</given-names></name><name><surname>Coletta</surname><given-names>R. D.</given-names></name><name><surname>Miranda</surname><given-names>R. T.</given-names></name><name><surname>Barros</surname><given-names>L. M.</given-names></name><name><surname>Swerts</surname><given-names>M. S.</given-names></name><name><surname>Bonan</surname><given-names>P. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Orofacial features of Treacher Collins syndrome</article-title>. <source/>Med. Oral Patol. Oral Cir. Bucal
<volume>14</volume>, <fpage>E344</fpage>–<lpage>E348</lpage>. <pub-id pub-id-type="pmid">19300363</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins Mussi</surname><given-names>M. C.</given-names></name><name><surname>Moffa</surname><given-names>E.</given-names></name><name><surname>Castro</surname><given-names>T.</given-names></name><name><surname>Lira Ortega</surname><given-names>A.</given-names></name><name><surname>Freitas</surname><given-names>G.</given-names></name><name><surname>Braga</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Salivary parameters and oral health in the Moebius syndrome</article-title>. <source/>Spec. Care Dentist.
<volume>36</volume>, <fpage>265</fpage>–<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1111/scd.12175</pub-id><pub-id pub-id-type="pmid">27061084</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruko</surname><given-names>E.</given-names></name><name><surname>Hayes</surname><given-names>C.</given-names></name><name><surname>Evans</surname><given-names>C. A.</given-names></name><name><surname>Padwa</surname><given-names>B.</given-names></name><name><surname>Mulliken</surname><given-names>J. B.</given-names></name></person-group> (<year>2001</year>). <article-title>Hypodontia in hemifacial microsomia</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>38</volume>, <fpage>15</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1597/1545-1569(2001)038&lt;0015:HIHM&gt;2.0.CO;2</pub-id><pub-id pub-id-type="pmid">11204676</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsune</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name><name><surname>Tohma</surname><given-names>T.</given-names></name><name><surname>Asada</surname><given-names>Y.</given-names></name><name><surname>Ohashi</surname><given-names>H.</given-names></name><name><surname>Maeda</surname><given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>Craniofacial and dental characteristics of Kabuki syndrome</article-title>. <source/>Am. J. Med. Genet.
<volume>98</volume>, <fpage>185</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1002/1096-8628(20010115)98:2&lt;185::AID-AJMG1029&gt;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">11223856</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClure</surname><given-names>P.</given-names></name><name><surname>Booy</surname><given-names>D.</given-names></name><name><surname>Katarincic</surname><given-names>J.</given-names></name><name><surname>Eberson</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Orthopedic manifestations of Mobius syndrome: case series and survey study</article-title>. <source/>Int. J. Pediatr.
<volume>2016</volume>:<fpage>9736723</fpage>. <pub-id pub-id-type="doi">10.1155/2016/9736723</pub-id><pub-id pub-id-type="pmid">26977161</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKay</surname><given-names>V. H.</given-names></name><name><surname>Touil</surname><given-names>L. L.</given-names></name><name><surname>Jenkins</surname><given-names>D.</given-names></name><name><surname>Fattah</surname><given-names>A. Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Managing the child with a diagnosis of Moebius syndrome: more than meets the eye</article-title>. <source/>Arch. Dis. Child.
<volume>101</volume>, <fpage>843</fpage>–<lpage>846</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2015-310043</pub-id><pub-id pub-id-type="pmid">26868039</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Meroni</surname><given-names>G.</given-names></name></person-group> (<year>1993</year>). <article-title>X-linked Opitz G/BBB syndrome</article-title>, in <source/>GeneReviews(R), eds <person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>R. A.</given-names></name><name><surname>Adam</surname><given-names>M. P.</given-names></name><name><surname>Ardinger</surname><given-names>H. H.</given-names></name><name><surname>Wallace</surname><given-names>S. E.</given-names></name><name><surname>Amemiya</surname><given-names>A.</given-names></name><name><surname>Bean</surname><given-names>L. J. H.</given-names></name><name><surname>Bird</surname><given-names>T. D.</given-names></name><name><surname>Fong</surname><given-names>C. T.</given-names></name><name><surname>Mefford</surname><given-names>H. C.</given-names></name><name><surname>Smith</surname><given-names>R. J. H.</given-names></name><name><surname>Stephens</surname><given-names>K.</given-names></name></person-group> (<publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington, Seattle University of Washington, Seattle</publisher-name>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK1327/">https://www.ncbi.nlm.nih.gov/books/NBK1327/</ext-link></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsiadis</surname><given-names>T. A.</given-names></name><name><surname>Tucker</surname><given-names>A. S.</given-names></name><name><surname>De Bari</surname><given-names>C.</given-names></name><name><surname>Cobourne</surname><given-names>M. T.</given-names></name><name><surname>Rice</surname><given-names>D. P.</given-names></name></person-group> (<year>2008</year>). <article-title>A regulatory relationship between Tbx1 and FGF signaling during tooth morphogenesis and ameloblast lineage determination</article-title>. <source/>Dev. Biol.
<volume>320</volume>, <fpage>39</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2008.04.006</pub-id><pub-id pub-id-type="pmid">18572158</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molsted</surname><given-names>K.</given-names></name><name><surname>Kjaer</surname><given-names>I.</given-names></name><name><surname>Giwercman</surname><given-names>A.</given-names></name><name><surname>Vesterhauge</surname><given-names>S.</given-names></name><name><surname>Skakkebaek</surname><given-names>N. E.</given-names></name></person-group> (<year>1997</year>). <article-title>Craniofacial morphology in patients with Kallmann's syndrome with and without cleft lip and palate</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>34</volume>, <fpage>417</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1597/1545-1569(1997)034&lt;0417:CMIPWK&gt;2.3.CO;2</pub-id><pub-id pub-id-type="pmid">9345610</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori-Akiyama</surname><given-names>Y.</given-names></name><name><surname>Akiyama</surname><given-names>H.</given-names></name><name><surname>Rowitch</surname><given-names>D. H.</given-names></name><name><surname>De Crombrugghe</surname><given-names>B.</given-names></name></person-group> (<year>2003</year>). <article-title>Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>100</volume>, <fpage>9360</fpage>–<lpage>9365</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1631288100</pub-id><pub-id pub-id-type="pmid">12878728</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzzin</surname><given-names>K. B.</given-names></name><name><surname>Harper</surname><given-names>L. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Smith-Lemli-Opitz syndrome: a review, case report and dental implications</article-title>. <source/>Spec. Care Dentist.
<volume>23</volume>, <fpage>22</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1111/j.1754-4505.2003.tb00285.x</pub-id><pub-id pub-id-type="pmid">12887150</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nekulova</surname><given-names>M.</given-names></name><name><surname>Holcakova</surname><given-names>J.</given-names></name><name><surname>Coates</surname><given-names>P.</given-names></name><name><surname>Vojtesek</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of p63 in cancer, stem cells and cancer stem cells</article-title>. <source/>Cell. Mol. Biol. Lett.
<volume>16</volume>, <fpage>296</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.2478/s11658-011-0009-9</pub-id><pub-id pub-id-type="pmid">21442444</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nopoulos</surname><given-names>P.</given-names></name><name><surname>Berg</surname><given-names>S.</given-names></name><name><surname>Canady</surname><given-names>J.</given-names></name><name><surname>Richman</surname><given-names>L.</given-names></name><name><surname>Van Demark</surname><given-names>D.</given-names></name><name><surname>Andreasen</surname><given-names>N. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Structural brain abnormalities in adult males with clefts of the lip and/or palate</article-title>. <source/>Genet. Med.
<volume>4</volume>, <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/00125817-200201000-00001</pub-id><pub-id pub-id-type="pmid">11839951</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nopoulos</surname><given-names>P.</given-names></name><name><surname>Langbehn</surname><given-names>D. R.</given-names></name><name><surname>Canady</surname><given-names>J.</given-names></name><name><surname>Magnotta</surname><given-names>V.</given-names></name><name><surname>Richman</surname><given-names>L.</given-names></name></person-group> (<year>2007a</year>). <article-title>Abnormal brain structure in children with isolated clefts of the lip or palate</article-title>. <source/>Arch. Pediatr. Adolesc. Med.
<volume>161</volume>, <fpage>753</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1001/archpedi.161.8.753</pub-id><pub-id pub-id-type="pmid">17679656</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nopoulos</surname><given-names>P.</given-names></name><name><surname>Richman</surname><given-names>L.</given-names></name><name><surname>Andreasen</surname><given-names>N.</given-names></name><name><surname>Murray</surname><given-names>J. C.</given-names></name><name><surname>Schutte</surname><given-names>B.</given-names></name></person-group> (<year>2007b</year>). <article-title>Cognitive dysfunction in adults with Van der Woude syndrome</article-title>. <source/>Genet. Med.
<volume>9</volume>, <fpage>213</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1097/GIM.0b013e3180335abd</pub-id><pub-id pub-id-type="pmid">17438385</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordgarden</surname><given-names>H.</given-names></name><name><surname>Lima</surname><given-names>K.</given-names></name><name><surname>Skogedal</surname><given-names>N.</given-names></name><name><surname>Folling</surname><given-names>I.</given-names></name><name><surname>Storhaug</surname><given-names>K.</given-names></name><name><surname>Abrahamsen</surname><given-names>T. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Dental developmental disturbances in 50 individuals with the 22q11.2 deletion syndrome; relation to medical conditions?</article-title>
<source/>Acta Odontol. Scand.
<volume>70</volume>, <fpage>194</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.3109/00016357.2011.629624</pub-id><pub-id pub-id-type="pmid">22070626</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nouri</surname><given-names>M.</given-names></name><name><surname>Farzan</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Nonsurgical treatment of Hemifacial Microsomia: a case report</article-title>. <source/>Iran. Red Crescent Med. J.
<volume>17</volume>:<fpage>e19920</fpage>. <pub-id pub-id-type="doi">10.5812/ircmj.19920</pub-id><pub-id pub-id-type="pmid">26734473</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nugent</surname><given-names>N.</given-names></name><name><surname>McGillivary</surname><given-names>A.</given-names></name><name><surname>Earley</surname><given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>22q11 chromosome abnormalities and the cleft service</article-title>. <source/>J. Plast. Reconstr. Aesthet. Surg.
<volume>63</volume>, <fpage>598</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjps.2009.01.021</pub-id><pub-id pub-id-type="pmid">19249264</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberoi</surname><given-names>S.</given-names></name><name><surname>Vargervik</surname><given-names>K.</given-names></name></person-group> (<year>2005a</year>). <article-title>Hypoplasia and hypodontia in Van der Woude syndrome</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>42</volume>, <fpage>459</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1597/04-028.1</pub-id><pub-id pub-id-type="pmid">16149825</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberoi</surname><given-names>S.</given-names></name><name><surname>Vargervik</surname><given-names>K.</given-names></name></person-group> (<year>2005b</year>). <article-title>Velocardiofacial syndrome with single central incisor</article-title>. <source/>Am. J. Med. Genet. A
<volume>132A</volume>, <fpage>194</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30434</pub-id><pub-id pub-id-type="pmid">15578625</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberoi</surname><given-names>S.</given-names></name><name><surname>Huynh</surname><given-names>L.</given-names></name><name><surname>Vargervik</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Velopharyngeal, speech and dental characteristics as diagnostic aids in 22q11.2 deletion syndrome</article-title>. <source/>J. Calif. Dent. Assoc.
<volume>39</volume>, <fpage>327</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="pmid">21721477</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongkosuwito</surname><given-names>E. M.</given-names></name><name><surname>de Gijt</surname><given-names>P.</given-names></name><name><surname>Wattel</surname><given-names>E.</given-names></name><name><surname>Carels</surname><given-names>C. E.</given-names></name><name><surname>Kuijpers-Jagtman</surname><given-names>A. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Dental development in hemifacial microsomia</article-title>. <source/>J. Dent. Res.
<volume>89</volume>, <fpage>1368</fpage>–<lpage>1372</lpage>. <pub-id pub-id-type="doi">10.1177/0022034510378425</pub-id><pub-id pub-id-type="pmid">20739700</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongkosuwito</surname><given-names>E. M.</given-names></name><name><surname>van Neck</surname><given-names>J. W.</given-names></name><name><surname>Wattel</surname><given-names>E.</given-names></name><name><surname>van Adrichem</surname><given-names>L. N.</given-names></name><name><surname>Kuijpers-Jagtman</surname><given-names>A. M.</given-names></name></person-group> (<year>2013a</year>). <article-title>Craniofacial morphology in unilateral hemifacial microsomia</article-title>. <source/>Br. J. Oral Maxillofac. Surg.
<volume>51</volume>, <fpage>902</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjoms.2012.10.011</pub-id><pub-id pub-id-type="pmid">23201060</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongkosuwito</surname><given-names>E. M.</given-names></name><name><surname>van Vooren</surname><given-names>J.</given-names></name><name><surname>van Neck</surname><given-names>J. W.</given-names></name><name><surname>Wattel</surname><given-names>E.</given-names></name><name><surname>Wolvius</surname><given-names>E. B.</given-names></name><name><surname>van Adrichem</surname><given-names>L. N.</given-names></name><etal></etal></person-group>. (<year>2013b</year>). <article-title>Changes of mandibular ramal height, during growth in unilateral hemifacial microsomia patients and unaffected controls</article-title>. <source/>J. Craniomaxillofac. Surg.
<volume>41</volume>, <fpage>92</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcms.2012.05.006</pub-id><pub-id pub-id-type="pmid">22789870</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onofre</surname><given-names>M. A.</given-names></name><name><surname>Brosco</surname><given-names>H. B.</given-names></name><name><surname>Taga</surname><given-names>R.</given-names></name></person-group> (<year>1997</year>). <article-title>Relationship between lower-lip fistulae and cleft lip and/or palate in Von der Woude syndrome</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>34</volume>, <fpage>261</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1597/1545-1569(1997)034&lt;0261:RBLLFA&gt;2.3.CO;2</pub-id><pub-id pub-id-type="pmid">9167079</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parashar</surname><given-names>S. Y.</given-names></name><name><surname>Anderson</surname><given-names>P. J.</given-names></name><name><surname>Cox</surname><given-names>T. C.</given-names></name><name><surname>McLean</surname><given-names>N.</given-names></name><name><surname>David</surname><given-names>D. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Multidisciplinary management of Opitz G BBB syndrome</article-title>. <source/>Ann. Plast. Surg.
<volume>55</volume>, <fpage>402</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1097/01.sap.0000174355.56130.0a</pub-id><pub-id pub-id-type="pmid">16186708</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>P. M.</given-names></name><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Pannetier</surname><given-names>S.</given-names></name><name><surname>Heron</surname><given-names>D.</given-names></name><name><surname>Hanauer</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Coffin-lowry syndrome</article-title>. <source/>Eur. J. Hum. Genet.
<volume>18</volume>, <fpage>627</fpage>–<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2009.189</pub-id><pub-id pub-id-type="pmid">19888300</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>R. B.</given-names></name><name><surname>Lindholm</surname><given-names>P.</given-names></name><name><surname>Bonde</surname><given-names>C. T.</given-names></name></person-group> (<year>2010</year>). <article-title>[Kabuki syndrome]</article-title>. <source/>Ugeskr. Laeg.
<volume>172</volume>, <fpage>1384</fpage>–<lpage>1385</lpage>. <pub-id pub-id-type="pmid">20444412</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzold</surname><given-names>D.</given-names></name><name><surname>Kratzsch</surname><given-names>E.</given-names></name><name><surname>Opitz</surname><given-names>C.</given-names></name><name><surname>Tinschert</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>The Kabuki syndrome: four patients with oral abnormalities</article-title>. <source/>Eur. J. Orthod.
<volume>25</volume>, <fpage>13</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1093/ejo/25.1.13</pub-id><pub-id pub-id-type="pmid">12608719</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyrard-Janvid</surname><given-names>M.</given-names></name><name><surname>Leslie</surname><given-names>E. J.</given-names></name><name><surname>Kousa</surname><given-names>Y. A.</given-names></name><name><surname>Smith</surname><given-names>T. L.</given-names></name><name><surname>Dunnwald</surname><given-names>M.</given-names></name><name><surname>Magnusson</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Dominant mutations in GRHL3 cause Van der Woude Syndrome and disrupt oral periderm development</article-title>. <source/>Am. J. Hum. Genet.
<volume>94</volume>, <fpage>23</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.11.009</pub-id><pub-id pub-id-type="pmid">24360809</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>M.</given-names></name><name><surname>Conte</surname><given-names>F.</given-names></name><name><surname>Khandelwal</surname><given-names>K. D.</given-names></name><name><surname>Ockeloen</surname><given-names>C. W.</given-names></name><name><surname>Bartzela</surname><given-names>T.</given-names></name><name><surname>Kleefstra</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Tooth agenesis and orofacial clefting: genetic brothers in arms?</article-title>
<source/>Hum. Genet.
<volume>135</volume>, <fpage>1299</fpage>–<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-016-1733-z</pub-id><pub-id pub-id-type="pmid">27699475</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinna</surname><given-names>V.</given-names></name><name><surname>Lanari</surname><given-names>V.</given-names></name><name><surname>Daniele</surname><given-names>P.</given-names></name><name><surname>Consoli</surname><given-names>F.</given-names></name><name><surname>Agolini</surname><given-names>E.</given-names></name><name><surname>Margiotti</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas</article-title>. <source/>Eur. J. Hum. Genet.
<volume>23</volume>, <fpage>1068</fpage>–<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2014.243</pub-id><pub-id pub-id-type="pmid">25370043</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzo</surname><given-names>G.</given-names></name><name><surname>Piscopo</surname><given-names>M. R.</given-names></name><name><surname>Pizzo</surname><given-names>I.</given-names></name><name><surname>Giuliana</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Oral manifestations of Smith-Lemli-Opitz syndrome: a paediatric case report</article-title>. <source/>Eur. J. Paediatr. Dent.
<volume>9</volume>, <fpage>19</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="pmid">19886368</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plomp</surname><given-names>R. G.</given-names></name><name><surname>Mathijssen</surname><given-names>I. M.</given-names></name><name><surname>Moolenburgh</surname><given-names>S. E.</given-names></name><name><surname>van Montfort</surname><given-names>K. A.</given-names></name><name><surname>van der Meulen</surname><given-names>J. J.</given-names></name><name><surname>Poublon</surname><given-names>R. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Nasal sequelae of Treacher Collins syndrome</article-title>. <source/>J. Plast. Reconstr. Aesthet. Surg.
<volume>68</volume>, <fpage>771</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjps.2015.02.029</pub-id><pub-id pub-id-type="pmid">25862218</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>F. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Cholesterol precursors and facial clefting</article-title>. <source/>J. Clin. Invest.
<volume>116</volume>, <fpage>2322</fpage>–<lpage>2325</lpage>. <pub-id pub-id-type="doi">10.1172/JCI29872</pub-id><pub-id pub-id-type="pmid">16955133</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posnick</surname><given-names>J. C.</given-names></name><name><surname>Ruiz</surname><given-names>R. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Treacher Collins syndrome: current evaluation, treatment, and future directions</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>37</volume>:<fpage>434</fpage>. <pub-id pub-id-type="doi">10.1597/1545-1569(2000)037&lt;0434:TCSCET&gt;2.0.CO;2</pub-id><pub-id pub-id-type="pmid">11034023</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poswillo</surname><given-names>D.</given-names></name></person-group> (<year>1975</year>). <article-title>The pathogenesis of the Treacher Collins syndrome (mandibulofacial dysostosis)</article-title>. <source/>Br. J. Oral Surg.
<volume>13</volume>, <fpage>1</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/0007-117X(75)90019-0</pub-id><pub-id pub-id-type="pmid">807232</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pradel</surname><given-names>W.</given-names></name><name><surname>Bartsch</surname><given-names>O.</given-names></name><name><surname>Muller</surname><given-names>R.</given-names></name><name><surname>Lauer</surname><given-names>G.</given-names></name><name><surname>Eckelt</surname><given-names>U.</given-names></name></person-group> (<year>2003</year>). <article-title>[DiGeorge syndrome/velcardiofacial syndrome: oral and maxillofacial surgery]</article-title>. <source/>HNO
<volume>51</volume>, <fpage>755</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1007/s00106-003-0874-2</pub-id><pub-id pub-id-type="pmid">12955254</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaderi</surname><given-names>N. A.</given-names></name><name><surname>Schweiger</surname><given-names>S.</given-names></name><name><surname>Gaudenz</surname><given-names>K.</given-names></name><name><surname>Franco</surname><given-names>B.</given-names></name><name><surname>Rugarli</surname><given-names>E. I.</given-names></name><name><surname>Berger</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22</article-title>. <source/>Nat. Genet.
<volume>17</volume>, <fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/ng1197-285</pub-id><pub-id pub-id-type="pmid">9354791</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname><given-names>A. M.</given-names></name><name><surname>Hernandez</surname><given-names>J. A.</given-names></name><name><surname>Gonzalez</surname><given-names>C. G.</given-names></name></person-group> (<year>2017</year>). <article-title>Functional analysis of the zebrafish ortholog of HMGCS1 reveals independent functions for cholesterol and isoprenoids in craniofacial development</article-title>. <source/>PLoS ONE
<volume>12</volume>:<fpage>e0180856</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0180856</pub-id><pub-id pub-id-type="pmid">28686747</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajpopat</surname><given-names>S.</given-names></name><name><surname>Moss</surname><given-names>C.</given-names></name><name><surname>Mellerio</surname><given-names>J.</given-names></name><name><surname>Vahlquist</surname><given-names>A.</given-names></name><name><surname>Ganemo</surname><given-names>A.</given-names></name><name><surname>Hellstrom-Pigg</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases</article-title>. <source/>Arch. Dermatol.
<volume>147</volume>, <fpage>681</fpage>–<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1001/archdermatol.2011.9</pub-id><pub-id pub-id-type="pmid">21339420</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranta</surname><given-names>R.</given-names></name></person-group> (<year>1986</year>). <article-title>A review of tooth formation in children with cleft lip/palate</article-title>. <source/>Am. J. Orthod. Dentofacial Orthop.
<volume>90</volume>, <fpage>11</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/0889-5406(86)90022-3</pub-id><pub-id pub-id-type="pmid">3524249</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranta</surname><given-names>R.</given-names></name><name><surname>Rintala</surname><given-names>A.</given-names></name></person-group> (<year>1982</year>). <article-title>Tooth anomalies associated with congenital sinuses of the lower lip and cleft lip/palate</article-title>. <source/>Angle Orthod.
<volume>52</volume>, <fpage>212</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="pmid">6959547</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remberger</surname><given-names>K.</given-names></name><name><surname>Krieg</surname><given-names>T.</given-names></name><name><surname>Kunze</surname><given-names>D.</given-names></name><name><surname>Weinmann</surname><given-names>H. M.</given-names></name><name><surname>Hubner</surname><given-names>G.</given-names></name></person-group> (<year>1985</year>). <article-title>Fibromatosis hyalinica multiplex (juvenile hyalin fibromatosis). Light microscopic, electron microscopic, immunohistochemical, and biochemical findings</article-title>. <source/>Cancer
<volume>56</volume>, <fpage>614</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1002/1097-0142(19850801)56:3&lt;614::AID-CNCR2820560331&gt;3.0.CO;2-T</pub-id><pub-id pub-id-type="pmid">2408738</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinne</surname><given-names>T.</given-names></name><name><surname>Hamel</surname><given-names>B.</given-names></name><name><surname>van Bokhoven</surname><given-names>H.</given-names></name><name><surname>Brunner</surname><given-names>H. G.</given-names></name></person-group> (<year>2006</year>). <article-title>Pattern of p63 mutations and their phenotypes–update</article-title>. <source/>Am. J. Med. Genet. A
<volume>140</volume>, <fpage>1396</fpage>–<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31271</pub-id><pub-id pub-id-type="pmid">16691622</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rintala</surname><given-names>A. E.</given-names></name><name><surname>Ranta</surname><given-names>R.</given-names></name></person-group> (<year>1981</year>). <article-title>Lower lip sinuses: I. Epidemiology, microforms and transverse sulci</article-title>. <source/>Br. J. Plast. Surg.
<volume>34</volume>, <fpage>26</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/0007-1226(81)90090-4</pub-id><pub-id pub-id-type="pmid">7459520</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizos</surname><given-names>M.</given-names></name><name><surname>Spyropoulos</surname><given-names>M. N.</given-names></name></person-group> (<year>2004</year>). <article-title>Van der Woude syndrome: a review. Cardinal signs, epidemiology, associated features, differential diagnosis, expressivity, genetic counselling and treatment</article-title>. <source/>Eur. J. Orthod.
<volume>26</volume>, <fpage>17</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1093/ejo/26.1.17</pub-id><pub-id pub-id-type="pmid">14994878</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robin</surname><given-names>P.</given-names></name></person-group> (<year>1923</year>). <article-title>Backward fall of the root of the tongue as cause of respiratory disturbances</article-title>. <source/>Bull. Acad. Nat. Med. <volume>89</volume>, <fpage>37</fpage>–<lpage>41</lpage>.</mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robin</surname><given-names>P.</given-names></name></person-group> (<year>1934</year>). <article-title>Glossoptosis due to atresia and hypotrophy of mandible</article-title>. <source/>Am. J. Dis. Child. <volume>48</volume>, <fpage>541</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1001/archpedi.1934.01960160063005</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>C. T.</given-names></name><name><surname>Peixoto</surname><given-names>I. T.</given-names></name><name><surname>Fernandes</surname><given-names>P. M.</given-names></name><name><surname>Torres</surname><given-names>C. P.</given-names></name><name><surname>de Queiroz</surname><given-names>A. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Dental findings in Kabuki make-up syndrome: a case report</article-title>. <source/>Spec. Care Dentist.
<volume>28</volume>, <fpage>53</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1111/j.1754-4505.2008.00011.x</pub-id><pub-id pub-id-type="pmid">18402617</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roelfsema</surname><given-names>N. M.</given-names></name><name><surname>Cobben</surname><given-names>J. M.</given-names></name></person-group> (<year>1996</year>). <article-title>The EEC syndrome: a literature study</article-title>. <source/>Clin. Dysmorphol.
<volume>5</volume>, <fpage>115</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1097/00019605-199604000-00003</pub-id><pub-id pub-id-type="pmid">8723561</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>G. F.</given-names></name><name><surname>Lim</surname><given-names>A. A.</given-names></name><name><surname>Mulliken</surname><given-names>J. B.</given-names></name><name><surname>Padwa</surname><given-names>B. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Effect of a syndromic diagnosis on mandibular size and sagittal position in Robin sequence</article-title>. <source/>J. Oral Maxillofac. Surg.
<volume>67</volume>, <fpage>2323</fpage>–<lpage>2331</lpage>. <pub-id pub-id-type="doi">10.1016/j.joms.2009.06.010</pub-id><pub-id pub-id-type="pmid">19837298</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>R. A.</given-names></name><name><surname>Solomon</surname><given-names>L. W.</given-names></name><name><surname>Sinha</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Tp63 in oral development, neoplasia, and autoimmunity</article-title>. <source/>J. Dent. Res.
<volume>91</volume>, <fpage>125</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1177/0022034511411302</pub-id><pub-id pub-id-type="pmid">21646640</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruggieri</surname><given-names>M.</given-names></name><name><surname>Huson</surname><given-names>S. M.</given-names></name></person-group> (<year>2001</year>). <article-title>The clinical and diagnostic implications of mosaicism in the neurofibromatoses</article-title>. <source/>Neurology
<volume>56</volume>, <fpage>1433</fpage>–<lpage>1443</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.56.11.1433</pub-id><pub-id pub-id-type="pmid">11409413</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>A. K.</given-names></name><name><surname>Goodship</surname><given-names>J. A.</given-names></name><name><surname>Wilson</surname><given-names>D. I.</given-names></name><name><surname>Philip</surname><given-names>N.</given-names></name><name><surname>Levy</surname><given-names>A.</given-names></name><name><surname>Seidel</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study</article-title>. <source/>J. Med. Genet.
<volume>34</volume>, <fpage>798</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.34.10.798</pub-id><pub-id pub-id-type="pmid">9350810</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saher</surname><given-names>G.</given-names></name><name><surname>Stumpf</surname><given-names>S. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Cholesterol in myelin biogenesis and hypomyelinating disorders</article-title>. <source/>Biochim. Biophys. Acta
<volume>1851</volume>, <fpage>1083</fpage>–<lpage>1094</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2015.02.010</pub-id><pub-id pub-id-type="pmid">25724171</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>D.</given-names></name><name><surname>Dixon</surname><given-names>J.</given-names></name><name><surname>Achilleos</surname><given-names>A.</given-names></name><name><surname>Dixon</surname><given-names>M.</given-names></name><name><surname>Trainor</surname><given-names>P. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>10328</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms10328</pub-id><pub-id pub-id-type="pmid">26792133</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sant'Anna</surname><given-names>E. F.</given-names></name><name><surname>Lau</surname><given-names>G. W.</given-names></name><name><surname>Marquezan</surname><given-names>M.</given-names></name><name><surname>de Souza Araujo</surname><given-names>M. T.</given-names></name><name><surname>Polley</surname><given-names>J. W.</given-names></name><name><surname>Figueroa</surname><given-names>A. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Combined maxillary and mandibular distraction osteogenesis in patients with hemifacial microsomia</article-title>. <source/>Am. J. Orthod. Dentofacial Orthop.
<volume>147</volume>, <fpage>566</fpage>–<lpage>577</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajodo.2014.12.027</pub-id><pub-id pub-id-type="pmid">25919102</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>N.</given-names></name><name><surname>Katsumata</surname><given-names>N.</given-names></name><name><surname>Kagami</surname><given-names>M.</given-names></name><name><surname>Hasegawa</surname><given-names>T.</given-names></name><name><surname>Hori</surname><given-names>N.</given-names></name><name><surname>Kawakita</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>89</volume>, <fpage>1079</fpage>–<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2003-030476</pub-id><pub-id pub-id-type="pmid">15001591</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarano</surname><given-names>A.</given-names></name><name><surname>Artese</surname><given-names>L.</given-names></name><name><surname>Annibali</surname><given-names>S.</given-names></name><name><surname>Piccolomini</surname><given-names>M.</given-names></name><name><surname>Piattelli</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Bilateral diffuse gingival enlargement in a patient with type 1 neurofibromatosis</article-title>. <source/>J. Otolaryngol.
<volume>34</volume>, <fpage>282</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.2310/7070.2005.34420</pub-id><pub-id pub-id-type="pmid">16048707</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrander-Stumpel</surname><given-names>C. T.</given-names></name><name><surname>Spruyt</surname><given-names>L.</given-names></name><name><surname>Curfs</surname><given-names>L. M.</given-names></name><name><surname>Defloor</surname><given-names>T.</given-names></name><name><surname>Schrander</surname><given-names>J. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Kabuki syndrome: clinical data in 20 patients, literature review, and further guidelines for preventive management</article-title>. <source/>Am. J. Med. Genet. A
<volume>132A</volume>, <fpage>234</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30331</pub-id><pub-id pub-id-type="pmid">15690368</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seow</surname><given-names>W. K.</given-names></name><name><surname>Urban</surname><given-names>S.</given-names></name><name><surname>Vafaie</surname><given-names>N.</given-names></name><name><surname>Shusterman</surname><given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>Morphometric analysis of the primary and permanent dentitions in hemifacial microsomia: a controlled study</article-title>. <source/>J. Dent. Res.
<volume>77</volume>, <fpage>27</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1177/00220345980770010201</pub-id><pub-id pub-id-type="pmid">9437397</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>N.</given-names></name><name><surname>Talwar</surname><given-names>T.</given-names></name><name><surname>Gupta</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Mobius syndrome associated with neurofibromatosis Type 1: a rare co-occurrence</article-title>. <source/>J. Pediatr. Neurosci.
<volume>10</volume>, <fpage>172</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.4103/1817-1745.159205</pub-id><pub-id pub-id-type="pmid">26167228</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>A.</given-names></name><name><surname>Longman</surname><given-names>C.</given-names></name><name><surname>Irving</surname><given-names>M.</given-names></name><name><surname>Splitt</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Neonatal teeth in X-linked Opitz (G/BBB) syndrome</article-title>. <source/>Clin. Dysmorphol.
<volume>15</volume>, <fpage>185</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1097/01.mcd.0000198931.09330.e8</pub-id><pub-id pub-id-type="pmid">16760742</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibazaki-Yorozuya</surname><given-names>R.</given-names></name><name><surname>Yamada</surname><given-names>A.</given-names></name><name><surname>Nagata</surname><given-names>S.</given-names></name><name><surname>Ueda</surname><given-names>K.</given-names></name><name><surname>Miller</surname><given-names>A. J.</given-names></name><name><surname>Maki</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Three-dimensional longitudinal changes in craniofacial growth in untreated hemifacial microsomia patients with cone-beam computed tomography</article-title>. <source/>Am. J. Orthod. Dentofacial Orthop.
<volume>145</volume>, <fpage>579</fpage>–<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajodo.2013.09.015</pub-id><pub-id pub-id-type="pmid">24785922</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>K. M.</given-names></name><name><surname>Hopwood</surname><given-names>B.</given-names></name><name><surname>Yi</surname><given-names>Z.</given-names></name><name><surname>Cox</surname><given-names>T. C.</given-names></name></person-group> (<year>2002</year>). <article-title>MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders</article-title>. <source/>BMC Cell Biol.
<volume>3</volume>:<fpage>1</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2121-3-1</pub-id><pub-id pub-id-type="pmid">11806752</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shprintzen</surname><given-names>R. J.</given-names></name><name><surname>Goldberg</surname><given-names>R. B.</given-names></name><name><surname>Lewin</surname><given-names>M. L.</given-names></name><name><surname>Sidoti</surname><given-names>E. J.</given-names></name><name><surname>Berkman</surname><given-names>M. D.</given-names></name><name><surname>Argamaso</surname><given-names>R. V.</given-names></name><etal></etal></person-group>. (<year>1978</year>). <article-title>A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome</article-title>. <source/>Cleft Palate J.
<volume>15</volume>, <fpage>56</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="pmid">272242</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shprintzen</surname><given-names>R. J.</given-names></name><name><surname>Goldberg</surname><given-names>R. B.</given-names></name><name><surname>Young</surname><given-names>D.</given-names></name><name><surname>Wolford</surname><given-names>L.</given-names></name></person-group> (<year>1981</year>). <article-title>The velo-cardio-facial syndrome: a clinical and genetic analysis</article-title>. <source/>Pediatrics
<volume>67</volume>, <fpage>167</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="pmid">7243439</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigillo</surname><given-names>R.</given-names></name><name><surname>Rivera</surname><given-names>H.</given-names></name><name><surname>Nikitakis</surname><given-names>N. G.</given-names></name><name><surname>Sauk</surname><given-names>J. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Neurofibromatosis type 1: a clinicopathological study of the orofacial manifestations in 6 pediatric patients</article-title>. <source/>Pediatr. Dent.
<volume>24</volume>, <fpage>575</fpage>–<lpage>580</lpage>. <pub-id pub-id-type="pmid">12528952</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjogreen</surname><given-names>L.</given-names></name><name><surname>Andersson-Norinder</surname><given-names>J.</given-names></name><name><surname>Jacobsson</surname><given-names>C.</given-names></name></person-group> (<year>2001</year>). <article-title>Development of speech, feeding, eating, and facial expression in Mobius sequence</article-title>. <source/>Int. J. Pediatr. Otorhinolaryngol.
<volume>60</volume>, <fpage>197</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-5876(01)00532-8</pub-id><pub-id pub-id-type="pmid">11551610</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjogreen</surname><given-names>L.</given-names></name><name><surname>Lohmander</surname><given-names>A.</given-names></name><name><surname>Kiliaridis</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Exploring quantitative methods for evaluation of lip function</article-title>. <source/>J. Oral Rehabil.
<volume>38</volume>, <fpage>410</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2842.2010.02168.x</pub-id><pub-id pub-id-type="pmid">20969612</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D. W.</given-names></name><name><surname>Lemli</surname><given-names>L.</given-names></name><name><surname>Opitz</surname><given-names>J. M.</given-names></name></person-group> (<year>1964</year>). <article-title>A newly recognized syndrome of multiple congenital abnormalities</article-title>. <source/>J. Pediatr.
<volume>64</volume>, <fpage>210</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(64)80264-X</pub-id><pub-id pub-id-type="pmid">14119520</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spano</surname><given-names>G.</given-names></name><name><surname>Campus</surname><given-names>G.</given-names></name><name><surname>Bortone</surname><given-names>A.</given-names></name><name><surname>Lai</surname><given-names>V.</given-names></name><name><surname>Luglie</surname><given-names>P. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Oral features in Kabuki make-up Syndrome</article-title>. <source/>Eur. J. Paediatr. Dent.
<volume>9</volume>, <fpage>149</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="pmid">18844445</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sripathomsawat</surname><given-names>W.</given-names></name><name><surname>Tanpaiboon</surname><given-names>P.</given-names></name><name><surname>Heering</surname><given-names>J.</given-names></name><name><surname>Dotsch</surname><given-names>V.</given-names></name><name><surname>Hennekam</surname><given-names>R. C.</given-names></name><name><surname>Kantaputra</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Phenotypic analysis of Arg227 mutations of TP63 with emphasis on dental phenotype and micturition difficulties in EEC syndrome</article-title>. <source/>Am. J. Med. Genet. A
<volume>155A</volume>, <fpage>228</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33768</pub-id><pub-id pub-id-type="pmid">21204238</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stalmans</surname><given-names>I.</given-names></name><name><surname>Lambrechts</surname><given-names>D.</given-names></name><name><surname>De Smet</surname><given-names>F.</given-names></name><name><surname>Jansen</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Maity</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>VEGF: a modifier of the del22q11 (DiGeorge) syndrome?</article-title>
<source/>Nat. Med.
<volume>9</volume>, <fpage>173</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1038/nm819</pub-id><pub-id pub-id-type="pmid">12539040</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stromland</surname><given-names>K.</given-names></name><name><surname>Sjogreen</surname><given-names>L.</given-names></name><name><surname>Miller</surname><given-names>M.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Wentz</surname><given-names>E.</given-names></name><name><surname>Johansson</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Mobius sequence–a Swedish multidiscipline study</article-title>. <source/>Eur. J. Paediatr. Neurol.
<volume>6</volume>, <fpage>35</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1053/ejpn.2001.0540</pub-id><pub-id pub-id-type="pmid">11993954</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suri</surname><given-names>S.</given-names></name><name><surname>Tompson</surname><given-names>B. D.</given-names></name><name><surname>Cornfoot</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Cranial base, maxillary and mandibular morphology in Down syndrome</article-title>. <source/>Angle Orthod.
<volume>80</volume>, <fpage>861</fpage>–<lpage>869</lpage>. <pub-id pub-id-type="doi">10.2319/111709-650.1</pub-id><pub-id pub-id-type="pmid">20578856</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szpalski</surname><given-names>C.</given-names></name><name><surname>Vandegrift</surname><given-names>M.</given-names></name><name><surname>Patel</surname><given-names>P. A.</given-names></name><name><surname>Appelboom</surname><given-names>G.</given-names></name><name><surname>Fisher</surname><given-names>M.</given-names></name><name><surname>Marcus</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Unilateral craniofacial microsomia: unrecognized cause of pediatric obstructive sleep apnea</article-title>. <source/>J. Craniofac. Surg.
<volume>26</volume>, <fpage>1277</fpage>–<lpage>1282</lpage>. <pub-id pub-id-type="doi">10.1097/SCS.0000000000001551</pub-id><pub-id pub-id-type="pmid">26080175</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanwar</surname><given-names>R.</given-names></name><name><surname>Iyengar</surname><given-names>A. R.</given-names></name><name><surname>Nagesh</surname><given-names>K. S.</given-names></name><name><surname>Subhash</surname><given-names>B. V.</given-names></name></person-group> (<year>2013</year>). <article-title>Crouzons syndrome: a case report with review of literature</article-title>. <source/>J. Indian Soc. Pedod. Prev. Dent.
<volume>31</volume>, <fpage>118</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.4103/0970-4388.115716</pub-id><pub-id pub-id-type="pmid">23886724</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>C. S.</given-names></name><name><surname>Silva</surname><given-names>C. R.</given-names></name><name><surname>Honjo</surname><given-names>R. S.</given-names></name><name><surname>Bertola</surname><given-names>D. R.</given-names></name><name><surname>Albano</surname><given-names>L. M.</given-names></name><name><surname>Kim</surname><given-names>C. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Dental evaluation of Kabuki syndrome patients</article-title>. <source/>Cleft Palate Craniofac. J.
<volume>46</volume>, <fpage>668</fpage>–<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1597/08-077.1</pub-id><pub-id pub-id-type="pmid">19860501</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tekin</surname><given-names>M.</given-names></name><name><surname>Fitoz</surname><given-names>S.</given-names></name><name><surname>Arici</surname><given-names>S.</given-names></name><name><surname>Cetinkaya</surname><given-names>E.</given-names></name><name><surname>Incesulu</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Niikawa-Kuroki (Kabuki) syndrome with congenital sensorineural deafness: evidence for a wide spectrum of inner ear abnormalities</article-title>. <source/>Int. J. Pediatr. Otorhinolaryngol.
<volume>70</volume>, <fpage>885</fpage>–<lpage>889</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijporl.2005.09.025</pub-id><pub-id pub-id-type="pmid">16325926</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temtamy</surname><given-names>S. A.</given-names></name><name><surname>Miller</surname><given-names>J. D.</given-names></name><name><surname>Hussels-Maumenee</surname><given-names>I.</given-names></name></person-group> (<year>1975</year>). <article-title>The Coffin-Lowry syndrome: an inherited faciodigital mental retardation syndrome</article-title>. <source/>J. Pediatr.
<volume>86</volume>, <fpage>724</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(75)80357-X</pub-id><pub-id pub-id-type="pmid">1133653</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>The Gene Ontology Consortium</collab></person-group> (<year>2015</year>). <article-title>Gene Ontology Consortium: going forward</article-title>. <source/>Nucleic Acids Res.
<volume>43</volume>, <fpage>D1049</fpage>–<lpage>D1056</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1179</pub-id><pub-id pub-id-type="pmid">25428369</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomason</surname><given-names>H. A.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Kouwenhoven</surname><given-names>E. N.</given-names></name><name><surname>Dotto</surname><given-names>G. P.</given-names></name><name><surname>Restivo</surname><given-names>G.</given-names></name><name><surname>Nguyen</surname><given-names>B. C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice</article-title>. <source/>J. Clin. Invest.
<volume>120</volume>, <fpage>1561</fpage>–<lpage>1569</lpage>. <pub-id pub-id-type="doi">10.1172/JCI40266</pub-id><pub-id pub-id-type="pmid">20424327</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tint</surname><given-names>G. S.</given-names></name><name><surname>Salen</surname><given-names>G.</given-names></name><name><surname>Batta</surname><given-names>A. K.</given-names></name><name><surname>Shefer</surname><given-names>S.</given-names></name><name><surname>Irons</surname><given-names>M.</given-names></name><name><surname>Elias</surname><given-names>E. R.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome</article-title>. <source/>J. Pediatr.
<volume>127</volume>, <fpage>82</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(95)70261-X</pub-id><pub-id pub-id-type="pmid">7608816</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toka</surname><given-names>O.</given-names></name><name><surname>Karl</surname><given-names>M.</given-names></name><name><surname>Dittrich</surname><given-names>S.</given-names></name><name><surname>Holst</surname><given-names>S.</given-names></name><name><surname>Holst</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Dental aspects in patients with DiGeorge syndrome</article-title>. <source/>Quintessence Int.
<volume>41</volume>, <fpage>551</fpage>–<lpage>556</lpage>. <pub-id pub-id-type="pmid">20614041</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Touraine</surname><given-names>R. L.</given-names></name><name><surname>Zeniou</surname><given-names>M.</given-names></name><name><surname>Hanauer</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>A syndromic form of X-linked mental retardation: the Coffin-Lowry syndrome</article-title>. <source/>Eur. J. Pediatr.
<volume>161</volume>, <fpage>179</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1007/s00431-001-0904-6</pub-id><pub-id pub-id-type="pmid">12014383</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trainor</surname><given-names>P. A.</given-names></name><name><surname>Andrews</surname><given-names>B. T.</given-names></name></person-group> (<year>2013</year>). <article-title>Facial dysostoses: etiology, pathogenesis and management</article-title>. <source/>Am. J. Med. Genet. C Semin. Med. Genet.
<volume>163</volume>, <fpage>283</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.31375</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuna</surname><given-names>E. B.</given-names></name><name><surname>Marsan</surname><given-names>G.</given-names></name><name><surname>Gencay</surname><given-names>K.</given-names></name><name><surname>Seymen</surname><given-names>F.</given-names></name></person-group> (<year>2012</year>). <article-title>Craniofacial and dental characteristics of Kabuki syndrome: nine years cephalometric follow-up</article-title>. <source/>J. Clin. Pediatr. Dent.
<volume>36</volume>, <fpage>393</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.17796/jcpd.36.4.u021164272805116</pub-id><pub-id pub-id-type="pmid">23019839</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>C.</given-names></name><name><surname>Lachlan</surname><given-names>K.</given-names></name><name><surname>Amerasinghe</surname><given-names>N.</given-names></name><name><surname>Hodgkins</surname><given-names>P.</given-names></name><name><surname>Maloney</surname><given-names>V.</given-names></name><name><surname>Barber</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Kabuki syndrome: new ocular findings but no evidence of 8p22-p23.1 duplications in a clinically defined cohort</article-title>. <source/>Eur. J. Hum. Genet.
<volume>13</volume>, <fpage>716</fpage>–<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201377</pub-id><pub-id pub-id-type="pmid">15785777</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twigg</surname><given-names>S. R.</given-names></name><name><surname>Wilkie</surname><given-names>A. O.</given-names></name></person-group> (<year>2015</year>). <article-title>New insights into craniofacial malformations</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>R50</fpage>–<lpage>R59</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv228</pub-id><pub-id pub-id-type="pmid">26085576</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uusitalo</surname><given-names>E.</given-names></name><name><surname>Leppavirta</surname><given-names>J.</given-names></name><name><surname>Koffert</surname><given-names>A.</given-names></name><name><surname>Suominen</surname><given-names>S.</given-names></name><name><surname>Vahtera</surname><given-names>J.</given-names></name><name><surname>Vahlberg</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Incidence and mortality of neurofibromatosis: a total population study in Finland</article-title>. <source/>J. Invest. Dermatol.
<volume>135</volume>, <fpage>904</fpage>–<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2014.465</pub-id><pub-id pub-id-type="pmid">25354145</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdez</surname><given-names>B. C.</given-names></name><name><surname>Henning</surname><given-names>D.</given-names></name><name><surname>So</surname><given-names>R. B.</given-names></name><name><surname>Dixon</surname><given-names>J.</given-names></name><name><surname>Dixon</surname><given-names>M. J.</given-names></name></person-group> (<year>2004</year>). <article-title>The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>101</volume>, <fpage>10709</fpage>–<lpage>10714</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0402492101</pub-id><pub-id pub-id-type="pmid">15249688</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Bokhoven</surname><given-names>H.</given-names></name><name><surname>Hamel</surname><given-names>B. C.</given-names></name><name><surname>Bamshad</surname><given-names>M.</given-names></name><name><surname>Sangiorgi</surname><given-names>E.</given-names></name><name><surname>Gurrieri</surname><given-names>F.</given-names></name><name><surname>Duijf</surname><given-names>P. H.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation</article-title>. <source/>Am. J. Hum. Genet.
<volume>69</volume>, <fpage>481</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1086/323123</pub-id><pub-id pub-id-type="pmid">11462173</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Woude</surname><given-names>A.</given-names></name></person-group> (<year>1954</year>). <article-title>Fistula labii inferioris congenita and its association with cleft lip and palate</article-title>. <source/>Am. J. Hum. Genet.
<volume>6</volume>, <fpage>244</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="pmid">13158329</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Zwaag</surname><given-names>B.</given-names></name><name><surname>Verzijl</surname><given-names>H. T.</given-names></name><name><surname>Beltran-Valero De Bernabe</surname><given-names>D.</given-names></name><name><surname>Schuster</surname><given-names>V. L.</given-names></name><name><surname>Van Bokhoven</surname><given-names>H.</given-names></name><name><surname>Kremer</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Mutation analysis in the candidate Mobius syndrome genes PGT and GATA2 on chromosome 3 and EGR2 on chromosome 10</article-title>. <source/>J. Med. Genet.
<volume>39</volume>:<fpage>E30</fpage>. <pub-id pub-id-type="doi">10.1136/jmg.39.6.e30</pub-id><pub-id pub-id-type="pmid">12070262</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Laarhoven</surname><given-names>P. M.</given-names></name><name><surname>Neitzel</surname><given-names>L. R.</given-names></name><name><surname>Quintana</surname><given-names>A. M.</given-names></name><name><surname>Geiger</surname><given-names>E. A.</given-names></name><name><surname>Zackai</surname><given-names>E. H.</given-names></name><name><surname>Clouthier</surname><given-names>D. E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>4443</fpage>–<lpage>4453</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv180</pub-id><pub-id pub-id-type="pmid">25972376</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Lieshout</surname><given-names>M. J.</given-names></name><name><surname>Joosten</surname><given-names>K. F.</given-names></name><name><surname>Hoeve</surname><given-names>H. L.</given-names></name><name><surname>Mathijssen</surname><given-names>I. M.</given-names></name><name><surname>Koudstaal</surname><given-names>M. J.</given-names></name><name><surname>Wolvius</surname><given-names>E. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Unravelling Robin sequence: considerations of diagnosis and treatment</article-title>. <source/>Laryngoscope
<volume>124</volume>, <fpage>E203</fpage>–<lpage>E209</lpage>. <pub-id pub-id-type="doi">10.1002/lary.24437</pub-id><pub-id pub-id-type="pmid">24115087</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaux</surname><given-names>K. K.</given-names></name><name><surname>Jones</surname><given-names>K. L.</given-names></name><name><surname>Jones</surname><given-names>M. C.</given-names></name><name><surname>Schelley</surname><given-names>S.</given-names></name><name><surname>Hudgins</surname><given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Developmental outcome in Kabuki syndrome</article-title>. <source/>Am. J. Med. Genet. A
<volume>132A</volume>, <fpage>263</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30338</pub-id><pub-id pub-id-type="pmid">15523636</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verzijl</surname><given-names>H. T.</given-names></name><name><surname>Van Der Zwaag</surname><given-names>B.</given-names></name><name><surname>Cruysberg</surname><given-names>J. R.</given-names></name><name><surname>Padberg</surname><given-names>G. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Mobius syndrome redefined: a syndrome of rhombencephalic maldevelopment</article-title>. <source/>Neurology
<volume>61</volume>, <fpage>327</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1212/01.WNL.0000076484.91275.CD</pub-id><pub-id pub-id-type="pmid">12913192</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>M.</given-names></name><name><surname>Genevieve</surname><given-names>D.</given-names></name><name><surname>Ostertag</surname><given-names>A.</given-names></name><name><surname>Marlin</surname><given-names>S.</given-names></name><name><surname>Lacombe</surname><given-names>D.</given-names></name><name><surname>Martin-Coignard</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Treacher Collins syndrome: a clinical and molecular study based on a large series of patients</article-title>. <source/>Genet. Med.
<volume>18</volume>, <fpage>49</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.29</pub-id><pub-id pub-id-type="pmid">25790162</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vink</surname><given-names>C. P.</given-names></name><name><surname>Ockeloen</surname><given-names>C. W.</given-names></name><name><surname>ten Kate</surname><given-names>S.</given-names></name><name><surname>Koolen</surname><given-names>D. A.</given-names></name><name><surname>Ploos van Amstel</surname><given-names>J. K.</given-names></name><name><surname>Kuijpers-Jagtman</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Variability in dentofacial phenotypes in four families with WNT10A mutations</article-title>. <source/>Eur. J. Hum. Genet.
<volume>22</volume>, <fpage>1063</fpage>–<lpage>1070</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2013.300</pub-id><pub-id pub-id-type="pmid">24398796</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visnapuu</surname><given-names>V.</given-names></name><name><surname>Peltonen</surname><given-names>S.</given-names></name><name><surname>Tammisalo</surname><given-names>T.</given-names></name><name><surname>Peltonen</surname><given-names>J.</given-names></name><name><surname>Happonen</surname><given-names>R. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Radiographic findings in the jaws of patients with neurofibromatosis 1</article-title>. <source/>J. Oral Maxillofac. Surg.
<volume>70</volume>, <fpage>1351</fpage>–<lpage>1357</lpage>. <pub-id pub-id-type="doi">10.1016/j.joms.2011.06.204</pub-id><pub-id pub-id-type="pmid">21856061</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallis</surname><given-names>C. E.</given-names></name></person-group> (<year>1988</year>). <article-title>Ectrodactyly (split-hand/split-foot) and ectodermal dysplasia with normal lip and palate in a four-generation kindred</article-title>. <source/>Clin. Genet.
<volume>34</volume>, <fpage>252</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.1988.tb02872.x</pub-id><pub-id pub-id-type="pmid">3233778</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J. L.</given-names></name><name><surname>Chen</surname><given-names>S. J.</given-names></name><name><surname>Chung</surname><given-names>M. Y.</given-names></name><name><surname>Niu</surname><given-names>D. M.</given-names></name><name><surname>Lin</surname><given-names>C. Y.</given-names></name><name><surname>Hwang</surname><given-names>B. T.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>DiGeorge syndrome with microdeletion of chromosome 22q11.2: report of one case</article-title>. <source/>Zhonghua Min. Guo. Xiao Er Ke Yi Xue Hui Za Zhi
<volume>38</volume>, <fpage>385</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="pmid">9401184</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>F.</given-names></name><name><surname>Tao</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Portnof</surname><given-names>J. E.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Utilization of three-dimensional computed tomography for craniofacial phenotypic analysis in children with velocardiofacial syndrome</article-title>. <source/>J. Craniofac. Surg.
<volume>20</volume>, <fpage>2013</fpage>–<lpage>2019</lpage>. <pub-id pub-id-type="doi">10.1097/SCS.0b013e3181bd2e34</pub-id><pub-id pub-id-type="pmid">19881378</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>Q.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>A cherubism with aneurysmal bone cyst</article-title>. <source/>Am. J. Neuroradiol.
<volume>30</volume>:<fpage>E98</fpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A1626</pub-id><pub-id pub-id-type="pmid">19386735</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessels</surname><given-names>M. W.</given-names></name><name><surname>Brooks</surname><given-names>A. S.</given-names></name><name><surname>Hoogeboom</surname><given-names>J.</given-names></name><name><surname>Niermeijer</surname><given-names>M. F.</given-names></name><name><surname>Willems</surname><given-names>P. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Kabuki syndrome: a review study of three hundred patients</article-title>. <source/>Clin. Dysmorphol.
<volume>11</volume>, <fpage>95</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1097/00019605-200204000-00004</pub-id><pub-id pub-id-type="pmid">12002156</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>G. N.</given-names></name><name><surname>Oliver</surname><given-names>W. J.</given-names></name></person-group> (<year>1988</year>). <article-title>Further delineation of the G syndrome: a manageable genetic cause of infantile dysphagia</article-title>. <source/>J. Med. Genet.
<volume>25</volume>, <fpage>157</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.25.3.157</pub-id><pub-id pub-id-type="pmid">3351901</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Zheng</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Characteristic face: a key indicator for direct diagnosis of 22q11.2 deletions in Chinese velocardiofacial syndrome patients</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e54404</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0054404</pub-id><pub-id pub-id-type="pmid">23342150</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H. C.</given-names></name><name><surname>Shyur</surname><given-names>S. D.</given-names></name><name><surname>Huang</surname><given-names>L. H.</given-names></name><name><surname>Chang</surname><given-names>Y. C.</given-names></name><name><surname>Wen</surname><given-names>D. C.</given-names></name><name><surname>Liang</surname><given-names>P. H.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>DiGeorge syndrome associated with solitary median maxillary central incisor</article-title>. <source/>Asian Pac. J. Allergy Immunol.
<volume>23</volume>, <fpage>159</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="pmid">16252847</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Matsuda</surname><given-names>K.</given-names></name><name><surname>Bialek</surname><given-names>P.</given-names></name><name><surname>Jacquot</surname><given-names>S.</given-names></name><name><surname>Masuoka</surname><given-names>H. C.</given-names></name><name><surname>Schinke</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome</article-title>. <source/>Cell
<volume>117</volume>, <fpage>387</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(04)00344-7</pub-id><pub-id pub-id-type="pmid">15109498</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>X. Q.</given-names></name><name><surname>Jin</surname><given-names>H. X.</given-names></name><name><surname>Shi</surname><given-names>L. S.</given-names></name><name><surname>Fan</surname><given-names>M. W.</given-names></name><name><surname>Song</surname><given-names>G. T.</given-names></name><name><surname>Fan</surname><given-names>H. L.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Identification of novel mutations of IRF6 gene in Chinese families with Van der Woude syndrome</article-title>. <source/>Int. J. Mol. Med.
<volume>16</volume>, <fpage>851</fpage>–<lpage>856</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.16.5.851</pub-id><pub-id pub-id-type="pmid">16211254</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>J. K.</given-names></name><name><surname>Ahn</surname><given-names>K. J.</given-names></name><name><surname>Kwon</surname><given-names>B. S.</given-names></name><name><surname>Kim</surname><given-names>G. B.</given-names></name><name><surname>Bae</surname><given-names>E. J.</given-names></name><name><surname>Noh</surname><given-names>C. I.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The strong association of left-side heart anomalies with Kabuki syndrome</article-title>. <source/>Korean J. Pediatr.
<volume>58</volume>, <fpage>256</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.3345/kjp.2015.58.7.256</pub-id><pub-id pub-id-type="pmid">26300940</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Alappat</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Shox2-deficient mice exhibit a rare type of incomplete clefting of the secondary palate</article-title>. <source/>Development
<volume>132</volume>, <fpage>4397</fpage>–<lpage>4406</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02013</pub-id><pub-id pub-id-type="pmid">16141225</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Congenital heart defects in Kabuki syndrome</article-title>. <source/>Cardiol. J.
<volume>20</volume>, <fpage>121</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.5603/CJ.2013.0023</pub-id><pub-id pub-id-type="pmid">23558868</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarnegar</surname><given-names>B. J.</given-names></name><name><surname>Webster</surname><given-names>D. E.</given-names></name><name><surname>Lopez-Pajares</surname><given-names>V.</given-names></name><name><surname>Vander Stoep Hunt</surname><given-names>B.</given-names></name><name><surname>Qu</surname><given-names>K.</given-names></name><name><surname>Yan</surname><given-names>K. J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63</article-title>. <source/>Am. J. Hum. Genet.
<volume>91</volume>, <fpage>435</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.07.007</pub-id><pub-id pub-id-type="pmid">22922031</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zenaty</surname><given-names>D.</given-names></name><name><surname>Bretones</surname><given-names>P.</given-names></name><name><surname>Lambe</surname><given-names>C.</given-names></name><name><surname>Guemas</surname><given-names>I.</given-names></name><name><surname>David</surname><given-names>M.</given-names></name><name><surname>Leger</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1)</article-title>. <source/>Mol. Cell. Endocrinol.
<fpage>254</fpage>–<lpage>255</lpage>, 78–83. <pub-id pub-id-type="doi">10.1016/j.mce.2006.04.006</pub-id><pub-id pub-id-type="pmid">16757108</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y. B.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Gu</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>10605</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms10605</pub-id><pub-id pub-id-type="pmid">26853712</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zielinski</surname><given-names>D.</given-names></name><name><surname>Markus</surname><given-names>B.</given-names></name><name><surname>Sheikh</surname><given-names>M.</given-names></name><name><surname>Gymrek</surname><given-names>M.</given-names></name><name><surname>Chu</surname><given-names>C.</given-names></name><name><surname>Zaks</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>OTX2 duplication is implicated in hemifacial microsomia</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e96788</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0096788</pub-id><pub-id pub-id-type="pmid">24816892</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuker</surname><given-names>R. M.</given-names></name><name><surname>Goldberg</surname><given-names>C. S.</given-names></name><name><surname>Manktelow</surname><given-names>R. T.</given-names></name></person-group> (<year>2000</year>). <article-title>Facial animation in children with Mobius syndrome after segmental gracilis muscle transplant</article-title>. <source/>Plast. Reconstr. Surg.
<volume>106</volume>, <fpage>1</fpage>–<lpage>8</lpage>. discussion: 9. <pub-id pub-id-type="doi">10.1097/00006534-200007000-00001</pub-id><pub-id pub-id-type="pmid">10883605</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>